0000910406 false FY http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2025#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://haincelestial.com/20250630#AccruedExpensesAndOtherCurrentLiabilities http://haincelestial.com/20250630#AccruedExpensesAndOtherCurrentLiabilities http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2025#LongTermDebtAndCapitalLeaseObligations http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment.3333.3333.3333 http://fasb.org/us-gaap/2025#OtherNonoperatingIncomeExpense 0 0 0 0 http://fasb.org/us-gaap/2025#CostOfGoodsAndServicesSold http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#PropertyPlantAndEquipmentRemovalOfMachineryExpense http://fasb.org/us-gaap/2025#CostOfGoodsAndServicesSold http://haincelestial.com/20250630#IntangiblesAndLongLivedAssetImpairment http://haincelestial.com/20250630#PropertyPlantAndEquipmentRemovalOfMachineryExpense http://haincelestial.com/20250630#PresidentAndChiefExecutiveOfficerMember 0000910406 hain:LongTermIncentivePlan20232025Member hain:AbsoluteTSRPerformanceSharesMember hain:PresidentAndChiefExecutiveOfficerMember 2023-01-01 2023-01-01 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember hain:ForeignCurrencyForwardContractsMember hain:AccruedExpensesAndOtherCurrentLiabilitiesMember 2025-06-30 0000910406 hain:ImagineMember 2024-07-01 2025-06-30 0000910406 us-gaap:ForeignExchangeForwardMember 2024-07-01 2025-06-30 0000910406 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0000910406 hain:MealPreparationMember 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2024-06-30 0000910406 hain:ImagineMember 2023-04-01 2023-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember hain:TermLoanMember 2025-06-30 0000910406 hain:ImagineAndQueenHeleneMember hain:NorthAmericaSegmentMember 2024-06-30 0000910406 us-gaap:FairValueInputsLevel3Member 2024-06-30 0000910406 country:US 2024-07-01 2025-06-30 0000910406 us-gaap:CurrencySwapMember us-gaap:FairValueHedgingMember 2025-06-30 0000910406 hain:UKReportingUnitMember 2025-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000910406 us-gaap:ContractTerminationMember 2024-07-01 2025-06-30 0000910406 hain:NorthAmericaSegmentMember 2024-07-01 2025-06-30 0000910406 hain:PersonalCareMember hain:NorthAmericaSegmentMember 2024-10-01 2024-12-31 0000910406 hain:PersonalCareMember hain:NorthAmericaSegmentMember 2024-07-01 2025-06-30 0000910406 srt:MinimumMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2025-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-06-30 0000910406 hain:OtherMember 2024-07-01 2025-06-30 0000910406 hain:PersonalCareBusinessMember hain:CanadaReportingUnitMember 2025-03-31 0000910406 2024-12-31 0000910406 hain:NorthAmericaSegmentMember 2024-10-01 2024-12-31 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:CurrencySwapMember 2025-06-30 0000910406 hain:THWRPurchaseAccountingMember 2022-07-01 2023-06-30 0000910406 hain:ParmCrispsMember 2023-07-01 2024-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20222024Member srt:MaximumMember 2023-07-01 2024-06-30 0000910406 hain:InternationalSegmentMember 2023-07-01 2024-06-30 0000910406 hain:SecondAmendmentBetweenUntilThirdAmendmentMember hain:TermSecuredOvernightFinancingRateSofrMember 2025-05-05 2025-05-05 0000910406 hain:ReductionsToValuationAllowanceMember 2023-07-01 2024-06-30 0000910406 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2025-06-30 0000910406 hain:CanadaReportingUnitMember 2025-04-01 0000910406 hain:RSUsAndPSUsMember 2022-06-30 0000910406 hain:SnacksMember 2022-07-01 2023-06-30 0000910406 hain:ThinstersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2023-07-01 2024-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:AbsoluteTSRPerformanceSharesMember 2023-07-01 2024-06-30 0000910406 country:US 2024-06-30 0000910406 us-gaap:ContractTerminationMember 2025-06-30 0000910406 country:US 2023-07-01 2024-06-30 0000910406 srt:MaximumMember 2025-06-30 0000910406 us-gaap:LeaseholdImprovementsMember 2024-06-30 0000910406 hain:AbsoluteTSRPerformanceSharesMember hain:LongTermIncentivePlan20222024Member 2021-07-01 2022-06-30 0000910406 hain:PersonalCareMember 2022-07-01 2023-06-30 0000910406 hain:PersonalCareMember 2023-07-01 2024-06-30 0000910406 us-gaap:ContractTerminationMember 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2025-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-07-01 2024-06-30 0000910406 us-gaap:CurrencySwapMember 2022-07-01 2023-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2023-06-30 0000910406 us-gaap:ForeignCountryMember 2025-06-30 0000910406 hain:ReductionsToValuationAllowanceMember 2024-07-01 2025-06-30 0000910406 hain:WesternEuropeMember 2025-06-30 0000910406 us-gaap:AllowanceForCreditLossMember 2022-06-30 0000910406 2024-06-30 0000910406 us-gaap:OtherRestructuringMember 2023-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2025-06-30 0000910406 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-01-01 2023-01-01 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:CurrencySwapMember us-gaap:ShortMember 2025-06-30 0000910406 us-gaap:NonUsMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2021-12-22 0000910406 hain:ImagineMember 2022-07-01 2023-06-30 0000910406 us-gaap:EmployeeSeveranceMember 2024-06-30 0000910406 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-01-01 2023-01-01 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember country:US 2025-05-05 0000910406 hain:TradeReceivableMember us-gaap:CustomerConcentrationRiskMember hain:CustomerOneMember 2023-07-01 2024-06-30 0000910406 hain:SecondAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember srt:MinimumMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-06-30 0000910406 us-gaap:OtherRestructuringMember 2024-06-30 0000910406 us-gaap:OtherIntangibleAssetsMember hain:ParmCrispsMember 2024-07-01 2025-06-30 0000910406 hain:QueenHeleneMember 2023-07-01 2024-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:InternationalSegmentMember 2022-07-01 2023-06-30 0000910406 hain:CashSettledAwardsMember 2025-06-30 0000910406 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember hain:CustomerOneMember 2023-07-01 2024-06-30 0000910406 hain:WesternEuropeMember 2022-07-01 2023-06-30 0000910406 us-gaap:LeaseholdImprovementsMember 2025-06-30 0000910406 hain:PlantClosureRelatedCostsNetMember 2024-07-01 2025-06-30 0000910406 hain:RSUsAndPSUsMember 2025-06-30 0000910406 us-gaap:CurrencySwapMember 2024-07-01 2025-06-30 0000910406 hain:AssetWriteDownsMember 2023-06-30 0000910406 hain:WesternEuropeMember 2024-07-01 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:NonUsMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-05-05 0000910406 hain:OtherMember 2022-07-01 2023-06-30 0000910406 country:GB 2025-06-30 0000910406 hain:InternationalSegmentMember 2024-07-01 2025-06-30 0000910406 us-gaap:LineOfCreditMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2024-07-01 2025-06-30 0000910406 us-gaap:CustomerRelationshipsMember hain:ParmCrispsMember 2022-07-01 2023-06-30 0000910406 us-gaap:InterestRateSwapMember 2022-07-01 2023-06-30 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:ShortMember us-gaap:ForeignExchangeForwardMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2024-06-30 0000910406 us-gaap:BaseRateMember srt:ScenarioForecastMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-16 2026-06-30 0000910406 us-gaap:CommonStockMember 2023-06-30 0000910406 country:US 2025-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2024-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember hain:TermLoanMember 2024-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:NorthAmericaSegmentMember 2022-07-01 2023-06-30 0000910406 hain:AdditionsToValuationAllowanceMember 2024-07-01 2025-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2022-06-30 0000910406 hain:ProductivityAndTransformationCostsInitiativeMember 2023-07-01 2024-06-30 0000910406 hain:CashSettledAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2024-06-30 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2021-12-22 0000910406 us-gaap:AllowanceForCreditLossMember 2024-07-01 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:RelativeTSRPerformanceSharesMember 2023-07-01 2024-06-30 0000910406 us-gaap:RestrictedStockUnitsRSUMember hain:PresidentAndChiefExecutiveOfficerMember 2024-07-01 2025-06-30 0000910406 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2025-06-30 0000910406 us-gaap:DomesticCountryMember 2025-06-30 0000910406 us-gaap:TrademarksAndTradeNamesMember 2024-06-30 0000910406 hain:RSUsAndPSUsMember 2024-06-30 0000910406 us-gaap:RetainedEarningsMember 2022-06-30 0000910406 us-gaap:AllowanceForCreditLossMember 2023-07-01 2024-06-30 0000910406 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember hain:CustomerOneMember 2024-07-01 2025-06-30 0000910406 hain:PlantClosureRelatedCostsNetMember 2023-07-01 2024-06-30 0000910406 us-gaap:LineOfCreditMember srt:MaximumMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:InternationalSegmentMember 2024-07-01 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20242026Member 2023-07-01 2024-06-30 0000910406 us-gaap:CommonStockMember 2024-07-01 2025-06-30 0000910406 hain:HealthValleyMember 2023-07-01 2024-06-30 0000910406 hain:OtherMember 2023-07-01 2024-06-30 0000910406 hain:CanadaReportingUnitMember 2025-01-01 2025-03-31 0000910406 hain:AbsoluteTSRPerformanceSharesMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2024-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember hain:AccumulatedNetGainLossFromFairValueHedgesAttributableToParentMember us-gaap:FairValueHedgingMember 2022-07-01 2023-06-30 0000910406 us-gaap:SecuredDebtMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-01 2025-06-30 0000910406 hain:CanadaReportingUnitMember 2025-04-01 2025-06-30 0000910406 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2023-06-30 0000910406 us-gaap:LineOfCreditMember srt:ScenarioForecastMember srt:MaximumMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-30 0000910406 hain:LongTermIncentivePlan20232025Member srt:MinimumMember 2023-07-01 2024-06-30 0000910406 us-gaap:RestrictedStockUnitsRSUMember hain:LongTermIncentivePlan20232025Member hain:PresidentAndChiefExecutiveOfficerMember 2023-01-01 2023-01-01 0000910406 country:CA 2022-07-01 2023-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20222024Member 2021-07-01 2022-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000910406 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2025-06-30 0000910406 hain:ThinstersMember hain:NorthAmericaSegmentMember 2024-01-01 2024-03-31 0000910406 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2024-06-30 0000910406 hain:RSUsAndPSUsMember 2023-06-30 0000910406 us-gaap:LineOfCreditMember srt:MinimumMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 hain:NorthAmericaSegmentMember 2024-06-30 0000910406 country:CA 2024-07-01 2025-06-30 0000910406 hain:SnacksMember 2024-07-01 2025-06-30 0000910406 hain:USReportingUnitMember 2024-10-01 2024-12-31 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember hain:AccruedExpensesAndOtherCurrentLiabilitiesMember 2024-06-30 0000910406 hain:USReportingUnitMember 2023-07-01 2024-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2022-07-01 2023-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2025-06-30 0000910406 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-01-01 2023-01-01 0000910406 2025-04-01 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0000910406 country:US 2022-07-01 2023-06-30 0000910406 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2025-06-30 0000910406 hain:USReportingUnitMember 2024-07-01 2024-09-30 0000910406 hain:MealPreparationMember 2022-07-01 2023-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2023-06-30 0000910406 hain:CanadaReportingUnitMember 2024-06-30 0000910406 us-gaap:RetainedEarningsMember 2025-06-30 0000910406 hain:HealthValleyMember 2022-07-01 2023-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2022-07-01 2023-06-30 0000910406 hain:QueenHeleneMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2024-06-03 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2025-06-30 0000910406 hain:UKReportingUnitMember 2024-06-30 0000910406 2023-06-30 0000910406 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember srt:MaximumMember 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2025-06-30 0000910406 hain:BeveragesMember 2023-07-01 2024-06-30 0000910406 hain:HappyAndJoyaMember 2024-04-01 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2025-06-30 0000910406 hain:TradeReceivableMember us-gaap:CustomerConcentrationRiskMember hain:CustomerOneMember 2022-07-01 2023-06-30 0000910406 us-gaap:ForeignExchangeForwardMember 2022-07-01 2023-06-30 0000910406 country:GB 2024-06-30 0000910406 us-gaap:FairValueInputsLevel1Member 2024-06-30 0000910406 hain:ParmCrispsMember 2022-07-01 2023-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2023-06-30 0000910406 hain:ThinstersMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2024-04-08 0000910406 us-gaap:LongMember us-gaap:CurrencySwapMember us-gaap:FairValueHedgingMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20242026Member 2025-06-30 0000910406 us-gaap:SecuredDebtMember hain:FirstAmendmentAndRestatedCreditAgreementMember 2023-09-30 0000910406 hain:NorthAmericaSegmentMember 2023-07-01 2024-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2024-06-30 0000910406 us-gaap:OperatingSegmentsMember 2024-07-01 2025-06-30 0000910406 us-gaap:EmployeeSeveranceMember 2023-07-01 2024-06-30 0000910406 us-gaap:OtherRestructuringMember 2023-07-01 2024-06-30 0000910406 hain:HappyAndJoyaMember 2022-07-01 2023-06-30 0000910406 hain:USReportingUnitMember 2025-01-01 2025-03-31 0000910406 hain:ImagineMember 2023-07-01 2024-06-30 0000910406 us-gaap:NetInvestmentHedgingMember hain:CrossCurrencySwapMember 2024-07-01 2025-06-30 0000910406 us-gaap:OperatingSegmentsMember 2023-07-01 2024-06-30 0000910406 hain:ProductivityAndTransformationCostsInitiativeMember 2024-07-01 2025-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2023-07-01 2024-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2023-06-30 0000910406 country:GB 2023-07-01 2024-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-06-30 0000910406 srt:ScenarioForecastMember us-gaap:CashFlowHedgingMember hain:CrossCurrencySwapMember 2025-07-01 2026-06-30 0000910406 us-gaap:ContractTerminationMember 2023-06-30 0000910406 hain:AbsoluteTSRPerformanceSharesMember hain:SubjectToAchievementMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 country:GB 2024-07-01 2025-06-30 0000910406 hain:CrossCurrencySwapMember us-gaap:FairValueHedgingMember 2025-04-01 2025-06-30 0000910406 us-gaap:FurnitureAndFixturesMember 2024-06-30 0000910406 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember hain:WestbraeNaturalMember 2022-07-01 2023-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:InternationalSegmentMember 2023-07-01 2024-06-30 0000910406 hain:CashSettledAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2023-06-30 0000910406 hain:MakeWholeRestrictedStockAwardMember hain:PresidentAndChiefExecutiveOfficerMember 2023-01-01 2023-01-01 0000910406 us-gaap:OtherRestructuringMember 2025-06-30 0000910406 us-gaap:FairValueInputsLevel2Member 2025-06-30 0000910406 hain:SnacksMember 2023-07-01 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2025-06-30 0000910406 hain:HappyAndJoyaMember hain:InternationalSegmentMember 2024-06-30 0000910406 hain:BabyKidsMember 2022-07-01 2023-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember hain:AccumulatedNetGainLossFromFairValueHedgesAttributableToParentMember us-gaap:FairValueHedgingMember 2023-07-01 2024-06-30 0000910406 country:GB 2022-07-01 2023-06-30 0000910406 hain:PlantClosureRelatedCostsNetMember 2022-07-01 2023-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember hain:AccruedExpensesAndOtherCurrentLiabilitiesMember 2025-06-30 0000910406 hain:THWRPurchaseAccountingMember 2024-07-01 2025-06-30 0000910406 us-gaap:MachineryAndEquipmentMember 2025-06-30 0000910406 us-gaap:ConstructionInProgressMember 2024-06-30 0000910406 hain:ParmCrispsMember hain:NorthAmericaSegmentMember 2024-01-01 2024-03-31 0000910406 2025-06-30 0000910406 hain:HealthValleyMember 2024-07-01 2025-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:NorthAmericaSegmentMember 2024-07-01 2025-06-30 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-15 0000910406 hain:ParmCrispsMember us-gaap:CustomerRelationshipsMember 2022-07-01 2023-06-30 0000910406 hain:CashBasedPerformanceSharesMember hain:LongTermIncentivePlan20222024Member srt:MaximumMember 2024-07-01 2025-06-30 0000910406 us-gaap:ForeignPlanMember 2024-07-01 2025-06-30 0000910406 us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2024-06-30 0000910406 us-gaap:LoansReceivableMember us-gaap:FairValueHedgingMember 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:SubjectToAchievementMember hain:RelativeTSRPerformanceSharesMember 2023-07-01 2024-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-07-01 2024-06-30 0000910406 hain:QueenHeleneMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2023-07-01 2024-06-30 0000910406 srt:ScenarioForecastMember hain:CrossCurrencySwapMember us-gaap:FairValueHedgingMember 2025-07-01 2026-06-30 0000910406 hain:BabyKidsMember 2024-07-01 2025-06-30 0000910406 2022-06-30 0000910406 hain:JoyaMember 2023-04-01 2023-06-30 0000910406 hain:SensiblePortionsMember 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2024-06-30 0000910406 us-gaap:InterestRateSwapMember 2024-07-01 2025-06-30 0000910406 us-gaap:OtherRestructuringMember 2024-07-01 2025-06-30 0000910406 hain:NorthAmericaSegmentMember 2023-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2025-06-30 0000910406 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2023-06-30 0000910406 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2024-06-30 0000910406 hain:SensiblePortionsMember 2023-07-01 2024-06-30 0000910406 srt:MinimumMember srt:ScenarioForecastMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-07-01 2025-09-30 0000910406 hain:QueenHeleneMember 2024-07-01 2025-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2024-06-30 0000910406 us-gaap:BaseRateMember hain:SecondAmendmentBetweenUntilThirdAmendmentMember 2023-08-23 2025-05-05 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember hain:FirstAmendmentAndRestatedCreditAgreementMember 2023-09-30 0000910406 hain:CEOSuccessionMember 2024-07-01 2025-06-30 0000910406 hain:AbsoluteTSRPerformanceSharesMember hain:SubjectToAchievementMember hain:LongTermIncentivePlan20222024Member 2023-07-01 2024-06-30 0000910406 us-gaap:LetterOfCreditMember hain:FourthAmendedAndRestatedCreditAgreementMember 2025-06-30 0000910406 us-gaap:EmployeeSeveranceMember 2024-07-01 2025-06-30 0000910406 2022-01-31 0000910406 hain:USReportingUnitMember 2025-04-01 2025-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000910406 us-gaap:FairValueInputsLevel1Member 2025-06-30 0000910406 us-gaap:DomesticCountryMember 2024-06-30 0000910406 hain:BabyKidsMember 2023-07-01 2024-06-30 0000910406 us-gaap:ContractTerminationMember 2023-07-01 2024-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000910406 us-gaap:EmployeeSeveranceMember 2023-06-30 0000910406 hain:ParmCrispsMember 2024-07-01 2025-06-30 0000910406 hain:WarehouseManufacturingConsolidationAndOtherCostsNetMember 2022-07-01 2023-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember hain:AccumulatedNetGainLossFromFairValueHedgesAttributableToParentMember us-gaap:FairValueHedgingMember 2024-07-01 2025-06-30 0000910406 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2024-06-30 0000910406 us-gaap:RetainedEarningsMember 2023-06-30 0000910406 hain:FirstAmendmentAndRestatedCreditAgreementMember 2023-09-30 0000910406 2024-07-01 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-05-05 0000910406 us-gaap:RetainedEarningsMember 2022-07-01 2023-06-30 0000910406 hain:SecondAmendmentBetweenUntilThirdAmendmentMember us-gaap:SecuredOvernightFinancingRateSofrMember 2023-08-23 2025-05-05 0000910406 us-gaap:CorporateNonSegmentMember 2022-07-01 2023-06-30 0000910406 us-gaap:InterestRateSwapMember srt:ScenarioForecastMember 2025-07-01 2026-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2023-07-01 2024-06-30 0000910406 us-gaap:LineOfCreditMember hain:FourthAmendedAndRestatedCreditAgreementMember 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2024-06-30 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember 2023-07-01 2024-06-30 0000910406 us-gaap:LandMember 2024-06-30 0000910406 hain:WarehouseManufacturingConsolidationAndOtherCostsNetMember 2023-07-01 2024-06-30 0000910406 us-gaap:FairValueInputsLevel2Member 2024-06-30 0000910406 hain:TranslationAdjustmentsToValuationAllowanceMember 2023-07-01 2024-06-30 0000910406 country:US 2024-07-01 2025-06-30 0000910406 hain:BelvedereMember us-gaap:CustomerRelationshipsMember 2024-07-01 2025-06-30 0000910406 us-gaap:OperatingSegmentsMember 2022-07-01 2023-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0000910406 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember hain:ParmCrispsMember 2024-07-01 2025-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2024-07-01 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember srt:ScenarioForecastMember srt:MaximumMember 2026-03-31 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2022-07-01 2023-06-30 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember 2024-07-01 2025-06-30 0000910406 hain:UKReportingUnitMember 2025-04-01 2025-06-30 0000910406 us-gaap:InterestRateSwapMember 2023-07-01 2024-06-30 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember country:US hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-15 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2023-06-30 0000910406 us-gaap:CurrencySwapMember us-gaap:ShortMember us-gaap:FairValueHedgingMember 2025-06-30 0000910406 hain:LongTermIncentivePlan20222024Member hain:RelativeTSRPerformanceSharesMember 2022-07-01 2023-06-30 0000910406 hain:JoyaMember 2024-06-30 0000910406 hain:PersonalCareMember hain:NorthAmericaSegmentMember 2024-01-01 2024-03-31 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-06-30 0000910406 hain:ProductivityAndTransformationCostsInitiativeMember 2022-07-01 2023-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2023-06-30 0000910406 us-gaap:CurrencySwapMember 2023-07-01 2024-06-30 0000910406 hain:USReportingUnitMember 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:AbsoluteTSRPerformanceSharesMember hain:SubjectToAchievementMember 2023-07-01 2024-06-30 0000910406 hain:PersonalCareMember hain:NorthAmericaSegmentMember 2024-03-31 0000910406 hain:AssetWriteDownsMember 2024-06-30 0000910406 us-gaap:PerformanceSharesMember srt:MinimumMember hain:LongTermIncentivePlan20222024Member 2023-07-01 2024-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2023-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2024-06-30 0000910406 us-gaap:TrademarksAndTradeNamesMember 2025-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-07-01 2025-06-30 0000910406 us-gaap:LoansReceivableMember us-gaap:FairValueHedgingMember 2024-06-30 0000910406 hain:WarehouseManufacturingConsolidationAndOtherCostsNetMember 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-06-30 0000910406 hain:FourthAmendmentAndRestatedCreditAgreementMember 2021-12-22 0000910406 us-gaap:CustomerRelationshipsMember hain:BelvedereMember hain:NorthAmericaSegmentMember 2024-10-01 2024-12-31 0000910406 us-gaap:RetainedEarningsMember 2024-07-01 2025-06-30 0000910406 hain:ParmCrispsMember hain:NorthAmericaSegmentMember 2024-03-31 0000910406 hain:AssetWriteDownsMember 2023-07-01 2024-06-30 0000910406 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember hain:WestbraeNaturalMember 2022-12-15 0000910406 hain:FoundersTableMember 2025-05-22 2025-05-22 0000910406 hain:RSUsAndPSUsMember 2023-07-01 2024-06-30 0000910406 hain:AssetWriteDownsMember 2024-07-01 2025-06-30 0000910406 us-gaap:ForeignCountryMember 2024-06-30 0000910406 srt:ScenarioForecastMember us-gaap:SecuredOvernightFinancingRateSofrMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-16 2026-06-30 0000910406 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember us-gaap:OtherOperatingIncomeExpenseMember hain:ParmCrispsMember 2024-07-01 2025-06-30 0000910406 hain:BeveragesMember 2024-07-01 2025-06-30 0000910406 hain:InternationalSegmentMember 2024-06-30 0000910406 us-gaap:LineOfCreditMember hain:SecondAmendmentAndRestatedCreditAgreementMember srt:MaximumMember 2023-12-31 0000910406 hain:SpectrumMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember hain:AccruedExpensesAndOtherCurrentLiabilitiesMember 2024-06-30 0000910406 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember hain:ParmCrispsMember 2024-08-30 0000910406 us-gaap:ForeignPlanMember 2023-07-01 2024-06-30 0000910406 us-gaap:LandMember 2025-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember hain:AccruedExpensesAndOtherCurrentLiabilitiesMember 2025-06-30 0000910406 hain:BeveragesMember 2022-07-01 2023-06-30 0000910406 us-gaap:OtherIntangibleAssetsMember hain:ParmCrispsMember 2023-07-01 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CurrencySwapMember 2025-06-30 0000910406 us-gaap:CustomerRelationshipsMember hain:ParmCrispsMember 2023-07-01 2024-06-30 0000910406 us-gaap:CommonStockMember 2025-06-30 0000910406 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20252027Member 2024-07-01 2025-06-30 0000910406 us-gaap:LongMember us-gaap:NetInvestmentHedgingMember us-gaap:ForeignExchangeForwardMember 2025-06-30 0000910406 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember hain:CustomerOneMember 2022-07-01 2023-06-30 0000910406 hain:ParmCrispsMember us-gaap:CustomerRelationshipsMember 2024-07-01 2025-06-30 0000910406 hain:PersonalCareBusinessMember hain:USReportingUnitMember 2025-03-31 0000910406 us-gaap:NonUsMember us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-15 0000910406 us-gaap:AllowanceForCreditLossMember 2022-07-01 2023-06-30 0000910406 us-gaap:ManufacturingFacilityMember 2023-07-01 2024-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:BaseRateMember 2025-05-05 2025-05-05 0000910406 hain:CanadaReportingUnitMember 2024-07-01 2025-06-30 0000910406 hain:BelvedereMember us-gaap:CustomerRelationshipsMember 2023-07-01 2024-06-30 0000910406 hain:SensiblePortionsImagineAndSpectrumMember 2025-04-01 2025-06-30 0000910406 hain:MakeWholeRestrictedStockAwardMember hain:PresidentAndChiefExecutiveOfficerMember 2025-05-06 2025-05-06 0000910406 hain:CEOSuccessionMember 2022-07-01 2023-06-30 0000910406 hain:THWRPurchaseAccountingMember 2023-07-01 2024-06-30 0000910406 us-gaap:BuildingAndBuildingImprovementsMember 2024-06-30 0000910406 us-gaap:OperatingSegmentsMember hain:NorthAmericaSegmentMember 2023-07-01 2024-06-30 0000910406 hain:QueenHeleneMember 2022-07-01 2023-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20252027Member srt:MaximumMember 2024-07-01 2025-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2025-06-30 0000910406 hain:HappyAndJoyaMember 2024-07-01 2025-06-30 0000910406 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2025-06-30 0000910406 srt:MinimumMember 2025-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000910406 hain:RelativeTSRPerformanceSharesMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 hain:CashBasedPerformanceSharesMember srt:MinimumMember hain:LongTermIncentivePlan20222024Member 2024-07-01 2025-06-30 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2024-07-01 2025-06-30 0000910406 hain:SubjectToAchievementMember hain:LongTermIncentivePlan20222024Member hain:RelativeTSRPerformanceSharesMember 2023-07-01 2024-06-30 0000910406 us-gaap:FurnitureAndFixturesMember 2025-06-30 0000910406 hain:ThinstersMember us-gaap:CustomerRelationshipsMember 2023-07-01 2024-06-30 0000910406 hain:USReportingUnitMember 2024-06-30 0000910406 us-gaap:AllowanceForCreditLossMember 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:RelativeTSRPerformanceSharesMember hain:PresidentAndChiefExecutiveOfficerMember 2023-01-01 2023-01-01 0000910406 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2023-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20232025Member 2022-07-01 2023-06-30 0000910406 hain:TranslationAdjustmentsToValuationAllowanceMember 2024-07-01 2025-06-30 0000910406 srt:NorthAmericaMember 2023-07-01 2024-06-30 0000910406 hain:InternationalSegmentMember 2023-07-01 2024-06-30 0000910406 hain:AbsoluteTSRPerformanceSharesMember hain:LongTermIncentivePlan20222024Member 2023-07-01 2024-06-30 0000910406 us-gaap:LineOfCreditMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2025-06-30 0000910406 hain:NorthAmericaSegmentMember 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:RelativeTSRPerformanceSharesMember hain:PresidentAndChiefExecutiveOfficerMember 2024-07-01 2025-06-30 0000910406 us-gaap:LineOfCreditMember srt:MinimumMember srt:ScenarioForecastMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-09-30 0000910406 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember country:US hain:FourthAmendmentAndRestatedCreditAgreementMember 2021-12-22 0000910406 us-gaap:CommonStockMember 2022-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20232025Member 2024-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember srt:ScenarioForecastMember srt:MaximumMember 2026-09-30 0000910406 country:CA 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2024-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2022-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember us-gaap:OtherNoncurrentLiabilitiesMember 2025-06-30 0000910406 hain:InternationalSegmentMember 2024-07-01 2025-06-30 0000910406 hain:WesternEuropeMember 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember hain:ForeignCurrencyForwardContractsMember 2025-06-30 0000910406 hain:ImagineMember 2025-06-30 0000910406 country:CA 2023-07-01 2024-06-30 0000910406 us-gaap:SecuredDebtMember hain:FirstAmendmentAndRestatedCreditAgreementMember 2025-05-31 0000910406 hain:SensiblePortionsMember 2025-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000910406 us-gaap:CommonStockMember 2024-06-30 0000910406 us-gaap:CorporateNonSegmentMember 2023-07-01 2024-06-30 0000910406 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember srt:MinimumMember hain:LongTermIncentivePlan20252027Member 2024-07-01 2025-06-30 0000910406 us-gaap:PerformanceSharesMember srt:MaximumMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 hain:ThinstersMember 2022-07-01 2023-06-30 0000910406 hain:InternationalSegmentMember 2025-06-30 0000910406 2025-09-09 0000910406 us-gaap:ConstructionInProgressMember 2025-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2025-06-30 0000910406 us-gaap:ForeignPlanMember 2022-07-01 2023-06-30 0000910406 us-gaap:SecuredDebtMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2021-12-22 0000910406 hain:PersonalCareBusinessMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-07-01 2025-06-30 0000910406 hain:LongTermIncentivePlan20232025Member srt:MaximumMember 2023-07-01 2024-06-30 0000910406 hain:AssetWriteDownsMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20222024Member 2024-06-30 0000910406 hain:MealPreparationMember 2023-07-01 2024-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2023-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2023-06-30 0000910406 us-gaap:LongMember us-gaap:NetInvestmentHedgingMember us-gaap:CurrencySwapMember 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20252027Member 2025-06-30 0000910406 hain:HealthValleyMember hain:NorthAmericaSegmentMember 2025-01-01 2025-03-31 0000910406 country:US 2023-07-01 2024-06-30 0000910406 hain:UKReportingUnitMember 2024-07-01 2025-06-30 0000910406 us-gaap:AllowanceForCreditLossMember 2023-06-30 0000910406 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2025-06-30 0000910406 hain:LongTermIncentivePlan20252027Member hain:RelativeTSRPerformanceSharesMember 2023-07-01 2024-06-30 0000910406 us-gaap:ComputerEquipmentMember 2025-06-30 0000910406 us-gaap:LineOfCreditMember srt:MaximumMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2023-09-30 0000910406 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2025-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2024-07-01 2025-06-30 0000910406 us-gaap:CustomerRelationshipsMember hain:ParmCrispsMember 2023-07-01 2024-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2024-06-30 0000910406 us-gaap:RetainedEarningsMember 2023-07-01 2024-06-30 0000910406 country:CA 2025-06-30 0000910406 country:US 2022-07-01 2023-06-30 0000910406 us-gaap:MachineryAndEquipmentMember 2024-06-30 0000910406 us-gaap:LineOfCreditMember hain:SecondAmendmentAndRestatedCreditAgreementMember srt:MaximumMember 2024-12-31 0000910406 srt:MinimumMember srt:ScenarioForecastMember hain:FourthAmendmentAndRestatedCreditAgreementMember 2025-07-01 2025-12-31 0000910406 hain:AdditionsToValuationAllowanceMember 2023-07-01 2024-06-30 0000910406 hain:QueenHeleneMember 2023-04-01 2023-06-30 0000910406 srt:NorthAmericaMember 2024-07-01 2025-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20222024Member 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-05-05 2025-05-05 0000910406 us-gaap:TreasuryStockCommonMember 2024-06-30 0000910406 us-gaap:PerformanceSharesMember srt:MinimumMember hain:LongTermIncentivePlan20222024Member 2024-07-01 2025-06-30 0000910406 us-gaap:RetainedEarningsMember 2024-06-30 0000910406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2023-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:InterestExpenseMember us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember 2024-06-30 0000910406 2022-07-01 2023-06-30 0000910406 us-gaap:CommonStockMember 2022-07-01 2023-06-30 0000910406 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2025-06-30 0000910406 hain:InternationalSegmentMember 2023-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2024-07-01 2025-06-30 0000910406 hain:BellCaProductionFacilityMember hain:NorthAmericaSegmentMember 2023-07-01 2024-06-30 0000910406 hain:BarnesComplaintMember 2021-12-29 2021-12-29 0000910406 us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember 2023-07-01 2024-06-30 0000910406 us-gaap:PerformanceSharesMember hain:LongTermIncentivePlan20222024Member srt:MaximumMember 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2025-06-30 0000910406 hain:ThirdAmendmentAndRestatedCreditAgreementMember us-gaap:LineOfCreditMember srt:ScenarioForecastMember srt:MaximumMember 2026-06-30 0000910406 hain:CashSettledAwardsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2025-06-30 0000910406 hain:RSUsAndPSUsMember 2024-07-01 2025-06-30 0000910406 hain:CEOSuccessionMember 2023-07-01 2024-06-30 0000910406 hain:LongTermIncentivePlan20232025Member hain:AbsoluteTSRPerformanceSharesMember hain:PresidentAndChiefExecutiveOfficerMember 2024-07-01 2025-06-30 0000910406 hain:ThinstersMember us-gaap:CustomerRelationshipsMember 2022-07-01 2023-06-30 0000910406 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-07-01 2025-06-30 0000910406 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0000910406 hain:CashSettledAwardsMember 2025-04-01 2025-06-30 0000910406 2023-07-01 2024-06-30 0000910406 us-gaap:TreasuryStockCommonMember 2022-07-01 2023-06-30 0000910406 us-gaap:NetInvestmentHedgingMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CurrencySwapMember 2022-07-01 2023-06-30 0000910406 us-gaap:StockCompensationPlanMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2025-06-30 0000910406 us-gaap:ComputerEquipmentMember 2024-06-30 0000910406 us-gaap:LineOfCreditMember srt:MaximumMember hain:SecondAmendmentAndRestatedCreditAgreementMember 2025-03-31 0000910406 hain:ThinstersMember us-gaap:CustomerRelationshipsMember 2024-07-01 2025-06-30 0000910406 hain:PersonalCareBusinessMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2025-06-30 0000910406 hain:SensiblePortionsMember 2022-07-01 2023-06-30 0000910406 us-gaap:AllowanceForCreditLossMember 2024-06-30 0000910406 hain:BelvedereMember us-gaap:CustomerRelationshipsMember 2022-07-01 2023-06-30 0000910406 us-gaap:ForeignExchangeForwardMember 2023-07-01 2024-06-30 0000910406 hain:ExecutiveOfficerSuccessionMember 2023-07-01 2024-06-30 0000910406 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:CurrencySwapMember 2024-06-30 0000910406 us-gaap:EmployeeSeveranceMember 2025-06-30 0000910406 us-gaap:FairValueInputsLevel3Member 2025-06-30 0000910406 us-gaap:CorporateNonSegmentMember 2024-07-01 2025-06-30 0000910406 hain:SubjectToAchievementMember hain:RelativeTSRPerformanceSharesMember hain:LongTermIncentivePlan20242026Member 2024-07-01 2025-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2023-06-30 0000910406 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2024-06-30 0000910406 us-gaap:CommonStockMember 2023-07-01 2024-06-30 0000910406 hain:RSUsAndPSUsMember 2022-07-01 2023-06-30 0000910406 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2022-07-01 2023-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2024-06-30 0000910406 hain:WesternEuropeMember 2023-07-01 2024-06-30 0000910406 hain:AccumulatedGainLossFairValueHedgingInstrumentsMember 2022-06-30 0000910406 hain:PersonalCareMember 2024-07-01 2025-06-30 0000910406 hain:HappyAndJoyaMember 2023-07-01 2024-06-30 0000910406 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-07-01 2024-06-30 hain:Segment iso4217:EUR hain:Federalcase xbrli:pure hain:Country xbrli:shares hain:Case iso4217:GBP hain:Instrument iso4217:USD iso4217:USD xbrli:shares

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ | Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

For the fiscal year ended June 30, 2025

or

☐ | Transition Report pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

for the transition period from to .

Commission File No. 0-22818

THE HAIN CELESTIAL GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware |  | 22-3240619
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
221 River Street, Hoboken, NJ |  | 07030
(Address of principal executive offices) |  | (Zip Code)

(516) 587-5000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, par value $0.01 per share | HAIN | The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☐ |  | Accelerated filer | ☒
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐
Emerging growth company | ☐ |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant based upon the closing price of the registrant’s common stock, as quoted by The Nasdaq Stock Market LLC on December 31, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, was $552,228,088.

As of September 9, 2025, there were 90,292,752 s hares outstanding of the registrant’s Common Stock, par value $0.01 per share.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of The Hain Celestial Group, Inc. Definitive Proxy Statement for the 2025 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

Table of Contents

THE HAIN CELESTIAL GROUP, INC.

|  | Page
PART I |  |
Item 1. | Business | 4
Item 1A. | Risk Factors | 12
Item 1B. | Unresolved Staff Comments | 22
Item 1C. | Cybersecurity | 22
Item 2. | Properties | 25
Item 3. | Legal Proceedings | 25
Item 4. | Mine Safety Disclosures | 25
PART II |  |
Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 26
Item 6. | [Reserved] | 27
Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 28
Item 7A. | Quantitative and Qualitative Disclosures About Market Risk | 44
Item 8. | Financial Statements and Supplementary Data | 45
Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure | 92
Item 9A. | Controls and Procedures | 92
Item 9B. | Other Information | 96
Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 96
PART III |  |
Item 10. | Directors, Executive Officers and Corporate Governance | 97
Item 11. | Executive Compensation | 97
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 97
Item 13. | Certain Relationships and Related Transactions, and Director Independence | 97
Item 14. | Principal Accountant Fees and Services | 97
PART IV |  |
Item 15. | Exhibit and Financial Statement Schedules | 98
Item 16. | Form 10-K Summary | 100
Exhibit Index |  | 101
Signatures |  | 105

2

Table of Contents

Forward-Looking Statements

This Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the “Form 10-K”) contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of The Hain Celestial Group, Inc. (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things: our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives and business strategy, including statements related to our personal care business; our supply chain, including the impact of tariffs and the availability and pricing of raw materials; our brand portfolio; pricing actions and product performance; inflation rates; and current or future macroeconomic trends.

Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; changes to consumer preferences; our ability to execute our business strategy; our ability to manage our supply chain effectively; input cost inflation, including as a result of tariffs; reliance on independent contract manufacturers; disruption of operations at our manufacturing facilities; customer concentration; reliance on independent distributors; risks associated with operating internationally; risks associated with outsourcing arrangements; risks associated with geopolitical conflicts or events; our reliance on independent certification for a number of our products; our ability to attract and retain highly skilled people; risks related to tax matters; compliance with our credit agreement and our ability to refinance our indebtedness; foreign currency exchange risk; general economic conditions; impairments in the carrying value of goodwill or other intangible assets; the reputation of our company and our brands; our ability to use and protect trademarks; cybersecurity incidents; disruptions to information technology systems; pending and future litigation, including litigation relating to Earth’s Best® baby food products; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; our ability to manage our financial reporting and internal control systems and processes; compliance with data privacy laws; the adequacy of our insurance coverage; climate impacts; liabilities, claims or regulatory change with respect to environmental matters; and other risks and matters described in Part I, Item 1A, “Risk Factors” and elsewhere in this Form 10-K as well as in other reports that we file in the future.

We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.

3

Table of Contents

PA RT I

THE HAIN CELESTIAL GROUP, INC.

Item 1. Bu siness

Overview

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) was founded in 1993. Hain Celestial is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby/kids, beverages and meal preparation are marketed and sold in over 70 countries around the world.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley's® jelly, Earth’s Best® Organic and Ella’s Kitchen® baby and kid's foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, The Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, among others.

Our Strategy

We are focused on five actions to win in the marketplace and drive growth: aggressively streamlining our portfolio, accelerating brand renovation and innovation, implementing price increases along with broader revenue growth management, driving productivity and working capital efficiency, and enhancing our digital capabilities, inclusive of ecommerce.

During the fourth quarter of fiscal year 2025, we announced that our Board of Directors was conducting a comprehensive review of the Company’s portfolio with the assistance of our independent financial advisor. The Board is considering a broad range of strategic options to enhance value. Also, in the third quarter of fiscal year 2025, we announced that we were exploring strategic alternatives regarding our personal care business to focus on our portfolio of better-for-you food and beverages.

Human Capital Resources

As of June 30, 2025, we had approximately 2,600 employees, with 43% located in North America and 57% located outside of North America. Substantially all of our employees are full-time, permanent employees.

Our Board of Directors and its committees provide oversight of our policies and strategies related to talent management and culture, including employee engagement, workplace health and safety, and communication programs. Our employees are critical to our success. The following programs, initiatives and principles encompass some of the human capital objectives and measures that we focus on in managing our business and in seeking to attract and retain a talented workforce.

Our Purpose, Mission and Values

We are guided by our Purpose, Mission and Values.

Purpose: To inspire healthier living for people, communities and the planet through better-for-you brands

Mission: To build purpose-driven brands that make healthier living more attainable by empowering our people, engaging our partners, and living our values

Values: (1) Be curious, (2) Foster inclusion, (3) Own it and (4) Win together

4

Table of Contents

Our Global Workforce

People have always been our greatest asset. They are the very heart of our Company, and we believe everyone should feel encouraged, respected and welcomed in our workplace.

We make certain workforce demographic data available at hain.com/impact. The information available at hain.com/impact is not a part of this Form 10-K or incorporated into any of our other filings made with Securities and Exchange Commission (the “SEC”).

Employee Health and Safety

Employee safety is always front and center. We invest in the health, safety, development and well-being of our employees. In an effort to ensure workplace safety, we train employees on how to follow our detailed, written safety standards and procedures, and the law, and to watch for and report anything potentially harmful. Our safety key performance indicators are reviewed weekly, monthly and annually to ensure quick feedback and to address safety issues as soon as they arise.

Learning and Development

We offer a number of programs that help our employees progress in their careers. These programs include access to online learning and development tools as well as many additional local initiatives across our global locations to support employees on their career paths and develop leadership qualities and career skills in our global workforce.

Benefits

Our employee benefits vary by region but generally include:

•
Medical, Dental, and Vision Benefits;
•
Retirement Savings Plans;
•
Commuter Benefits;
•
Wellness Initiatives;
•
Tuition Reimbursement; and
•
Paid Parental Leave including births, adoptions or placements of foster children.

Employee Satisfaction and Engagement

We aim to foster a culture of open communications and have implemented a global systematic employee engagement process in which employees are surveyed periodically. Our Executive Leadership Team regularly reviews the results and considers and implements action items to address areas that need improvement. We have additional regional programs and policies in place to encourage open communications with management and Human Resources about employees’ ideas, concerns and how they are doing.

Impact

We are a global health and wellness company whose purpose is to inspire healthier living for people, communities, and the planet through better-for-you brands. Our Impact strategy focuses on our commitment to environmentally sound business practices, creating and selling better-for-you products, stakeholder and community impact initiatives and sustainable manufacturing processes. More details about our Impact strategy and goals, including our most recent Impact Report, are available at hain.com/company/impact.

Our Impact Reports and the other information available at hain.com/company/impact are not, and shall not be deemed to be, a part of this Form 10-K or incorporated into any of our other filings made with the SEC.

Products

Our brand portfolio focuses on growing global brands in categories where we believe we have the most potential. We continuously evaluate our existing products for quality, taste, nutritional value and cost and make improvements where possible. We discontinue products or stock keeping units when sales of those items do not warrant further production. The segments section details the various products that are categorized under distinct brands corresponding to our reportable segments.

5

Table of Contents

Seasonality

Certain of our product lines have seasonal fluctuations in demand. Hot tea and soup sales are stronger in colder months, while sales of snack foods are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. Historically, net sales and profitability in the first fiscal quarter have typically been the lowest of our four quarters.

Segments

The Company’s organization structure consists of two geographic based reportable segments: North America and International, which are also the Company’s operating segments. This structure is in line with how our Chief Operating Decision Maker (“CODM”) assesses the Company’s performance and allocates resources. The Company uses segment net sales and segment Adjusted EBITDA in order to analyze segment results and trends.

See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 and Note 21, Segment Information, in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K for additional details.

North America Segment:

United States

Our products are sold throughout the U.S. Our customer base consists principally of supermarkets and natural food stores, mass-market, club stores, specialty and natural food distributors, e-commerce retailers, and away from home channels, including drug and convenience stores and food service. Our products are sold through a combination of direct salespeople, brokers and distributors. We believe that our direct salespeople combined with brokers and distributors provide an effective means of reaching a broad and diverse customer base. Brokers act as agents for us within designated territories and receive commissions. A portion of our direct sales force is organized into dedicated teams to serve our significant customers.

A significant portion of the products marketed by us are sold through independent distributors. Food distributors purchase products from us for resale to retailers.

The brands sold in the U.S. include:

•
Garden Veggie™ snack products including Garden Veggie Straws®, Garden Veggie Chips, Flavor Burst™ and Apple Straws®, Terra® varieties of root vegetable chips, potato chips, and other exotic vegetable chips and Garden of Eatin’® tortilla chips.
•
Tea products under the Celestial Seasonings® brand and include varieties of herbal, green, black, wellness, rooibos and chai teas, with well-known names and products such as Sleepytime®, Lemon Zinger®, Red Zinger®, Cinnamon Apple Spice, Bengal Spice®, Country Peach Passion® and Tea Well®.
•
Baby and kid food products include infant and toddler formula, infant cereals, baby food pouches, snacks and frozen toddler and kids’ foods under the Earth’s Best® brand.
•
Yogurt products include The Greek Gods® Greek-style yogurt products.
•
Personal care products include hand, skin, hair and sun care products under the Alba Botanica®, Avalon Organics® and JASON® brands.
•
Other products include Spectrum® culinary oils, vinegars and condiments, Spectrum Essentials® nutritional oils and supplements, MaraNatha® nut butters, Imagine® broths.

Canada

Our products are sold throughout Canada. Our customer base consists principally of grocery supermarkets, club stores, mass merchandisers, natural food distributors, drug store chains, personal care distributors, and food service distributors. Our products are sold through our own retail direct sales force. We also utilize third-party brokers who receive commissions and sell to food service and retail customers. We utilize a third-party merchandising team for retail execution. As in the U.S., a portion of the products marketed by us are sold through independent distributors.

The brands sold in Canada include Earth’s Best® infant formula, MaraNatha® nut butters, Spectrum® cooking and culinary oils, Imagine® soups, The Greek Gods® Greek-style yogurt and Robertson’s® marmalades. Other food and beverage brands include Celestial Seasonings® teas, Terra® chips and Garden Veggie™ and Sensible Portions® snack products. Our personal care products include skin, hair and oral care products, sun care products and deodorants under the Alba Botanica®, Avalon Organics®, JASON®

6

Table of Contents

and Live Clean® brands. In the first quarter of fiscal year 2026, we announced the closure of the Yves Veggie Cuisine® refrigerated and frozen meat-alternative snacks and meals business, which is expected to occur in the second quarter of fiscal year 2026.

International Segment:

United Kingdom

In the United Kingdom, our products include baby and toddler food, soups, plant-based and meat-free dishes and meals, as well as ambient products such as jams, fruit spreads, jellies, marmalades, nut butters, syrups and dessert sauces.

The products sold in the United Kingdom include Ella’s Kitchen® premium organic infant and toddler foods, New Covent Garden Soup Co.®, Yorkshire Provender® and Cully and Sully® chilled soups, private label and Farmhouse Fare™ hot-eat desserts, Linda McCartney’s® (under license) frozen plant-based dishes and meals, Hartley’s® jams, fruit spreads and jellies, Sun-Pat® nut butters, Clarks™ natural sweeteners and Robertson’s®, Frank Cooper’s® and Rose’s® (under license) marmalades and conserves. We also provide a comprehensive range of private label products to many grocery and organic food retailers, convenience stores and food service providers in the following categories: fresh soup, chilled desserts, meat-free dishes and meals and ambient grocery products.

Our products are principally sold throughout the United Kingdom and Ireland but are also sold in Europe and other parts of the world. Our customer base consists principally of retailers, convenience stores, food service providers, business to business, natural food and ethnic specialty distributors, club stores, e-commerce retailers and wholesalers.

Western Europe

Our products sold by the Western Europe reporting unit include, among others, products sold under the Joya®, Lima® and Natumi® brands. The Lima® brand includes a wide range of organic products such as soy sauce and condiments, plant-based beverages and coffee alternatives. Our Natumi® brand includes plant-based beverages, including rice, almond, soy, oat, cashew and spelt. Our Joya® brand includes soy, almond, oat, rice and nut-based drinks as well as plant-based yogurts, desserts and creamers. We also sell our Hartley’s® jams, fruit spreads and jellies, Celestial Seasonings® teas, Linda McCartney’s® (under license) frozen plant-based dishes and meals, Cully & Sully® chilled soups and ready meals, Happy Rice® drink and private label products in Western Europe.

Our products are sold in grocery stores and organic food stores throughout Europe, the Middle East and Africa. Our products are sold using our own direct sales force and local distributors.

Customers

Walmart Inc. and its affiliates together accounted for approximately 18%, 18% and 16% of our consolidated sales for the fiscal years ended June 30, 2025, 2024 and 2023, respectively, which was related to both of our reportable segments, North America and International. No other customer accounted for at least 10% of our net sales in any of the past three fiscal years.

Foreign Operations

We sell our products to customers worldwide. Sales outside of the U.S. represented approximately 50%, 46% and 43% of our consolidated net sales in fiscal 2025, 2024 and 2023, respectively.

Marketing

We aim to meet the consumer at multiple points in their journey, across the digital and omni channel ecosystem, communicating both in-store and online. We use a combination of trade and consumer advertising and promotion. Trade advertising and promotion include placement fees, cooperative advertising, feature advertising in distribution catalogs and in-store merchandising in prominent and secondary locations.

Consumer advertising and promotion is used to build brand awareness and equity, drive trial to bring in new consumers and retain existing users to increase household penetration and consumption. Paid social and digital advertising, including retailer media and public relations programs, are the main drivers of brand awareness. Trial and conversion tactics include, but are not limited to, product search on Google and e-commerce sites, digital coupons, product sampling, direct mail and e-consumer relationship programs. Additionally, brand specific websites and social media pages are used to engage consumers with lifestyle, product and usage information related to specific brands.

7

Table of Contents

We also utilize marketing arrangements with third parties to help create awareness and advocacy and leverage various influencers to help increase brand reach and relevance.

New Product Initiatives Through Research and Development

Innovation, including new product development, is a key component of our growth strategy. We continuously seek to understand our consumers and develop products that address their desire for better-for-you alternatives to conventional packaged foods. We have a demonstrated track record of extending our product offerings into other product categories. A team of professional product developers, including microbiologists, nutritionists, food scientists, chefs and chemists, work to develop products to meet changing consumer needs. Our research and development staff incorporates product ideas from all areas of our business in order to formulate new products. In addition to developing new products, the research and development staff routinely reformulates and improves existing products based on advances in ingredients, packaging and technology. In addition to our Company-sponsored research and development activities, in order to quickly and economically introduce our new products to market, we may partner with contract manufacturers that make our products according to our formulas or other specifications. The Company also partners with certain customers from time to time on exclusive customer initiatives. The Company’s research and development expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product ideas and market them under the Company’s brands.

Production

Manufacturing

During fiscal 2025, 2024 and 2023, approximately 64%, 65% and 58%, respectively, of our revenue was derived from products manufactured at our own facilities.

Our North America reportable segment operates the following manufacturing facilities:

•
Boulder, Colorado, which produces Celestial Seasonings® teas;
•
Mountville, Pennsylvania, which produces Garden Veggie™, Sensible Portions® and Terra® snack products;
•
Lancaster, Pennsylvania, which produces snack products; and
•
Mississauga, Ontario, which produces Live Clean®, Alba Botanica®, Avalon Organics®, and JASON® personal care products (see Note 4, Assets and Liabilities Held for Sale).

In connection with the above-noted closure of the Yves Veggie Cuisine® business, we expect to close the associated manufacturing facility in Vancouver, British Columbia.

Our International reportable segment operates the following manufacturing facilities:

•
Histon, England, which produces our ambient grocery products including Hartley’s®, Frank Cooper’s®, Robertson’s® and Clarks™;
•
Grimsby, England, which produces our New Covent Garden Soup Co.® and Yorkshire Provender® chilled soups;
•
Clitheroe, England, which produces our private label and Farmhouse Fare TM hot-eat desserts;
•
Fakenham, England, which produces Linda McCartney’s® (under license) meat-free frozen and chilled dishes and meals;
•
Troisdorf, Germany, which produces Natumi®, Lima®, Joya® and other plant-based beverages and private label products;
•
Oberwart, Austria, which produces our Lima® and Joya® plant-based foods and beverages, creamers, cooking creams and private label products; and
•
Schwerin, Germany, which also produces our Lima® and Joya® plant-based foods and beverages and private label products.

See “Item 2: Properties” of this Form 10-K for more information on the manufacturing facilities that we operate.

Contract Manufacturers

In addition to the products manufactured in our own facilities, independent third-party contract manufacturers, who are referred to in our industry as co-manufacturers or co-packers, manufacture many of our products. In general, utilizing co-packers provides us with the flexibility to produce a large variety of products and the ability to enter new categories quickly and economically. Our contract manufacturers have been selected based on their production capabilities, capitalization and specific product category expertise, and we expect to continue to partner with them to improve and expand our product offerings. During fiscal 2025, 2024 and 2023, approximately 36%, 35% and 42%, respectively, of our sales were derived from products manufactured by co-packers. We require that our co-packers comply with all applicable regulations and our quality and food safety program requirements, and

8

Table of Contents

compliance is verified through auditing and other activities. Additionally, the co-packers are required to ensure our products are manufactured in accordance with our finished goods specifications to ensure we meet customer expectations.

Suppliers of Ingredients and Packaging

Agricultural commodities and ingredients, including vegetables, fruits, oils, grains, beans, nuts, tea and herbs, spices, and dairy products, are the principal inputs used in our food and beverage products. Plant-based surfactants, glycerin and alcohols are the main inputs used in our personal care products. Our primary packaging supplies are cartons, pouches, printed film, paper, paperboard and jars. We strive to maintain a global supplier base that provides innovative ideas and sustainable packaging alternatives.

Our raw materials and packaging materials are obtained from various suppliers around the world. The Company works with its suppliers to ensure the quality and safety of their ingredients and that such ingredients meet our specifications and comply with applicable regulations. These assurances are supported by our purchasing contracts, supplier expectations manual, supplier code of conduct, supplier scorecards and technical assessments, including questionnaires, scientific data, certifications, affidavits, certificates of analysis and analytical testing, where required. Our purchasers and quality team visit major suppliers around the world to procure competitively priced, quality ingredients that meet our specifications.

We maintain long-term relationships with many of our suppliers. Purchases are made through purchase orders or contracts, and price, delivery terms and product specifications vary.

Agricultural commodities and ingredients are subject to price volatility which can be caused by a variety of factors. We attempt to mitigate the input price volatility with a combination of price increases to our customers, purchasing strategies, cost savings initiatives and operating efficiencies.

Competition

We operate in a highly competitive environment. Our products compete with both large conventional packaged goods companies and natural and organic packaged foods companies. Many of these competitors enjoy significantly greater resources. Large conventional packaged foods competitors include Campbell Soup Company, Conagra Brands, Inc., Danone S.A., General Mills, Inc., The Hershey Company, The J.M. Smucker Company, Kellanova, Mondelez International, Inc., Nestle S.A. and PepsiCo, Inc. Large conventional personal care products companies with whom we compete include, but are not limited to, The Clorox Company, Colgate-Palmolive Company, Johnson & Johnson, The Procter & Gamble Company and S. C. Johnson & Son, Inc. Certain of these large conventional packaged foods and personal care companies compete with us by selling both conventional products and natural and/or organic products. In addition to these competitors, in each of our categories we compete with many regional and small, local niche brands. Given limited retailer shelf space and merchandising events, competitors actively support their respective brands with marketing, advertising and promotional spending. In addition, most retailers market similar items under their own private label, which compete for the same shelf space.

Competitive factors in the packaged foods industry include product quality and taste, brand awareness and loyalty, price, product variety, interesting or unique product names, product packaging and package design, shelf space, reputation, advertising, promotion and nutritional claims.

Trademarks

We believe that brand awareness is a significant component in a consumer’s decision to purchase one product over another in the highly competitive consumer packaged goods industry. We generally register our trademarks and brand names in the U.S., Canada, the European Union, and the United Kingdom (“U.K.”) and/or other foreign countries depending on the area of distribution of the applicable products. We intend to keep these filings current and seek protection for new trademarks to the extent consistent with business needs. We monitor trademark registers worldwide and take action to enforce our rights as we deem appropriate. We believe that our trademarks are significant to the marketing and sale of our products and that the inability to utilize certain of these names and marks, and/or the inability to prevent third parties from using similar names or marks, could have a material adverse effect on our business.

We also market products under brands licensed under trademark license agreements, including Linda McCartney’s®, Rose’s®, as well as the Paddington Bear image on certain of our Robertson’s® products.

Government Regulation

We are subject to extensive regulations in the U.S. by federal, state and local government authorities. In the U.S., the federal agencies governing the manufacture, marketing and distribution of our products include, among others, the Federal Trade Commission (“FTC”), the United States Food & Drug Administration (“FDA”), the United States Department of Agriculture (“USDA”), the United States Environmental Protection Agency (“EPA”) and the Occupational Safety and Health Administration

9

Table of Contents

(“OSHA”). Under various statutes, these agencies prescribe and establish, among other things, the requirements and standards for quality, safety and representation of our products to the consumer in labeling and advertising.

Internationally, we are subject to the laws and regulatory authorities of the foreign jurisdictions in which we manufacture and sell our products, including the Canadian Food Inspection Agency, Health Canada, Food Standards Agency in the United Kingdom, and the European Food Safety Authority.

Quality Control

We utilize a comprehensive product safety and quality management program, which employs strict manufacturing procedures, expert technical knowledge on food safety science, employee training, ongoing process innovation, use of quality ingredients and both internal and independent auditing.

In the U.S., each of our own food manufacturing facilities has a Food Safety Plan (“FSP”), which focuses on preventing food safety risks and is compliant with the requirements set forth under the Food Safety Modernization Act (“FSMA”). In addition, we have individuals on the Quality team that have Preventive Controls Qualified Individual (“PCQI”) and Foreign Supplier Verification Training; each training follows a standardized curriculum recognized by the FDA.

We conduct audits of our contract manufacturers to address topics such as allergen control; ingredient, packaging and product specifications; and sanitation. Under FSMA, each of our contract manufacturers is required to have a FSP, a Hazard Analysis Critical Control Plant (“HACCP”) plan or a hazard analysis critical control points plan that identifies critical pathways for contaminants and mandates control measures to be in place to mitigate food-borne hazards.

Independent Certifications

Substantially all of our Company-owned manufacturing sites and a significant number of our contract manufacturers are certified against a recognized standard such as the Global Food Safety Initiative (“GFSI”), which includes Safe Quality Foods (“SQF”) and British Retail Consortium (“BRC”), or ISO 9001 Quality Management Systems and ISO 22716 GMP Cosmetic and Personal Care. All facilities where our food products are manufactured are GFSI compliant. These standards are integrated product safety and quality management protocols designed specifically for the food and personal care sectors and offer a comprehensive methodology to manage product safety and quality. Certification provides an independent and external validation that a product, process or service complies with applicable regulations and standards.

In the U.S., our organic food products are certified in accordance with the USDA’s National Organic Program through Quality Assurance International (“QAI”), a third-party certifying agency. For products marketed as organic outside of the U.S., we use accredited certifying agencies to ensure compliance with country-specific government regulations for selling organic products or reciprocity, where available.

Many of our products are certified kosher under the supervision of accredited agencies including The Union of Orthodox Jewish Congregations and “KOF-K” Kosher Supervision.

We also work with other non-governmental organizations such as NSF International, which developed the NSF/ANSI 305 Standard for Personal Care Products Containing Organic Ingredients and provides third-party certification through QAI for certain of our personal care products. In addition, we work with other nongovernmental organizations such as the Gluten Free Intolerance Group, Fair Trade USA, The Skin Cancer Foundation, Coalition for Consumer Information on Cosmetics/Leaping Bunny, The Roundtable on Sustainable Palm Oil and the Non-GMO Project.

Company Website and Available Information

The following information can be found, free of charge, in the “Investor Relations” section of our corporate website at ir.hain.com:

•
our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC;
•
our policies related to corporate governance, including our Code of Conduct applying to our directors, officers and employees (including our principal executive officer, principal financial officer and principal accounting officer) that we have adopted to meet the requirements set forth in the rules and regulations of the SEC and The Nasdaq Stock Market LLC; and
•
the charters of the Audit, Compensation, Nominating and Governance and Strategy Committees of our Board of Directors.

If the Company ever were to amend or waive any provision of its Code of Ethics that applies to the Company’s principal executive officer, principal financial officer, principal accounting officer or any person performing similar functions, the Company intends

10

Table of Contents

to satisfy its disclosure obligations, if any, with respect to any such waiver or amendment by posting such information on its website set forth above rather than by filing a Current Report on Form 8-K.

The Company may use its website as a distribution channel of material Company information. Financial and other important information regarding the Company is routinely posted on and accessible through the Company’s investor relations website at ir.hain.com. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting “E-mail Alerts” under the "IR Resources" section of our investor relations website. Information on the Company’s website is not incorporated by reference herein and is not a part of this Form 10-K.

11

Table of Contents

Item 1 A. Risk Factors

Our business, operations and financial condition are subject to various risks and uncertainties. While we believe we have identified and discussed below the key risk factors affecting our business, there may be additional risks and uncertainties not presently known to us or that we currently consider immaterial. If any of the following risks and uncertainties develop into actual events, our business, financial condition or results of operations could be materially adversely affected. In such case, the trading price of our common stock could decline, and you may lose all or part of your investment. You should not interpret the disclosure of any risk factor to imply that the risk has not already materialized. These risk factors should be read in conjunction with the other information in this Annual Report on Form 10-K and in the other documents that we file from time to time with the SEC.

Risks Related to Our Business, Operations and Industry

Our markets are highly competitive.

We operate in highly competitive geographic and product markets. Numerous brands and products compete for limited retailer shelf space, where competition is based on product quality, brand recognition, brand loyalty, price, product innovation and variety, packaging, convenience, promotional activity, availability, taste and health or functional attributes among other things. Retailers also market competitive products under their own private labels, which are generally sold at lower prices and compete with some of our products.

Some of our markets are dominated by multinational corporations with greater resources and more substantial operations than us. We may not be able to successfully compete for sales to distributors or retailers that purchase from larger competitors that have greater financial, managerial, sales, technical and operational resources. Larger food companies may be able to use their resources and scale to respond to competitive pressures and changes in consumer preferences by introducing new products or reformulating their existing products, reducing prices or increasing promotional activities. We also compete with other organic and natural packaged food brands and companies, which may be more innovative and able to bring new products to market faster and may be better able to quickly exploit and serve niche markets. As a result of this competition, retailers may take actions that negatively affect us. Consequently, we may need to increase our marketing, advertising and promotional spending to protect our existing market share. Furthermore, we may experience price pressure due to competitors’ promotional activity and pricing, which may be particularly strong during adverse economic periods and periods of high inflation. Increased competition could have an adverse impact on our sales, margins, profitability and market share.

Our growth and continued success depend upon consumer preferences for our products, which could change.

Our business is primarily focused on sales of better-for-you products and could be harmed if consumer demand for such categories were to decrease. During an economic downturn or inflationary environment, factors such as increased unemployment, decreases in disposable income and declines in consumer confidence could cause a decrease in demand for our overall product set, particularly higher priced better-for-you products, or consumers may stop buying the categories of products that we sell entirely. Moreover, consumer preferences continuously evolve due to a variety of factors, including changes in demographics, consumption patterns and diet trends (including as a result of the use of weight loss drugs), channel preferences, pricing, product quality, packaging and perceptions of certain ingredients, among others. While we continue to diversify our product offerings, developing new products entails risks, and demand for our products may not continue at current levels or increase in the future. The success of our innovation and product improvement effort depends on our ability to anticipate changes in consumers’ preferences, the availability of funding, the technical capability of our research and development staff in developing, formulating and testing product prototypes, including complying with governmental regulations, the success of management’s go-to-market strategy and competitor responses such as increased promotional activity or advertising.

In addition, consumption has continued to shift toward the e-commerce channel. Some products we sell via the e-commerce channel have lower margins than those sold in traditional brick and mortar retailers and present unique challenges in order fulfillment. The growth in e-commerce has also encouraged the entry of new competitors and business models, intensifying competition by simplifying distribution and lowering barriers to entry. If we are unsuccessful in implementing product improvements or introducing new products that satisfy the demands of consumers, our business could be harmed.

If we are unable to successfully execute our business strategy, or if our strategy proves to be ineffective, our business, operating results and financial condition may be adversely affected.

In the fourth quarter of fiscal year 2025, we announced the launch of a formal process to review our portfolio to maximize shareholder value as we continue to pursue our strategy of being a pure-play better-for-you food company. Our ability to execute on this strategy is dependent on a number of factors, including the ability of our management to execute the strategy, our ability to innovate to meet changing consumer demand, our ability to effectively manage our supply chain and pricing, and the ability of our employees to perform at a high level. If we are unable to execute our strategy, or if the public perceives that we are not executing on our strategy, it could adversely affect our business, financial performance, and growth.

12

Table of Contents

Relatedly, from time to time, we evaluate potential acquisitions or dispositions that align with our strategic objectives. For example, in the third quarter of 2025, we announced that we would be exploring strategic alternatives for our personal care business. The success of these initiatives depends upon our ability to identify suitable buyers and successfully negotiate contract terms, among other factors. These initiatives may present operational risks, including diversion of management’s attention from other matters or difficulties separating businesses from our operations. If we are not successful in executing desired strategic transactions, our business, operating results and financial condition could be adversely affected.

If we do not manage our supply chain effectively or if there are disruptions in our supply chain, our business and results of operations may be adversely affected.

The success of our business depends, in part, on maintaining a strong sourcing and manufacturing platform and efficient distribution channels. Our ability to ensure a continuing supply of natural, organic and specialty ingredients used in certain of our products at competitive prices depends on many factors beyond our control, such as the number and size of farms that grow natural and organic crops, the number of producers of specialty ingredients, climate conditions, high demand for certain ingredients by our competitors, global unrest, changes in national and global economic conditions, currency fluctuations and tariffs. Certain ingredients that we use in the production of our products (including, among others, vegetables, fruits, nuts and grains) are vulnerable to adverse weather conditions and natural disasters, such as floods, droughts, water scarcity, temperature extremes, wildfires, frosts, earthquakes and pestilences. Natural disasters and adverse weather conditions can lower crop yields and reduce crop size and crop quality, which in turn could reduce our supplies of ingredients or increase the prices of ingredients. If our supplies of ingredients are reduced, we may not be able to find enough supplemental supply sources on favorable terms, if at all.

Moreover, the inability or failure of any independent contract manufacturer or third-party distributor to deliver or perform for us in a timely or cost-effective manner could cause our operating costs to increase and our profit margins to decrease, especially as it relates to our products that have a short shelf life. If we do not continuously monitor our inventory and product mix against forecasted demand, we risk having inadequate supplies to meet consumer demand or alternatively having too much inventory on hand that may reach its expiration date and become unsaleable. In addition, disputes with significant suppliers, including disputes regarding pricing or performance, could adversely affect our ability to supply products to our customers and could materially and adversely affect our product sales, financial condition, and results of operations.

We must also manage our third-party distribution, warehouse and transportation providers to ensure they are able to support the efficient distribution of our products to retailers. A disruption in transportation services could result in an inability to supply materials to our or our co-manufacturers’ facilities or finished products to our distribution centers or customers. Activity at third-party distribution centers could be disrupted by a number of factors, including labor issues, quality control issues, failure to meet customer standards, natural disasters or financial issues affecting the third-party providers.

If we are unable to manage our supply chain efficiently and ensure that our products are available to meet consumer demand and customer orders, our sales and profitability could be materially adversely impacted.

Our future results of operations may be adversely affected by input cost inflation, including as a result of tariffs.

Many aspects of our business have been, and may continue to be, directly affected by volatile commodity costs and other inflationary pressures, including U.S. government tariffs and the imposition of any counter-tariffs. Agricultural commodities and ingredients are subject to price volatility that can be caused by commodity market fluctuations, crop yields, seasonal cycles, weather conditions, temperature extremes and natural disasters, pest and disease problems, changes in currency exchange rates, imbalances between supply and demand, and government programs and policies, including tariffs, among other factors. Volatile fuel costs and other factors translate into unpredictable costs for the products and services we receive from our third-party providers including, but not limited to, freight and other distribution costs for our products and packaging costs. Moreover, the cost of distribution has generally increased in recent years due to an increase in transportation and logistics costs as a result of high levels of long-haul driver turnover and increased railroad traffic and service issues.

While we seek to offset increased input costs with a combination of price increases to our customers, purchasing strategies, cost savings initiatives and operating efficiencies, we may be unable to fully offset our increased costs or unable to do so in a timely manner. Increases in pricing resulting from input cost inflation may impact our volume of products sold and could adversely affect our financial results.

13

Table of Contents

We rely on independent contract manufacturers to manufacture certain of our products, and the loss of or disruption in our relationship with one or more of these parties could adversely affect our business.

During fiscal 2025, 2024 and 2023, approximately 36%, 35% and 42%, respectively, of our sales were derived from products manufactured by independent contract manufacturers, or co-manufacturers. In some cases, an individual co-manufacturer may produce all of our requirements for a particular brand. We believe there are a limited number of competent, high-quality co-manufacturers in the industry, and many of our co-manufacturers produce products for other companies as well. Therefore, if we lose or need to change one or more co-manufacturers, fail to retain co-manufacturers for newly acquired or developed products or brands, or if our relationship with one or more of our co-manufacturers is disrupted, production of our products may be delayed or postponed and/or the availability of some of our products may be reduced or eliminated, which could have a material adverse effect on our business, results of operations and financial condition.

Disruption or loss of operations at one or more of our manufacturing facilities could harm our business.

For the fiscal years ended June 30, 2025, 2024 and 2023, approximately 64%, 65% and 58%, respectively, of our sales were derived from products manufactured at our own manufacturing facilities. A disruption of or the loss of operations at one or more of these facilities, which may be caused by disease outbreaks or pandemics, labor issues, natural disasters, governmental actions or other events beyond our control, could delay or postpone production of our products, which could have a material adverse effect on our business, results of operations and financial condition. Labor market shortages have impacted, and may continue to impact, operations at our manufacturing facilities.

A significant percentage of our sales is concentrated among a small number of customers, and consolidation of customers or the loss of a significant customer could negatively impact our sales and profitability.

Our growth and continued success depend upon, among other things, our ability to maintain and increase sales volumes with existing customers, our ability to attract new customers, the financial condition of our customers and our ability to provide products that appeal to customers at the right price. A significant percentage of our sales is concentrated among a small number of customers. For example, sales to Walmart Inc. and its affiliates approximated 18%, 18% and 16% of sales during the fiscal years ended June 30, 2025, 2024 and 2023, respectively. With the growing trend toward retail trade consolidation, the growing presence of large-format retailers, discounters and e-commerce retailers, shrinking retail footprints and store closures and the integration of traditional and digital operations at key retailers, we are increasingly dependent on certain retailers that may have greater bargaining strength than we do. Retailers may use their leverage to demand higher trade discounts, allowances, slotting fees or increased investment, which could result in reduced sales or profitability in certain markets. Our customers are generally not contractually obligated to purchase from us and their decision to purchase from us is driven by multiple factors, including consumer preferences and demand, price, product quality, customer service performance, availability and other factors. The loss of any large customer, a reduction of purchasing levels or the cancellation of any business from a large customer for an extended length of time could negatively impact our sales and profitability.

We rely on independent distributors for a substantial portion of our sales.

In the United States and other markets, we rely upon sales made by or through non-affiliated distributors to customers. Distributors purchase directly for their own account for resale. The loss of, or business disruption at, one or more of these distributors may harm our business. If we are required to obtain additional or alternative distribution agreements or arrangements in the future, we cannot be certain that we will be able to do so on satisfactory terms or in a timely manner. Our inability to enter into satisfactory distribution agreements may inhibit our ability to implement our business plan or to establish markets necessary to successfully expand the distribution of our products.

We are subject to risks associated with our international sales and operations, including tariffs, foreign currency and compliance and other trade risks.

For the fiscal years ended June 30, 2025, 2024 and 2023, approximately 50%, 46% and 43%, respectively, of our consolidated sales were generated outside the United States. Sales from outside our U.S. markets may continue to represent a significant portion of our consolidated sales in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting business abroad, many of which are outside our control, including:

•
tariffs, quotas, trade barriers or sanctions, other trade protection measures and import or export licensing requirements imposed by governments that might negatively affect our sales, including, but not limited to, Canadian and European Union tariffs imposed on certain U.S. food and beverages;
•
difficulties in managing a global enterprise, including differing labor standards and design and implementation of effective control environment processes across our diverse operations and employee base;

14

Table of Contents

•
difficulties associated with operating under a wide variety of complex foreign laws, treaties and regulations, including compliance with food safety regulations, marketing and labeling laws and regulations, antitrust and competition laws, anti-modern slavery laws, anti-bribery and anti-corruption laws, data privacy laws, including the European Union General Data Protection Regulation (“GDPR”), tax laws and regulations and a variety of other local, national and multi-national regulations and laws;
•
currency exchange rate fluctuations;
•
varying abilities to enforce intellectual property and contractual rights;
•
periodic economic downturns and the instability of governments, including default or deterioration in the creditworthiness of local governments, geopolitical regional conflicts, terrorist activity, political unrest, civil strife, acts of war, public corruption, instability in the financial services sector, expropriation and other economic or political uncertainties;
•
compliance with U.S. laws affecting operations outside of the United States, such as the U.S. Foreign Corrupt Practices Act and the Office of Foreign Assets Control trade sanction regulations and anti-boycott regulations; and
•
greater risk of uncollectible accounts and longer collection cycles.

We have outsourced certain functions to third-party service providers, and any service failures or disruptions related to these outsourcing arrangements could adversely affect our business.

We have outsourced certain business processes in the areas of supply chain, accounting and information technology to managed service providers, globally. Failure by these third parties to meet their contractual, regulatory and other obligations to us, or our failure to adequately monitor their performance, could result in our inability to achieve the expected cost savings or efficiencies and could result in additional costs to correct errors made by such service providers. Moreover, we have diminished control over the quality and timeliness of the outsourced services, including the cybersecurity protections implemented by these third parties. As a result of these outsourcing arrangements, we may experience interruptions or delays in our processes, loss or theft of sensitive data or other cybersecurity issues, compliance issues, challenges in maintaining and reporting financial and operational information, and increased costs to remediate any unanticipated issues that arise, any of which could materially and adversely affect our business, financial condition and results of operations.

Geopolitical conflicts could continue to cause challenges and create risks for our business.

Our business, financial conditions and results of operations have been impacted in the past and may be impacted in the future by disruptions in the global economy. Although we have no material assets in Russia, Belarus, Ukraine, Israel, China or Taiwan, our supply chain has been, and may continue to be, adversely impacted by the Russia-Ukraine war and conflicts in the Middle East and between China and Taiwan. In particular, these conflicts have added significant costs to existing inflationary pressures through increased fuel and raw material prices and labor costs. Further, beyond increased costs, labor challenges and other factors have led to supply chain disruptions. While, to date, we have been able to identify replacement raw materials where necessary, we have incurred increased costs in doing so. Geopolitical conflicts may also result in an increased risk of cybersecurity incidents or disruptions to information systems. Although we are continuing to monitor and manage the impacts of these conflicts on our business, such conflicts and the related economic impacts could continue to have a material adverse effect on our business and operating results.

We rely on independent certifications for a number of our products.

We rely on independent third-party certifications, such as certifications of our products as “organic,” “Non-GMO” or “kosher,” to differentiate our products from others. We must comply with the requirements of independent organizations or certification authorities in order to label our products. For example, we can lose our “organic” certification if a manufacturing plant becomes contaminated with non-organic materials, or if it is not properly cleaned after a production run. In addition, all raw materials must be certified organic. Similarly, we can lose our “kosher” certification if a manufacturing plant and raw materials do not meet the requirements of the appropriate kosher supervision organization. The loss of any independent certifications could adversely affect our market position as an organic and natural products company, which could harm our business.

We may not be able to attract and retain the highly skilled people we need to support our business.

We depend on the skills and continued service of key personnel. In addition, our ability to achieve our strategic and operating goals depends on our ability to identify, hire, train and retain qualified individuals. We also compete with other companies both within and outside of our industry for talented personnel, and we may lose key personnel or fail to attract, train and retain other talented personnel. Any such loss or failure may adversely affect our business or financial results.

15

Table of Contents

We face risks related to tax matters, including changes in tax rates, disagreements with taxing authorities and imposition of new taxes.

The Company is subject to taxes in the U.S. and foreign jurisdictions where the Company’s subsidiaries are organized. Tax rates in the U.S. and various foreign jurisdictions have been and may continue to be subject to significant change. The Organization for Economic Cooperation and Development (“OECD”) has introduced a framework to implement a global minimum corporate income tax. To the extent that additional OECD guidance leads to legislative changes in countries where we operate, it is possible the changes may adversely impact our effective tax rate. This new minimum tax is not expected to be material to the Company. We are also subject to regular reviews, examinations and audits by the Internal Revenue Service and other taxing authorities with respect to taxes inside and outside of the U.S. Although we believe our tax estimates are reasonable, if a taxing authority disagrees with the positions we have taken, we could face additional tax liability, including interest and penalties. There can be no assurance that payment of such additional amounts upon final adjudication of any disputes will not have a material impact on our results of operations and financial position. We also need to comply with new, evolving or revised tax laws and regulations. The enactment of or increases in tariffs, sales or value-added tax, or other changes in the application of existing taxes, may have an adverse effect on our business or on our results of operations.

Risks Related to Financial and Economic Considerations

Any default under our credit agreement or inability to refinance our indebtedness could have significant consequences.

Our credit agreement contains covenants imposing certain restrictions on our business. These restrictions may affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. The credit agreement requires us to satisfy certain financial covenants, such as maintaining a maximum consolidated secured leverage ratio, a minimum consolidated interest coverage ratio and, in certain periods, minimum levels of consolidated EBITDA as defined in the credit agreement. The credit agreement also contains restrictive covenants including, with specified exceptions, limitations on our ability to engage in certain business activities, incur debt and liens, pay dividends or make other distributions, enter into affiliate transactions, consolidate, merge or acquire or dispose of assets, and make certain investments, acquisitions and loans.

Our ability to comply with these covenants under the credit agreement may be affected by events beyond our control, including prevailing economic, financial and industry conditions. The breach of any of these covenants could result in a default, which would permit the lenders to declare all outstanding debt to be due and payable, together with accrued and unpaid interest. Our obligations under the credit agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions. Any default by us under the credit agreement could have a material adverse effect on our business and financial condition.

In addition, our credit agreement matures in December 2026. Prior to that maturity date, we will need to refinance our indebtedness, which could include obtaining new financing. We may not be able to refinance on terms that are as favorable as provided in our current credit agreement, or at all. To facilitate our refinancing efforts and in order to reduce our overall indebtedness, we may consider actions such as strategic dispositions, sales of assets or reductions or delays of capital expenditures. Any inability to refinance our indebtedness or do so on favorable terms could have a material adverse effect on our business and financial condition.

Currency exchange rate fluctuations could adversely affect our consolidated financial results and condition.

We are subject to risks related to fluctuations in currency exchange rates. Our consolidated financial statements are presented in U.S. Dollars, requiring us to translate our assets, liabilities, revenue and expenses into U.S. Dollars. As a result, changes in the values of currencies may unpredictably and adversely impact our consolidated operating results, our asset and liability balances and our cash flows in our consolidated financial statements even if their value has not changed in their original currency. Given our global operations, we also pay for the ingredients, raw materials and commodities used in our business in numerous currencies. Fluctuations in exchange rates, including as a result of inflation, central bank monetary policies, currency controls or other currency exchange restrictions or geopolitical instability have had, and could continue to have, an adverse impact on our financial performance.

Disruptions in the worldwide economy and the financial markets may adversely impact our business and results of operations.

Adverse and uncertain economic and market conditions, such as inflation, economic slowdowns or recessions, increased unemployment, decreases in disposable income and declines in consumer confidence, particularly in the locations in which we operate, may impact customer and consumer demand for our products and our ability to manage normal commercial relationships with our customers, suppliers and creditors. Consumers may shift purchases to lower-priced or other perceived value offerings, which may adversely affect our results of operations. Consumers may also reduce the number of better-for-you products that they purchase where there are less expensive conventional or private label alternatives. Distributors and retailers may also become

16

Table of Contents

more conservative in response to these conditions and seek to reduce their inventories. Prolonged unfavorable economic conditions may have an adverse effect on any of these factors and, therefore, could adversely impact our sales and profitability.

Risks Related to Our Reputation, Brands, Intangible Assets and Intellectual Property

An impairment in the carrying value of goodwill or other acquired intangible assets could materially and adversely affect our consolidated results of operations and net worth.

As of June 30, 2025, we had goodwill of $501.0 million and trademarks and other intangibles assets of $210.9 million, which in the aggregate represented 44.4% of our total consolidated assets. The net carrying value of goodwill represents the fair value of acquired businesses in excess of identifiable assets and liabilities as of the acquisition date (or subsequent impairment date, if applicable), less any amounts ascribed to disposed businesses. The fair value of trademarks and other intangibles exceeded or represented the net carrying value of trademarks, customer relationships and other acquired intangibles as of the acquisition date (or subsequent impairment date, if applicable), net of accumulated amortization. Goodwill and other acquired intangibles expected to contribute indefinitely to our cash flows are not amortized but must be evaluated by management at least annually for impairment. Amortized intangible assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amounts of these assets may not be recoverable. Impairments to goodwill and other intangible assets may be caused by factors outside our control, such as increasing competitive pricing pressures, changes in discount rates based on changes in cost of capital (interest rates, etc.), lower than expected sales and profit growth rates, changes in industry Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) multiples, the inability to quickly replace lost co-manufacturing business, or the bankruptcy of a significant customer.

We have in the past recorded, and may in the future be required to record, significant charges in our consolidated financial statements during the period in which any impairment of our goodwill or intangible assets is determined. For example, during fiscal 2025, fiscal 2024 and fiscal 2023, we recorded aggregate non-cash impairment charges of $37.8 million, $44.6 million and $174.9 million, respectively, related to certain trademarks and intangible assets to reduce their carrying value to their estimated fair value. Further, during fiscal 2025, we also recorded aggregate non-cash goodwill impairment charges of $357.7 million related to the U.S. and Canada reporting units, and $71.2 million related to the U.K. reporting unit goodwill to reduce their carrying values to their estimated fair values. The incurrence of additional impairment charges could negatively affect our results of operations and adversely impact our net worth and our consolidated earnings in the period of such charge. For further information, see Note 9, Goodwill and Other Intangible Assets, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K, and Critical Accounting Estimates, in the Management's Discussion and Analysis of Financial Condition and Results of Operations included in Item 7 of this Form 10-K.

If the reputation of our Company or our brands erodes significantly, it could have a material impact on our business.

Our financial success is directly dependent on the perception of our Company and our brands among our customers, consumers, employees and other constituents. Our results could be negatively impacted if our Company or one or more of our brands suffers substantial damage to its reputation due to real or perceived issues related to the quality or safety of our products or the Company’s societal impact. Further, the growing use of social media by consumers has greatly increased the speed and extent that information or misinformation and opinions can be shared. Negative posts or comments about us, our brands, or our products on social media could seriously damage our brands and reputation. Additionally, negative reaction to our marketing and advertising, including our social media content, could result in damage to our brands and reputation.

Our inability to use our trademarks or the trademarks we license from third parties could have a material adverse effect on our business.

We believe that brand awareness is a significant component in a consumer’s decision to purchase one product over another in the highly competitive food, beverage and personal care industries. Although we endeavor to protect our trademarks and tradenames, these efforts may not be successful, and third parties may challenge our right to use one or more of our trademarks or tradenames. We believe that our trademarks and tradenames are significant to the marketing and sale of our products and that the inability to utilize certain of these names and marks, and/or the inability to prevent third parties from using similar names or marks, could have a material adverse effect on our business, results of operations and financial condition. In addition, if, in the course of developing new products or improving existing products, we are found to have infringed the intellectual property rights of others, directly or indirectly, such finding could have an adverse impact on our business, financial condition or results of operations.

In addition, we market products under brands licensed under trademark license agreements. If in the future we are unable to enforce, renew or renegotiate our licensing arrangements on terms acceptable to us, our financial results could be materially and adversely affected.

Risks Related to Cybersecurity and Technology

17

Table of Contents

A cybersecurity incident or other technology disruptions could negatively impact our business and our relationships with customers.

We depend on information systems and technology, including public websites and cloud-based services, in substantially all aspects of our business, including communications among our employees and with suppliers, customers and consumers. Such uses of information systems and technology give rise to cybersecurity risks, including system disruption, security breach, malware, ransomware, theft, espionage and inadvertent release of information. We have become more reliant on mobile devices, remote communication and other technologies as part of the recent change in office working patterns, exacerbating our cybersecurity risk. Our business involves the storage and transmission of numerous classes of sensitive and/or confidential information and intellectual property, including customers’ and suppliers’ information, private information about employees, and financial and strategic information about the Company and its business partners. As we pursue new initiatives that improve our operations and cost structure, we are also expanding and improving our information technologies, resulting in a larger technological presence and increased exposure to cybersecurity risk. In addition, the rapid evolution and increased adoption of emerging technologies, such as artificial intelligence, may intensify our cybersecurity risks. If we fail to assess and identify cybersecurity risks associated with new initiatives, we may become increasingly vulnerable to such risks. While we currently maintain insurance coverage that, subject to its terms and conditions, is intended to address costs associated with certain aspects of cybersecurity incidents and information technology failures, this insurance coverage may not, depending on the specific facts and circumstances surrounding an incident, cover any or all losses or types of claims that arise from an incident, or the damage to our business, reputation or brands that may result from an incident. As the frequency and magnitude of cybersecurity incidents increase globally, we may be unable to obtain the insurance coverage that we think is appropriate or necessary to offset the risk.

We have experienced cybersecurity threats and vulnerabilities in our systems and those of our third-party providers. Although, to date, such prior events have not had a material impact on our financial condition, results of operations or financial condition, the potential consequences of a future material cybersecurity attack could be significant and could include reputational damage, litigation with third parties, government enforcement actions, penalties, disruption to systems, unauthorized release of confidential or otherwise protected information, corruption of data and increased cybersecurity protection and remediation costs, which in turn could adversely affect our competitiveness, results of operations and financial condition. Due to the evolving nature of such security threats, the potential impact of any future incident cannot be predicted. For more information regarding the Company’s cybersecurity risk management, see Item 1C of this Annual Report on Form 10-K.

Our business operations could be disrupted if our information technology systems fail to perform adequately.

The efficient operation of our business depends on our information technology systems. We rely on our information technology systems to effectively manage our business data, communications, supply chain, order entry and fulfillment, and other business processes. The failure of our information technology systems to perform as we anticipate could disrupt our business and could result in transaction errors, processing inefficiencies and the loss of sales and customers, causing our business and results of operations to suffer. In addition, our information technology systems may be vulnerable to damage or interruption from circumstances beyond our control, including fire, natural disasters, system failures and viruses. Any such damage or interruption could have a material adverse effect on our business.

Risks Related to Litigation, Government Regulation and Compliance

Pending and future litigation may lead us to incur significant costs.

We are, or may become, party to various lawsuits and claims arising in the normal course of business, which may include lawsuits or claims relating to contracts, intellectual property, product recalls, product liability, the marketing and labeling of products, employment matters, environmental matters, data protection or other aspects of our business as well as any securities class action and stockholder derivative litigation. For example, as discussed in Note 18, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K, we are currently subject to class actions and derivative complaints arising out of or related to the Company’s prior internal accounting review. Certain of our former officers and former members of our Board of Directors, as individual defendants, are also subject to lawsuits related to such accounting review, and we may have an obligation to indemnify them in relation to these matters. Additionally, as discussed further in Note 18, Commitments and Contingencies, we are subject to consumer class actions, and other lawsuits alleging some form of personal injury, relating to our Earth’s Best® baby food products.

Even when not merited, the defense of these lawsuits may divert our management’s attention, and we may incur significant expenses in defending these lawsuits. The results of litigation and other legal proceedings are inherently uncertain, and adverse judgments or settlements in some or all of these legal disputes may result in monetary damages, penalties or injunctive relief against us, which could have a material adverse effect on our results of operations and financial condition. Any claims or litigation, even if fully indemnified or insured, could damage our reputation and make it more difficult to compete effectively or to obtain adequate insurance in the future.

18

Table of Contents

We may be subject to significant liability should the consumption of any of our products cause illness or physical harm.

The sale of products for human use and consumption involves the risk of injury or illness to consumers. Such injuries may result from inadvertent mislabeling, tampering by unauthorized third parties, product contamination, food-borne illnesses, allergens or spoilage. Under certain circumstances, we may be required to recall or withdraw products, suspend production of our products or cease operations, which could result in increased costs (including payment of fines and/or judgments, cleaning and remediation costs and legal fees, and costs associated with alternative sources of production), cancellation of customer orders and a decline in consumer confidence and demand, any of which could have a material adverse effect on our business. Even if a situation does not necessitate a recall or market withdrawal, product liability claims might be asserted against us. While we are subject to governmental inspection and regulations and believe our facilities and those of our co-manufacturers and suppliers comply in all material respects with all applicable laws and regulations, if the consumption of any of our products causes, or is alleged to have caused, an illness or physical harm, we may become subject to claims or lawsuits relating to such matters. For example, as discussed in Note 18, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K, we are subject to consumer class actions, and other lawsuits alleging some form of personal injury, relating to our Earth’s Best® baby food products. Even if a claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products were mislabeled, unsafe or caused illness or physical harm could adversely affect our reputation with existing and potential customers and consumers and our corporate and brand image. Our business could also be adversely affected if consumers lose confidence in the quality, safety and integrity of certain food products or ingredients, or the food safety system generally, even if such loss of confidence is unrelated to products in our portfolio. Although we maintain product liability and product recall insurance in an amount that we believe to be adequate, we may incur claims or liabilities for which we are not insured or that exceed the amount of our insurance coverage. A product liability judgment against us or a product recall could have a material adverse effect on our business, results of operations and financial condition.

Government regulation could subject us to civil and criminal penalties, and any changes in the legal and regulatory frameworks in which we operate could make it more costly or challenging to manufacture and sell our products.

We operate in a highly regulated environment with constantly evolving legal and regulatory frameworks. Consequently, we are subject to a heightened risk of legal claims, government investigations and other regulatory enforcement actions. We are subject to extensive regulations in the United States, United Kingdom, Canada, Europe and any other countries where we manufacture, distribute and/or sell our products. The conduct of our business is subject to numerous laws and regulations relating to the registration and approval of our products, sourcing, manufacturing, storing, labeling, marketing, advertising, content (including whether a product contains genetically modified ingredients), quality, safety, transportation, supply chain, traceability, distribution, packaging, disposal, recycling, employment and occupational health and safety, environmental matters, machine learning and artificial intelligence and data privacy and protection. Enforcement of existing laws and regulations, changes in legal or regulatory requirements and/or evolving interpretations of existing requirements may result in increased compliance costs or otherwise make it more costly or challenging to manufacture and sell our products, which could materially adversely affect our business, financial condition or operating results.

Moreover, a failure to maintain effective control processes could lead to violations, unintentional or otherwise, of laws and regulations. Legal claims, government investigations or regulatory enforcement actions arising out of our failure or alleged failure to comply with applicable laws and regulations could subject us to civil and criminal penalties that could materially and adversely affect our product sales, reputation, financial condition and operating results. In addition, the costs and other effects of defending potential and pending litigation and administrative actions against us may be difficult to determine and could adversely affect our financial condition and operating results.

We have identified a material weakness in our internal control over financial reporting relating to goodwill and indefinite-lived intangible asset impairment testing. If we are unable to remediate this material weakness, or if we experience additional material weaknesses or deficiencies in the future or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or timely report our financial results, in which case our business may be harmed, investors may lose confidence in the accuracy and completeness of our financial reports and the price of our common stock may decline.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

In connection with our most recent year-end assessment of internal control over financial reporting, we identified a material weakness in our internal control over financial reporting as of June 30, 2025. Specifically, we did not design and operate effective controls as of June 30, 2025 to review on a timely basis and in sufficient detail the projected financial information and certain key assumptions and underlying calculations used in goodwill and indefinite-lived intangible asset quantitative impairment tests that were performed throughout the year related to our reporting units. These control deficiencies did not result in a material misstatement of the impairment losses in the interim or annual consolidated financial statements and there were no changes to

19

Table of Contents

previously issued financial statements. For a more detailed discussion of our internal control over financial reporting and a description of the identified material weakness, see Part II, Item 9A, “Controls and Procedures.”

As further described in Item 9A “Controls and Procedures – Management’s Report on Internal Control Over Financial Reporting,” we are conducting a detailed review and performing remediation activities, including implementation of control design changes to ensure that control objectives are met. The material weakness in our internal control over financial reporting will not be considered remediated until the remediated controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We may not be successful in making the improvements necessary to remediate the material weakness identified by management or be able to do so in a timely manner, or be able to identify and remediate additional control deficiencies or material weaknesses in the future. Any implementation delays, or disruption in the transition to new or enhanced procedures or controls, could harm our ability to record and report financial information on a timely and accurate basis, which could cause stockholders to lose confidence in our reported financial information and adversely affect our business and the value of our common stock.

Compliance with data privacy laws may be costly, and non-compliance with such laws may result in significant liability.

Many jurisdictions in which the Company operates have laws and regulations relating to data privacy and protection of personal information, including the European Union GDPR and the California Consumer Privacy Act of 2018 (“CCPA”), as amended by the California Privacy Rights Act (“CPRA”), among other U.S. state laws. Failure to comply with GDPR or CCPA requirements or other data privacy laws could result in litigation, adverse publicity and significant penalties and damages. The law in this area continues to develop, and the changing nature of privacy laws could impact the Company’s processing of personal information related to the Company’s job applicants, employees, consumers, customers and vendors. The enactment of more restrictive laws, rules or regulations or future enforcement actions or investigations could impact us through increased costs or restrictions on our business, and noncompliance could result in regulatory penalties and significant liability.

We may be subject to significant liability that is not covered by insurance.

While we believe that the extent of our insurance coverage is consistent with industry practice, such coverage does not cover all losses we may incur, even in areas for which we have coverage. Our insurance policies are subject to coverage exclusions, deductibles and caps, and any claim we make under our insurance policies may be subject to such limitations. Any claim we make may not be honored fully, in a timely manner, or at all, and we may not have purchased sufficient insurance to cover all losses incurred. If we were to incur substantial liabilities or if our business operations were interrupted for a substantial period of time, we could incur costs and suffer losses. Additionally, in the future, insurance coverage may not be available to us at commercially acceptable premiums, or at all.

Risks Related to Environmental Considerations

Climate impacts may negatively affect our business and operations.

There is concern that carbon dioxide and other greenhouse gases in the atmosphere may have an adverse impact on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters. There have recently been numerous extreme weather and climate-related events, including historic droughts, heatwaves, wildfires, extreme cold and flooding. To the extent that these events have a negative effect on agricultural productivity, we may be subject to decreased availability or less favorable pricing for certain commodities that are necessary for our products, such as vegetables, fruits, grains, beans and nuts. We may also be subjected to decreased availability of water, deteriorated quality of water or less favorable pricing for water, which could adversely impact our manufacturing and distribution operations.

In light of climate impacts, demand for sustainable products may increase, requiring us to incur incremental costs for additional transparency, due diligence and reporting. Moreover, the investment community, customers, consumers, employees, activists, media, regulators and other stakeholders, some of whom may have conflicting opinions, may scrutinize our sustainability initiatives, including any related goals, targets, methodologies or timelines. Any failure to meet stakeholder expectations on environmental or sustainability matters or any perception of a failure to act responsibly with respect to the environment could lead to adverse publicity, adversely impact our financial results and/or expose us to regulatory and legal risks. As a result, climate impacts and our actions related thereto could negatively affect our business and operations.

Liabilities, claims or new laws or regulations with respect to environmental matters could have a significant negative impact on our business.

The nature of our operations exposes us to the risk of liabilities and claims with respect to environmental matters, including those relating to the disposal and release of hazardous substances. Furthermore, our operations are governed by laws and regulations relating to workplace safety and worker health, which, among other things, regulate employee exposure to hazardous chemicals

20

Table of Contents

in the workplace. Any material costs incurred in connection with such liabilities or claims could have a material adverse effect on our business, results of operations and financial condition.

Global focus on climate impacts may lead to new environmental laws and regulations that impact our business. For example, there are a growing number of laws and regulations regarding product packaging, particularly in Europe. Our compliance with such existing laws and regulations and any new laws or regulations enacted in the future, or any changes in how existing laws or regulations will be enforced, administered or interpreted, may lead to an increase in compliance costs, cause us to change the way we operate or expose us to additional risk of liabilities and claims, which could have a material adverse effect on our business, results of operations and financial condition.

Risks Related to the Ownership of Our Securities

Our ability to issue preferred stock may deter takeover attempts.

Our Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights, which could decrease the amount of earnings and assets available for distribution to holders of our common stock and adversely affect the relative voting power or other rights of the holders of our common stock. In the event of issuance, the preferred stock could be used as a method of discouraging, delaying or preventing a change in control. Our amended and restated certificate of incorporation authorizes the issuance of up to 5 million shares of “blank check” preferred stock with such designations, rights and preferences as may be determined from time to time by our Board of Directors. Although we have no present intention to issue any shares of our preferred stock, we may do so in the future under appropriate circumstances.

21

Table of Contents

Item 1B. Un resolved Staff Comments

None

22

Table of Contents

Item 1C. Cybersecurity

Cybersecurity Risk Management and Strategy

Our enterprise risk management framework considers cybersecurity risk alongside other applicable risks as part of our overall risk assessment process. Within our comprehensive enterprise risk management framework, our cybersecurity risk management program is focused on assessing, identifying, and managing risks arising out of our use of information technology (“IT”) including the risk of cybersecurity incidents and threats. The program is informed by recognized frameworks such as the National Institute of Standards and Technology Cybersecurity Framework (“NIST CSF”). Our cybersecurity team utilizes a variety of tools, processes and outside resources to continue to raise and maintain its maturity across the elements of NIST CSF.

Our cybersecurity risk management program includes a Cyber Security Incident Response Plan (“CSIRP”). Our CSIRP supports the Company in identifying, containing, and tracking cybersecurity incidents experienced by us or our third-party service providers or suppliers. The CSIRP was established to minimize the impact of cybersecurity incidents on our networks, IT systems, users and business processes, and to ensure the timely and accurate reporting of material cybersecurity incidents, should they occur. The execution of our CSIRP is led by our Chief Information Officer and Head of Business Services (“CIO”), with support from a designated IT Incident Response Manager leading an Incident Response Team consisting of subject matter experts, as well as our Executive Response Team when appropriate. In the event of an incident, these individuals work together to assess its severity, notify and brief the appropriate team members, escalate to our Board of Directors as needed, and implement containment procedures. The Company also conducts tabletop exercises to enhance incident response preparedness and engage s third parties, including consultants and other professionals, on an as-needed basis to assess and support our cybersecurity practices and procedures.

Our cybersecurity risk management program is integrated into our operations and is widely communicated to employees through periodic (not less than annual) employee and contractor cybersecurity awareness training, which includes information about how to identify and report cybersecurity concerns and incidents. Our information technology organization also conducts phishing simulations and testing scenarios to help ensure compliance with our cybersecurity policies and procedures. These awareness measures are coupled with ongoing implementation of technology aimed to reduce vulnerabilities (including external testing and validation) and to monitor and assess threats. Our program includes monitoring on a continuous basis through automated tools and 24x7 managed services that detect threats and trigger alerts for assessment, investigation, and remediation by our information technology organization.

We maintain business continuity and disaster recovery plans to prepare for potential information technology disruptions. We also maintain insurance coverage that, subject to its terms and conditions, is intended to address costs associated with certain aspects of cyber incidents and information systems failures. Based on the information we have as of the date of this Form 10-K, we do not believe any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. See “Item 1A. Risk Factors – Risks Related to Cybersecurity and Technology” for further information about these risks.

Cybersecurity Governance

Our Board of Directors has risk oversight responsibility for the Company, which it administers directly and with assistance from its committees. The Audit Committee assists the Board in its oversight of the cybersecurity risk management program. The Audit Committee is tasked with reviewing and receiving periodic reports from management regarding the Company’s information technology system controls and security and, at least annually, evaluating the adequacy of the Company’s information technology security program, compliance, governance processes, training and controls. The Audit Committee specifically oversees:

•
management’s evaluation of the potential impact of cybersecurity risk exposures on the Company’s business, financial results, operations and reputation,
•
the steps management has taken to monitor and mitigate such exposures,
•
major legislative and regulatory developments that could materially impact such exposure, and
•
the Company’s incident response planning (including escalation protocols), including with respect to the prompt reporting of material cybersecurity threats or incidents to management, the Audit Committee and the Board of Directors.

Our CIO periodically provides the Executive Leadership Team, which consists of the Company’s executive officers and other senior leaders, with cybersecurity briefings, information and trainings, and updates the Audit Committee on cybersecurity

23

Table of Contents

biannually or more frequently as appropriate. At any time, Board members may raise concerns regarding the Company’s cybersecurity posture and recommend changes regarding controls or procedures to management. Our CSIRP includes a process for incidents to be evaluated for material impact, with an escalation protocol requiring reporting of material incidents to the Executive Response Team and to the Board of Directors.

The CIO is the management position with primary responsibility for the development, operation, and maintenance of our cybersecurity risk management program. The CIO has deep experience in information systems and technology, including developing information and cybersecurity programs, roll-outs of new technology, information security audit and assessments, and cybersecurity operations focused on identification, mitigation and response to cybersecurity threats. The CIO has experience overseeing and executing technology strategies in complex, global, and matrixed environments. The CIO joined the Company in 2020, bringing over 15 years of experience leading IT strategy and change initiatives in the consumer packaged goods industry, and reports directly to our interim CEO.

24

Table of Contents

Item 2. Pr operties

Our principal facilities, which are leased except where otherwise indicated, are as follows:

Primary Use |  | Location |  | Approximate Square Feet |  |  | Expiration of Lease
North America: |  |  |  |  |  |  |
Global Headquarters |  | Hoboken, NJ |  |  | 39,990 |  |  | 2034
Distribution - All brands |  | Allentown, PA |  |  | 497,000 |  |  | 2032
Manufacturing and distribution center (Snack products) |  | Mountville, PA |  |  | 161,000 |  |  | 2040
Manufacturing and offices (Tea) |  | Boulder, CO |  |  | 158,000 |  |  | Owned
Distribution (Dry goods) |  | Mississauga, ON, Canada |  |  | 136,000 |  |  | 2029
Manufacturing and distribution (Snack products)* |  | Lancaster, PA |  |  | 119,000 |  |  | 2031
Distribution (Personal care) |  | Mississauga, ON, Canada |  |  | 81,000 |  |  | 2029
Manufacturing (Plant-based foods)* |  | Vancouver, BC, Canada |  |  | 76,000 |  |  | Owned
Manufacturing and offices (Personal care) |  | Mississauga, ON, Canada |  |  | 61,000 |  |  | 2028
Distribution (Tea) |  | Boulder, CO |  |  | 57,000 |  |  | 2031
International: |  |  |  |  |  |  |
Manufacturing and offices (Ambient grocery products) |  | Histon, England |  |  | 303,000 |  |  | Owned
Manufacturing, distribution and offices (Plant-based beverages) |  | Troisdorf, Germany |  |  | 131,000 |  |  | 2037
Manufacturing (Plant-based foods and beverages) |  | Oberwart, Austria |  |  | 117,000 |  |  | At will
Manufacturing (Plant-based frozen and chilled products) |  | Fakenham, England |  |  | 101,000 |  |  | Owned
Distribution |  | Gent, Belgium |  |  | 64,000 |  |  | At will
Distribution |  | Niederziers, Germany |  |  | 54,000 |  |  | At will
Manufacturing (Chilled soups) |  | Grimsby, England |  |  | 54,000 |  |  | 2029
Distribution (Soups, hot-eat desserts, chilled products, grocery) |  | Peterborough, England |  |  | 43,000 |  |  | 2026
Manufacturing (Hot-eat desserts) |  | Clitheroe, England |  |  | 42,000 |  |  | 2031
Distribution |  | Loipersdorf, Austria |  |  | 41,000 |  |  | At will
Manufacturing and distribution (Plant-based foods and beverages) |  | Schwerin, Germany |  |  | 36,000 |  |  | Owned

* Property is planned to be closed in fiscal 2026.

We also lease space for other smaller offices and facilities in the United States, United Kingdom, Canada, Western Europe and other parts of the world.

In addition to the foregoing distribution facilities operated by us, we also utilize bonded public warehouses from which deliveries are made to customers.

For further information regarding our lease obligations, see Note 8, Leases, in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K. For further information regarding the use of our properties by segments, see Item 1, “Business - Production” of this Form 10-K.

Item 3. Le gal Proceedings

The information called for by this item is incorporated herein by reference to Note 18, Commitments and Contingencies, in the Notes to the Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K.

Item 4. Mine Safety Disclosures

Not applicable.

25

Table of Contents

PA RT II

Item 5. Market for Regist rant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Outstanding shares of our common stock, par value $0.01 per share, are listed on The Nasdaq Stock Market LLC under the ticker symbol “HAIN”.

Holders

As of September 9, 2025, there were 219 holders of record of our common stock.

Dividends

We have not paid any cash dividends on our common stock to date. The payment of all dividends will be at the discretion of our Board of Directors and will depend on, among other things, future earnings, operations, capital requirements, contractual restrictions, including restrictions under our credit facility, our general financial condition and general business conditions.

Issuance of Unregistered Securities

None.

Issuer Purchases of Equity Securities

During the three months ended June 30, 2025, there were no shares repurchased under share repurchase programs approved by the Board of Directors.

During the three months ended June 30, 2025, there were 13,062 shares withheld by the Company to satisfy tax withholding obligations in connection with shares issued under stock-based compensation plans, at an average price of $2.54 per share. These shares withheld to satisfy tax withholding obligations do not constitute repurchases by the Company.

Share Repurchase Program

In January 2022, the Company’s Board of Directors authorized the repurchase of up to $200 million of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the fiscal year ended June 30, 2025, the Company did not repurchase any shares under the repurchase program. As of June 30, 2025, the Company had $173.5 million of remaining authorization under the share repurchase program.

26

Table of Contents

Stock Performance Graph

The following graph compares the cumulative total shareholder return on our common stock during the period from June 30, 2020 through June 30, 2025 to the cumulative total shareholder return during such period on (1) the S&P SmallCap 600 Index and (2) the S&P Food & Beverage Select Industry Index (in which the Company is included).

Item 6. [Re served]

27

Table of Contents

Item 7. Management’s Discussi on and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (this “MD&A”) should be read in conjunction with Item 1A and the Consolidated Financial Statements and the related notes thereto for the period ended June 30, 2025 included in Item 8 of this Form 10-K. Forward-looking statements in this Form 10-K are qualified by the cautionary statement included under the heading, “Forward-Looking Statements” at the beginning of this Form 10-K.

This MD&A generally discusses fiscal 2025 and fiscal 2024 items and year-to-year comparisons between fiscal 2025 and fiscal 2024. Discussions of fiscal 2023 items and year-to-year comparisons between fiscal 2024 and fiscal 2023 that are not included in this Form 10-K can be found in “Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024, which was filed with the SEC on August 27, 2024 and is available on the SEC’s website at www.sec.gov.

Overview

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” “Hain Celestial,” “we,” “us” or “our”) is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby/kids, beverages and meal preparation are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley’s® jelly, Earth’s Best® Organic and Ella’s Kitchen® baby and kid’s foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, The Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, among others.

Strategic Review

We are focused on five actions to win in the marketplace and drive growth: aggressively streamlining our portfolio, accelerating brand renovation and innovation, implementing price increases along with broader revenue growth management, driving productivity and working capital efficiency, and enhancing our digital capabilities, inclusive of ecommerce.

During the fourth quarter of fiscal year 2025, we announced that our Board of Directors was conducting a comprehensive review of the Company’s portfolio with the assistance of our independent financial advisor. The Board is considering a broad range of strategic options to enhance value. Also, in the third quarter of fiscal year 2025, we announced that we were exploring strategic alternatives regarding our personal care business to focus on our portfolio of better-for-you food and beverages.

Restructuring Program

During the first quarter of fiscal year 2024, we initiated a multi-year growth, transformation and restructuring program (the “Restructuring Program”) intended to drive shareholder returns. The savings initiatives impact our reportable segments and Corporate and Other. The program is intended to optimize our portfolio, improve underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth.

Implementation of the Restructuring Program is expected to be completed by the end of the 2027 fiscal year. Cumulative pretax charges associated with the Restructuring Program are expected to be $100 million - $110 million comprised of contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses, which represents an increase of $10 million from the previously reported range. For the fiscal years ended June 30, 2025 and June 30, 2024, we incurred pretax charges of $26 million and $60 million, respectively, associated with the Restructuring Program.

As part of the Restructuring Program, the Company completed the sale of three non-core brands and our investment in a joint venture during fiscal 2024 and fiscal 2025. We also announced the exit of the Yves Veggie Cuisine® plant-based business in Canada, which is expected to be completed in the second quarter of fiscal 2026. We initiated actions to consolidate our personal care manufacturing footprint and exit our non-strategic joint venture in India, which were substantially completed in the first quarter of fiscal 2025. The Company also initiated actions to: (i) simplify its distribution footprint in the U.S.; (ii) rationalize certain product categories for greater capacity utilization, cost reduction and margin expansion; and (iii) reduce office space. Annualized pretax savings are expected to be $130 million - $150 million. The gross savings to date reflect operating model savings, productivity delivery and benefits from revenue growth management initiatives, offset by volume deleveraging and input cost inflation.

28

Table of Contents

CEO Succession

On May 7, 2025, the Company announced that Ms. Davidson departed as President and Chief Executive Officer and as a member of the Board effective May 6, 2025. The Hain Board is executing its leadership succession plan to identify the Company’s next CEO. The Board has a transition plan in place and has appointed Alison E. Lewis, a member of the Board since September 2024, as Interim President and CEO.

Global Economic Environment

The duration and intensity of inflation fluctuations, alterations in consumer shopping and consumption patterns, and shifts in geopolitical events, such as the ongoing Russia-Ukraine conflict, have led and may continue to lead to increased supply chain expenses and other business impacts. Moreover, our industry has experienced and is anticipating the possibility of further increased supply chain challenges, input cost increases and consumer and economic uncertainty as a result of U.S. government tariffs and the imposition of any counter-tariffs. We continually assess the nature and extent of these potential and evolving impacts on our business, consolidated operational results, liquidity, and capital resources.

Results of Operations

Comparison of Fiscal Year Ended June 30, 2025 to Fiscal Year Ended June 30, 2024

Consolidated Results

The following table compares our results of operations, including as a percentage of net sales, on a consolidated basis, for the fiscal years ended June 30, 2025 and 2024 (dollars in thousands, other than per share amounts and percentages, which may not add due to rounding):

|  | Fiscal Year Ended June 30, |  |  | Change in |
|  | 2025 |  |  | 2024 |  |  | Dollars |  |  | Percentage |
Net sales |  | $ | 1,559,780 |  |  |  | 100.0 | % |  | $ | 1,736,286 |  |  |  | 100.0 | % |  | $ | (176,506 | ) |  |  | (10.2 | )%
Cost of sales |  |  | 1,225,722 |  |  |  | 78.6 | % |  |  | 1,355,454 |  |  |  | 78.1 | % |  |  | (129,732 | ) |  |  | (9.6 | )%
Gross profit |  |  | 334,058 |  |  |  | 21.4 | % |  |  | 380,832 |  |  |  | 21.9 | % |  |  | (46,774 | ) |  |  | (12.3 | )%
Selling, general and administrative expenses |  |  | 271,833 |  |  |  | 17.4 | % |  |  | 290,116 |  |  |  | 16.7 | % |  |  | (18,283 | ) |  |  | (6.3 | )%
Goodwill impairment |  |  | 428,882 |  |  |  | 27.5 | % |  |  | — |  |  |  | — |  |  |  | 428,882 |  |  | ** |
Intangibles and long-lived asset impairment |  |  | 66,940 |  |  |  | 4.3 | % |  |  | 76,143 |  |  |  | 4.4 | % |  |  | (9,203 | ) |  |  | (12.1 | )%
Productivity and transformation costs |  |  | 21,530 |  |  |  | 1.4 | % |  |  | 27,741 |  |  |  | 1.6 | % |  |  | (6,211 | ) |  |  | (22.4 | )%
Amortization of acquired intangible assets |  |  | 6,476 |  |  |  | 0.4 | % |  |  | 5,780 |  |  |  | 0.3 | % |  |  | 696 |  |  |  | 12.0 | %
Operating loss |  |  | (461,603 | ) |  |  | (29.6 | )% |  |  | (18,948 | ) |  |  | (1.1 | )% |  |  | (442,655 | ) |  | ** |
Interest and other financing expense, net |  |  | 51,253 |  |  |  | 3.3 | % |  |  | 57,213 |  |  |  | 3.3 | % |  |  | (5,960 | ) |  |  | (10.4 | )%
Other expense, net |  |  | 875 |  |  |  | 0.1 | % |  |  | 4,120 |  |  |  | 0.2 | % |  |  | (3,245 | ) |  |  | (78.8 | )%
Loss before income taxes and equity in net loss of equity-method investees |  |  | (513,731 | ) |  |  | (32.9 | )% |  |  | (80,281 | ) |  |  | (4.6 | )% |  |  | (433,450 | ) |  | ** |
Provision (benefit) for income taxes |  |  | 15,297 |  |  |  | 1.0 | % |  |  | (7,820 | ) |  |  | (0.5 | )% |  |  | 23,117 |  |  | * |
Equity in net loss of equity-method investees |  |  | 1,813 |  |  |  | 0.1 | % |  |  | 2,581 |  |  |  | 0.1 | % |  |  | (768 | ) |  |  | (29.8 | )%
Net loss |  | $ | (530,841 | ) |  |  | (34.0 | )% |  | $ | (75,042 | ) |  |  | (4.3 | )% |  | $ | (455,799 | ) |  | ** |
Adjusted EBITDA |  | $ | 113,789 |  |  |  | 7.3 | % |  | $ | 154,522 |  |  |  | 8.9 | % |  | $ | (40,733 | ) |  |  | (26.4 | )%
Basic and diluted net loss per common share |  | $ | (5.89 | ) |  |  |  |  | $ | (0.84 | ) |  |  |  |  | $ | (5.05 | ) |  | ** |

* Percentage is not meaningful due to one or more amounts being negative.

** Percentage is not meaningful due to significantly lower number or nil value in the comparative period.

29

Table of Contents

Net Sales

Net sales in fiscal 2025 were $1.56 billion, a decrease of $176.5 million, or 10.2%, from net sales of $1.74 billion in fiscal 2024. Results for fiscal 2025 included an unfavorable impact of $87.1 million, or 4.4%, related to divestitures, held for sale businesses, discontinued brands and exited product categories and a favorable impact of $11.6 million, or 0.7%, from foreign exchange, as compared to the prior year. Organic net sales, defined as net sales adjusted to exclude the impact of acquisitions, divestitures, held for sale businesses, discontinued brands, exited product categories and foreign exchange, decreased $101.0 million, or 6.5%, from the prior year. The decrease in each of net sales and organic net sales was primarily due to declines in both the North America and International reportable segments. Additionally, the decrease in organic net sales was comprised of a 4.9% decrease in volume/mix and a 1.6% decrease in price. Further details of changes in net sales by segment are provided below in the Segment Results section.

Gross Profit

Gross profit in fiscal 2025 was $334.1 million, a decrease of $46.8 million, or 12.3%, from $380.8 million in fiscal 2024. Gross profit margin was 21.4% of net sales, compared to 21.9% in the prior year. The decrease in gross profit was driven primarily by the North America reportable segment, mainly due to volume and mix softness along with higher trade spend and inflation, partially offset by productivity improvements. Gross profit also decreased in the International reportable segment mainly due to inflation and volume and mix softness, partially offset by productivity and pricing.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $271.8 million in fiscal 2025, a decrease of $18.3 million, or 6.3%, from $290.1 million in fiscal 2024. The decrease was primarily due to lower broker expenses, employee-related expenses and professional fees.

Goodwill Impairment

As a result of a significant reduction in actual and projected performance and cash flows, as well as the continued decline in the Company’s market capitalization in fiscal 2025, the Company completed quantitative impairment tests for goodwill ascribed to all its reporting units at various times throughout fiscal 2025. Consequently, the Company recorded aggregate non-cash goodwill impairment charges of $357.7 million within the North America segment related to such reporting units and $71.2 million within the International segment related to its U.K. reporting unit. See Note 9, Goodwill and Other Intangible Assets, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.

Intangibles and Long-Lived Asset Impairment

During the fiscal year ended June 30, 2025, the Company recognized aggregate non-cash impairment charges of $66.9 million, including (i) $37.8 million related to Sensible Portions®, Belvedere™ , Imagine®, Health Valley®, and certain North America personal care intangible assets (Avalon Organics® and JASON®) and (ii) a $26.8 million charge primarily related to the personal care assets held for sale. See Note 4, Assets and Liabilities Held for Sale, Note 9, Goodwill and Other Intangible Assets and Note 16, Fair Value Measurements, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

During the fiscal year ended June 30, 2024, the Company recognized aggregate non-cash impairment charges of $76.1 million, including (i) $44.6 million primarily related to ParmCrisps®, Thinsters®, Joya®, Happy™, and certain North America personal care intangible assets (Alba Botanica®, Avalon Organics®, and JASON®) and (ii) a $20.7 million charge related to our Bell, CA production facility in the North America reportable segment. See Note 7, Property, Plant and Equipment, Net, Note 9, Goodwill and Other Intangible Assets, and Note 16, Fair Value Measurements, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

Productivity and Transformation Costs

Productivity and transformation costs were $21.5 million in fiscal 2025, a decrease of $6.2 million or 22.4% from $27.7 million in fiscal 2024. The decrease primarily reflected a reduction in restructuring costs incurred in connection with the Restructuring Program.

Productivity and transformation costs of $21.5 million in fiscal 2025 were primarily comprised of consultancy and employee-related costs in the amount of $13.2 million and $8.3 million, respectively. See Note 19, Transformation Program, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

30

Table of Contents

Amortization of Acquired Intangible Assets

Amortization of acquired intangibles was $6.5 million in fiscal 2025, an increase of $0.7 million, or 12.0%, from $5.8 million in fiscal 2024. The increase was due to the fact that during the fourth quarter of fiscal 2024, personal care tradenames and MaraNatha® and Happy TM and Joya® trademarks were reclassified from indefinite to definite-lived and ascribed a useful life of 10 years.

Operating Loss

Operating loss in fiscal 2025 was $461.6 million compared to $18.9 million in fiscal 2024 due to the items described above.

Interest and Other Financing Expense, Net

Interest and other financing expense, net totaled $51.3 million in fiscal 2025, a decrease of $6.0 million, or 10.4%, from $57.2 million in the prior year. The decrease resulted primarily from a lower outstanding debt balance and the impact of a reduction in borrowing rates compared to the prior year. See Note 11, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

Other Expense, Net

Other expense, net was $0.9 million in fiscal 2025, compared to $4.1 million in the prior year. Other expense, net in fiscal 2025 reflected a $5.4 million pretax gain from the sale of the Company’s minority equity interest in Chop’t Creative Salad Company LLC, predecessor to Founders Table, and a $1.6 million pretax gain on the sale of assets related to the Company’s former Bell, CA production facility. These gains were partially offset by a $3.9 million pretax loss recognized on the sale of ParmCrisps® .and net foreign currency losses. Other expense, net in fiscal 2024 primarily reflected losses on the dispositions of Thinsters® cookie business and Queen Helene® brand, partially offset by net foreign currency gains. See Note 5, Dispositions and Note 15, Investments, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.

Loss Before Income Taxes and Equity in Net Loss of Equity-Method Investees

Loss before income taxes and equity in the net loss of our equity-method investees for fiscal 2025 was $513.7 million compared to $80.3 million in fiscal 2024. The decrease was due to the items discussed above.

Provision (benefit) for Income Taxes

The provision (benefit) for income taxes includes federal, foreign, state and local income taxes. Our income tax expense was $15.3 million for fiscal 2025 compared to a benefit of $7.8 million for fiscal 2024. Income tax in fiscal 2025 reflected current tax on operations in certain jurisdictions and an increase in the accrual for uncertain tax positions, partially offset by a release in the valuation allowance against certain deferred tax assets. We did not record income tax benefits for losses incurred in certain jurisdictions, as it is not more likely than not that we will utilize such benefits due to the combination of our history of pretax losses and our inability to carry forward or carry back tax losses or credits.

The effective income tax rate was an expense of 3.0% and a benefit of 9.7% for the fiscal year ended June 30, 2025 and 2024, respectively. The effective income tax rate for the year ended June 30, 2025 was primarily impacted by the recognition of a valuation allowance as a result of the reduction in deferred tax liabilities due to the above-noted impairment charges on intangible assets and recognition of uncertain tax positions.

The effective income tax rate for the year ended June 30, 2024 was primarily impacted by the recognition of a valuation allowance against deferred tax assets.

Our effective tax rate may change from period-to-period based on recurring and nonrecurring factors including the geographical mix of earnings, enacted tax legislation, state and local income taxes and tax audit settlements.

See Note 12, Income Taxes, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K for additional information.

Equity in Net Loss of Equity-Method Investees

Our equity in the net loss from our equity method investments for fiscal 2025 was $1.8 million compared to $2.6 million for fiscal 2024. See Note 15, Investments, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.

31

Table of Contents

Net Loss

Net loss for fiscal 2025 was $530.8 million, or $5.91 per diluted share, compared to $75.0 million, or $0.84 per diluted share, in fiscal 2024. The change was attributable to the factors noted above.

Adjusted EBITDA

Our consolidated Adjusted EBITDA was $113.8 million and $154.5 million for fiscal 2025 and 2024, respectively, as a result of the factors discussed above. See Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation of our net income to Adjusted EBITDA.

Segment Results

The following table provides a summary of net sales and Adjusted EBITDA by reportable segment for the fiscal years ended June 30, 2025 and 2024:

(Dollars in thousands) |  | North America |  |  | International |  |  | Corporate and Other |  |  | Consolidated |
Net Sales |  |  |  |  |  |  |  |  |  |  |  |
Fiscal 2025 |  | $ | 888,626 |  |  | $ | 671,154 |  |  | $ | — |  |  | $ | 1,559,780 |
Fiscal 2024 |  | $ | 1,055,527 |  |  | $ | 680,759 |  |  | $ | — |  |  | $ | 1,736,286 |
$ change |  | $ | (166,901 | ) |  | $ | (9,605 | ) |  | n/a |  |  | $ | (176,506 | )
% change |  |  | (15.8 | )% |  |  | (1.4 | )% |  | n/a |  |  |  | (10.2 | )%
Adjusted EBITDA |  |  |  |  |  |  |  |  |  |  |  |
Fiscal 2025 |  | $ | 65,470 |  |  | $ | 86,000 |  |  | $ | (37,681 | ) |  | $ | 113,789 |
Fiscal 2024 |  | $ | 98,728 |  |  | $ | 94,974 |  |  | $ | (39,180 | ) |  | $ | 154,522 |
$ change |  | $ | (33,258 | ) |  | $ | (8,974 | ) |  | $ | 1,499 |  |  | $ | (40,733 | )
% change |  |  | (33.7 | )% |  |  | (9.4 | )% |  |  | 3.8 | % |  |  | (26.4 | )%
Adjusted EBITDA margin |  |  |  |  |  |  |  |  |  |  |  |
Fiscal 2025 |  |  | 7.4 | % |  |  | 12.8 | % |  | n/a |  |  |  | 7.3 | %
Fiscal 2024 |  |  | 9.4 | % |  |  | 14.0 | % |  | n/a |  |  |  | 8.9 | %

See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations and Note 21, Segment Information, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for a reconciliation of segment Adjusted EBITDA.

North America

Our net sales in the North America reportable segment for fiscal 2025 were $888.6 million, a decrease of $166.9 million, or 15.8%, including an unfavorable impact of $85.2 million, or 6.4%, related to divestitures, held for sale businesses, discontinued brands and exited product categories, as compared to the prior year. Organic net sales decreased $79.6 million, or 9.2%, to $788.9 million from $868.5 million in the prior year.

The decrease in net sales was primarily due to lower sales in the snacks, meal preparation and personal care categories. The decrease in organic net sales was largely attributable to softness in the snacks category, as a result of velocity challenges and distribution losses, and to a lesser extent, by lower sales in the meal preparation category. The decline in meal preparation was primarily driven by softness in oils and nut butters, partially offset by growth in yogurt.

Adjusted EBITDA in fiscal 2025 was $65.5 million, a decrease of $33.2 million from $98.7 million in fiscal 2024. The decrease was primarily related to volume and mix softness along with higher trade spend, partially offset by productivity initiatives and a reduction in selling, general, and administrative expenses, mainly due to lower selling expenses and employee-related costs. Adjusted EBITDA margin was 7.1%, a 200-basis point decrease from the prior year.

32

Table of Contents

International

Net sales in the International reportable segment for fiscal 2025 were $671.2 million, a decrease of $9.6 million, or 1.4%, including a favorable impact of $13.7 million or 2.0% related to foreign exchange, as compared to the prior year. Organic net sales decreased $21.4 million, or 3.2%, to $654.7 million from $676.1 million in fiscal 2024.

The decrease in net sales for fiscal 2025 was primarily driven by lower sales in the beverage and snacks categories. Organic net sales also declined, mainly due to softness in the meal preparation and beverages categories. The decline in meal preparation was primarily driven by lower sales in meat-free and private label spreads and drizzles, partially offset by growth in soups in the United Kingdom. The decline in beverages was primarily driven by softness in private label non-dairy beverage in Western Europe.

Adjusted EBITDA in fiscal 2025 was $86.0 million, a decrease of $9.0 million from $95.0 million in fiscal 2024. The decrease was primarily driven by inflation and volume and mix softness, partially offset by productivity and pricing. Adjusted EBITDA margin was 12.8%, a 120-basis point decrease from the prior year.

Corporate and Other

The decrease in Corporate and Other expenses primarily reflected lower consulting charges and employee-related expenses. Refer to Note 21, Segment Information, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for additional details.

33

Table of Contents

Liquidity and Capital Resources

We finance our operations and growth primarily with the cash flows we generate from our operations and from borrowings available to us under our Credit Agreement (as defined below). We believe that our cash flows from operations and borrowing capacity under our Credit Agreement (as defined below) will be adequate to meet anticipated operating and other expenditures for the foreseeable future. See Note 11, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

Amended and Restated Credit Agreement

On December 22, 2021, the Company entered into a Fourth Amended and Restated Credit Agreement (as subsequently amended, the “Credit Agreement”). The Credit Agreement originally provided for senior secured financing of $1,100.0 million in the aggregate, consisting of (1) $300.0 million in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800.0 million senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and was originally comprised of a $440.0 million U.S. revolving credit facility and $360.0 million global revolving credit facility) (the “Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. The Company’s obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement. Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023, 5.00:1.00 until December 31, 2024, and 4.25:1.00 thereafter. See below for a description of the Third Amendment and Fourth Amendment (each as defined below). Following the Fourth Amendment, the Company’s maximum consolidated secured leverage ratio under the Credit Agreement was 5.00:1.00 until June 30, 2025 and is 5.50:1.00 for the quarter ending September 30, 2025 and thereafter. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00 and, through June 30, 2025, its minimum interest coverage ratio was 2.50:1.00. As of June 30, 2025, the Company’s consolidated secured leverage ratio, consolidated leverage ratio and consolidated interest coverage ratio were 4.69:1.00, 4.69:1.00 and 2.93:1.00, respectively, and the Company was in compliance with all associated covenants. The aforementioned financial covenants are being reported as calculated under the Credit Agreement and not pursuant to accounting principles generally accepted in the U.S. (“GAAP”). Please refer to the Credit Agreement and amendments filed as exhibits to this Form 10-K for further information related to the calculation thereof. For risks related to our indebtedness and compliance with these covenants, please refer to the risk factor “Any default under our credit agreement or inability to refinance our indebtedness could have significant consequences” set forth in Part I, Item 1A, “Risk Factors” of this Form 10-K.

From the date of the Second Amendment until the date of the Third Amendment, loans under the Credit Agreement bore interest at (a) the Secured Overnight Financing Rate plus a credit spread adjustment of 0.10% (“Term SOFR”) plus 2.5% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 1.5% per annum.

On May 5, 2025, the Company entered into a Third Amendment (the “Third Amendment”) to the Credit Agreement. Pursuant to the Third Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 4.75:1.00 for the quarter ending June 30, 2025 through (and including) the quarter ending March 31, 2026, 4.50:1.00 for the quarter ending June 30, 2026, and 4.25:1.00 for the quarter ending September 30, 2026 and thereafter.

Commencing on the date of the Third Amendment, loans under the Credit Agreement bore interest at (a) Term SOFR plus 3.00% per annum or (b) the Base Rate plus 2.00% per annum.

The Third Amendment also reduced the size of the Revolver from $800.0 million to $700.0 million in the aggregate, with the U.S. revolving credit facility reduced from $440.0 million to $385.0 million and the global revolving credit facility reduced from $360.0 million to $315.0 million.

On September 11, 2025, the Company entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement. Pursuant to the Fourth Amendment, (x) the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 for the quarter ending June 30, 2025 and 5.50:1.00 for the quarter ending September 30, 2025 and thereafter, (y) the Company’s minimum consolidated interest coverage ratio was amended to be 2.00:1.00 for the quarter ending September 30, 2025 and thereafter and (z) a covenant was added requiring the Company to maintain a minimum Consolidated EBITDA (as such term is defined in the Credit Agreement as amended by the Fourth Amendment) of (i) $17.0 million for the quarter ending September 30, 2025 and (ii) $52.0 million for the cumulative two quarters ending September 30, 2025 and on December 31, 2025. The aforementioned financial covenants use financial measures that are defined under the Credit Agreement and not

34

Table of Contents

pursuant to GAAP. Please refer to the Credit Agreement and amendments filed as exhibits to this Form 10-K for further information related to the calculation thereof.

Commencing on the date of the Fourth Amendment, loans under the Credit Agreement bear interest at (a) Term SOFR plus 4.00% per annum or (b) the Base Rate plus 3.00% per annum.

The Fourth Amendment also reduced the size of the Revolver from $700.0 million to $600.0 million in the aggregate, with the U.S. revolving credit facility reduced from $385.0 million to $330.0 million and the global revolving credit facility reduced from $315.0 million to $270.0 million.

Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 7.34%. The Company uses interest rate swaps to hedge a portion of the interest rate risk related to its outstanding variable rate debt. As of June 30, 2025, the notional amount of the interest rate swaps was $400.0 million with fixed rate payments of 6.12%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 6.41%. Additionally, the Credit Agreement contains a commitment fee of 0.25% per annum on the amount unused under the Credit Agreement.

As of June 30, 2025, there were $450.5 million of loans under the Revolver, $255.6 million of Term Loans, and $2.8 million of letters of credit outstanding under the Credit Agreement. As of June 30, 2025 and June 30, 2024, $246.7 million and $321.8 million, respectively, was available under the Credit Agreement, subject to compliance with the financial covenants. As of June 30, 2025, the Company was in compliance with all associated covenants.

Cash and Cash Equivalents

Our cash and cash equivalents balance was relatively consistent at June 30, 2025 at $54.4 million as compared to $54.3 million at June 30, 2024. Our working capital was $252.9 million at June 30, 2025, a decrease of $22.7 million from $275.6 million at the end of fiscal 2024. Additionally, our total debt decreased by $39.3 million at June 30, 2025 to $704.8 million as compared to $744.1 million at June 30, 2024 as a result of net repayments carried out during the year.

Our cash balances are held in the U.S., U.K., Canada, Western Europe, the Middle East and India. As of June 30, 2025, substantially all cash was held outside of the U.S.

We maintain our cash and cash equivalents primarily in money market funds or their equivalent. Accordingly, we do not believe that our investments have significant exposure to interest rate risk.

Cash Provided by (Used in) Operating, Investing and Financing Activities

Cash provided by (used in) operating, investing and financing activities is summarized below.

|  | Fiscal Year Ended June 30, |  |  |  |
(Amounts in thousands) |  | 2025 |  |  | 2024 |  |  | Change in Dollars |
Cash flows provided by (used in): |  |  |  |  |  |  |  |  |
Operating activities |  | $ | 22,115 |  |  | $ | 116,355 |  |  | $ | (94,240 | )
Investing activities |  |  | 3,619 |  |  |  | (23,922 | ) |  |  | 27,541 |
Financing activities |  |  | (43,886 | ) |  |  | (89,729 | ) |  |  | 45,843 |
Effect of exchange rate changes on cash |  |  | 18,200 |  |  |  | (1,761 | ) |  |  | 19,961 |
Net increase in cash and cash equivalents |  | $ | 48 |  |  | $ | 943 |  |  | $ | (895 | )

Cash provided by operating activities was $22.1 million for the fiscal year ended June 30, 2025, a decrease of $94.2 million from cash provided by operating activities of $116.4 million in the prior year. This decrease in cash provided by operating activities versus the prior year resulted primarily from a reduction in cash earnings and higher cash utilization of $41.6 million for our working capital accounts, which was mainly due to higher inventory and a reduced benefit from accounts payable and accrued expenses, partially offset by an increase in accounts receivable recovery.

Cash provided by investing activities was $3.6 million for the fiscal year ended June 30, 2025, an increase of $27.5 million from cash used in investing activities of $23.9 million in the prior year. The increase in cash provided by investing activities was primarily driven by the 2025 receipt of sale proceeds and dividends from the sale of our equity method investment of $12.6 million, an $8.2 million reduction in capital expenditures, and an increase in proceeds from asset sales of $4.4 million. See Note 5, Dispositions and Note 15, Investments, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

35

Table of Contents

Cash used in financing activities was $43.9 million for the fiscal year ended June 30, 2025, a decrease of $45.8 million compared to $89.7 million in the prior year, primarily reflecting a reduction in the repayment of borrowings.

Free Cash Flow

Our Free Cash Flow was negative $3.2 million for fiscal 2025, a decrease of $86.1 million from fiscal 2024. This year-over-year decline was primarily driven by a $94.2 million reduction in cash flows from operating activities, as explained above, partially offset by lower capital expenditures. See the Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures following the discussion of our results of operations for definitions and a reconciliation from our net cash provided by operating activities to Free Cash Flow.

Share Repurchase Program

In January 2022, the Company’s Board of Directors authorized the repurchase of up to $200.0 million of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the fiscal year ended June 30, 2025, the Company did not repurchase any shares under the repurchase program. As of June 30, 2025, the Company had $173.5 million of remaining authorization under the share repurchase program.

Reconciliation of Non-U.S. GAAP Financial Measures to U.S. GAAP Measures

We have included in this report measures of financial performance that are not defined by U.S. GAAP. We believe that these measures provide useful information to investors and include these measures in other communications to investors.

For each of these non-U.S. GAAP financial measures, we are providing below a reconciliation of the differences between the non-U.S. GAAP measure and the most directly comparable U.S. GAAP measure, an explanation of why our management and Board of Directors believe the non-U.S. GAAP measure provides useful information to investors and any additional purposes for which our management and Board of Directors use the non-U.S. GAAP measures. These non-U.S. GAAP measures should
be viewed in addition to, and not in lieu of, the comparable U.S. GAAP measures.

Organic Net Sales

As noted above, we define organic net sales as net sales excluding the impact of acquisitions, divestitures, held for sale businesses, discontinued brands, exited product categories and foreign exchange. To adjust organic net sales for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To adjust organic net sales for the impact of divestitures, held for sale businesses, discontinued brands and exited product categories, the net sales of a divested business, held for sale business, discontinued brand or exited product category are excluded from all periods. To adjust organic net sales for the impact of foreign exchange, current period net sales for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year.

36

Table of Contents

A reconciliation between reported net sales and organic net sales is as follows:

(Dollars in thousands) |  | North America |  |  | International |  |  | Hain Consolidated |
Net sales - Twelve months ended June 30, 2025 |  | $ | 888,626 |  |  | $ | 671,154 |  |  | $ | 1,559,780 |
Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories |  |  | 101,789 |  |  |  | 2,771 |  |  |  | 104,560 |
Less: Impact of foreign currency exchange |  |  | (2,074 | ) |  |  | 13,691 |  |  |  | 11,617 |
Organic net sales - Twelve months ended June 30, 2025 |  | $ | 788,911 |  |  | $ | 654,692 |  |  | $ | 1,443,603 |
Net sales - Twelve months ended June 30, 2024 |  | $ | 1,055,527 |  |  | $ | 680,759 |  |  | $ | 1,736,286 |
Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories |  |  | 186,979 |  |  |  | 4,709 |  |  |  | 191,688 |
Organic net sales - Twelve months ended June 30, 2024 |  | $ | 868,548 |  |  | $ | 676,050 |  |  | $ | 1,544,598 |
Net sales decline |  |  | (15.8 | )% |  |  | (1.4 | )% |  |  | (10.2 | )%
Less: Impact of divestitures, held for sale businesses, discontinued brands and exited product categories |  |  | (6.4 | )% |  |  | (0.2 | )% |  |  | (4.4 | )%
Less: Impact of foreign currency exchange |  |  | (0.2 | )% |  |  | 2.0 | % |  |  | 0.7 | %
Organic net sales decline |  |  | (9.2 | )% |  |  | (3.2 | )% |  |  | (6.5 | )%

Adjusted EBITDA

The Company defines Adjusted EBITDA as net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity investees, stock-based compensation, net, unrealized and certain realized currency losses, certain litigation expenses, net, CEO succession costs, plant closure related costs, net, warehouse and manufacturing consolidation and other costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, (gains) losses on sales of assets, goodwill impairment, intangibles and long-lived asset impairment and other adjustments. The Company’s management believes that this presentation provides useful information to management, analysts and investors regarding certain additional financial and business trends relating to its results of operations and financial condition. In addition, management uses this measure for reviewing the financial results of the Company and as a component of performance-based executive compensation. Adjusted EBITDA is a non-U.S. GAAP measure and may not be comparable to similarly titled measures reported by other companies.

We do not consider Adjusted EBITDA in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. The principal limitation of Adjusted EBITDA is that it excludes certain expenses and income that are required by U.S. GAAP to be recorded in our consolidated financial statements. In addition, Adjusted EBITDA is subject to inherent limitations as this metric reflects the exercise of judgment by management about which expenses and income are excluded or included in determining Adjusted EBITDA. In order to compensate for these limitations, management presents Adjusted EBITDA in connection with U.S. GAAP results.

37

Table of Contents

A reconciliation of net loss to Adjusted EBITDA is as follows:

|  | Fiscal Year Ended June 30, |
(Amounts in thousands) |  | 2025 |  |  | 2024 |
Net loss |  | $ | (530,841 | ) |  | $ | (75,042 | )
Depreciation and amortization |  |  | 44,259 |  |  |  | 44,665 |
Equity in net loss of equity-method investees |  |  | 1,813 |  |  |  | 2,581 |
Interest expense, net |  |  | 47,773 |  |  |  | 54,232 |
Provision (benefit) for income taxes |  |  | 15,297 |  |  |  | (7,820 | )
Stock-based compensation, net |  |  | 8,149 |  |  |  | 12,704 |
Unrealized and certain realized currency losses |  |  | 3,823 |  |  |  | 17 |
Certain litigation expenses, net(a) |  |  | 3,473 |  |  |  | 7,262 |
Restructuring activities |  |  |  |  |  |
Productivity and transformation costs |  |  | 21,530 |  |  |  | 27,741 |
Plant closure related costs, net |  |  | 1,215 |  |  |  | 5,251 |
Warehouse/manufacturing consolidation and other costs, net |  |  | 384 |  |  |  | 995 |
CEO succession |  |  | 4,774 |  |  |  | — |
Acquisitions, divestitures and other |  |  |  |  |  |
(Gain) loss on sale of assets |  |  | (3,194 | ) |  |  | 4,384 |
Transaction and integration costs, net |  |  | (488 | ) |  |  | (34 | )
Impairment charges |  |  |  |  |  |
Goodwill impairment |  |  | 428,882 |  |  |  | — |
Intangibles and long-lived asset impairment |  |  | 66,940 |  |  |  | 76,143 |
Other |  |  | — |  |  |  | 1,443 |
Adjusted EBITDA |  | $ | 113,789 |  |  | $ | 154,522 |

(a)
Expenses and items relating to securities class action, baby food litigation, and SEC investigation.

Free Cash Flow

In our internal evaluations, we use the non-GAAP financial measure “Free Cash Flow.” The difference between Free Cash Flow and cash flows provided by or used in operating activities, which is the most comparable U.S. GAAP financial measure, is that Free Cash Flow reflects the impact of purchases of property, plant and equipment (“capital expenditure”). Since capital expenditure is essential to maintaining our operational capabilities, we believe that it is a recurring and necessary use of cash. As such, we believe investors should also consider capital expenditure when evaluating our cash flows provided by or used in operating activities. We view Free Cash Flow as an important measure because it is one factor in evaluating the amount of cash available for discretionary investments. We do not consider Free Cash Flow in isolation or as an alternative to financial measures determined in accordance with U.S. GAAP. A reconciliation from cash flows provided by operating activities to Free Cash Flow is as follows:

|  | Fiscal Year Ended June 30, |
(Amounts in thousands) |  | 2025 |  |  | 2024 |
Net cash provided by operating activities |  | $ | 22,115 |  |  | $ | 116,355 |
Purchases of property, plant and equipment |  |  | (25,284 | ) |  |  | (33,461 | )
Free Cash Flow |  | $ | (3,169 | ) |  | $ | 82,894 |

Contractual Obligations

We are party to contractual obligations involving commitments to make payments to third parties, which impact our short-term and long-term liquidity and capital resource needs. Our contractual obligations primarily consist of long-term debt and related interest payments and operating leases. See Note 8, Leases, and Note 11, Debt and Borrowings, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

38

Table of Contents

Critical Accounting Estimates

The discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States. Our significant accounting policies are described in Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K. The policies below have been identified as the critical accounting policies we use which require us to make estimates and assumptions and exercise judgment that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. We believe in the quality and reasonableness of our critical accounting estimates; however, materially different amounts might be reported under different conditions or using assumptions, estimates or making judgments different from those that we have applied. Our critical accounting policies, including our methodology for estimates made and assumptions used, are as follows:

Variable Consideration

In addition to fixed contract consideration, many of the Company’s contracts include some form of variable consideration. The Company offers various trade promotions and sales incentive programs to customers and consumers, such as price discounts, slotting fees, in-store display incentives, cooperative advertising programs, new product introduction fees and coupons. The expenses associated with these programs are accounted for as reductions to the transaction price of products and are therefore deducted from sales to determine reported net sales. Trade promotions and sales incentive accruals are subject to significant management estimates and assumptions. The critical assumptions used in estimating the accruals for trade promotions and sales incentives include the Company’s estimate of expected levels of performance and redemption rates. The Company exercises judgment in developing these assumptions. These assumptions are based upon historical performance of the retailer or distributor customers with similar types of promotions adjusted for current trends. The Company regularly reviews and revises, when deemed necessary, estimates of costs to the Company for these promotions and incentives based on what has been incurred by the customers. The terms of most of the promotion and incentive arrangements do not exceed a year and therefore do not require highly uncertain long-term estimates. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for deductions taken by a customer from amounts otherwise due to the Company. Differences between estimated expense and actual promotion and incentive costs are recognized in earnings in the period such differences are determined. Actual expenses may differ if the level of redemption rates and performance were to vary from estimates.

Valuation of Long-lived Assets

The Company periodically evaluates the carrying value of long-lived assets held and used in the business and with definite lives, when events and circumstances occur indicating that the carrying amount of the asset or its asset group may not be recoverable. An impairment test is performed when the estimated undiscounted cash flows associated with the asset or asset group is less than its carrying value. If the undiscounted cash flows are less than the carrying value of the asset or its asset group, the Company performs test to fair value the asset or its asset group. A loss is recognized based on the amount, if any, by which the carrying value exceeds the estimated fair value of the asset or asset group.

Goodwill

Goodwill is not amortized but rather is tested at least annually for impairment on April 1 of each year, or more often if events or changes in circumstances indicate that more likely than not the carrying amount of the asset may not be recoverable.

Goodwill is tested for impairment at the reporting unit level. A reporting unit represents an operating segment or a component of an operating segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill.

We may elect not to perform the qualitative assessment for some or all reporting units and instead perform a quantitative impairment test. The estimate of the fair values of our reporting units are based on the best information available as of the date of the assessment. We base our fair value estimates on assumptions we believe to be reasonable, but which are unpredictable and inherently uncertain. We generally use a blended analysis of the Discounted Cash Flow (“DCF”) method income approach and the Guideline Public Company Method (“GPCM”) market approach.

The DCF method estimates the value based on the present value of estimated future cash flows and economic benefits that are expected to be produced. Considerable management judgment is necessary to evaluate the impact of operating and external economic factors in estimating our future cash flows. The assumptions we use in our tests include projections of growth rates and profitability, our estimated working capital needs, as well as our weighted average cost of capital (“WACC”).

39

Table of Contents

The GPCM approach estimates the value of a reporting unit through analysis of recent sales of comparable assets or business entities by comparing it to comparable publicly-disclosed transactions in similar businesses. Estimates used in the guideline public company method include the identification of similar businesses with comparable business factors.

The key assumptions used in our quantitative impairment tests are inherently uncertain. They require a high degree of estimation and are subject to change based on, among other factors, industry and geopolitical conditions, our ability to navigate changing macroeconomic conditions and trends and the timing and success of strategic initiatives. Changes in economic and operating conditions impacting the assumptions we made could result in goodwill impairment in future periods. If the carrying amount of a reporting unit exceeds its fair value, goodwill is considered impaired. A goodwill impairment loss is recognized for the amount that the carrying amount of a reporting unit exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit.

In fiscal 2025, the Company recorded aggregated non-cash goodwill impairment charges of $357,679 within its North America segment and $71,203 within our International reportable segment as a result of goodwill impairment testing discussed below. The fair values for the quantitatively tested reporting units were estimated using a blended approach of the Discounted Cash Flow (“DCF”) method income approach and the Guideline Public Company Methodology (“GPCM”) market approach. Set forth is a table of each reporting unit’s goodwill carrying value as of, and impairment charges and other activity recorded during, the periods presented:

|  | Reporting Unit |
(Dollars in thousands) |  | U.S. |  |  | Canada |  |  | U.K. |
Goodwill as of June 30, 2024 |  | $ | 641,053 |  |  | $ | 48,415 |  |  | $ | 173,538 |
Impairment charge during three months ended September 30, 2024 |  |  | — |  |  |  | — |  |  |  | — |
Divestiture during three months ended September 30, 2024 |  |  | (7,280 | ) |  |  | — |  |  |  | — |
Impairment charge during three months ended December 31, 2024 |  |  | (91,267 | ) |  |  | — |  |  |  | — |
Impairment charge during three months ended March 31, 2025 |  |  | (88,712 | ) |  |  | (21,539 | ) |  |  | — |
Reclassification of goodwill to held for sale during three months ended March 31, 2025 |  |  | (3,291 | ) |  |  | (7,873 | ) |  |  | — |
Impairment charge during three months ended June 30, 2025 |  |  | (138,182 | ) |  |  | (17,979 | ) |  |  | (71,203 | )
Translation |  |  | — |  |  |  | (1,024 | ) |  |  | 13,877 |
Goodwill as of June 30, 2025 |  | $ | 312,321 |  |  | $ | — |  |  | $ | 116,212 |

As of June 30, 2024, the Company had tested its U.S. reporting unit’s goodwill for impairment and, as previously disclosed, determined that the U.S. reporting unit’s goodwill was at risk, given that the fair value of the reporting unit was greater than its carrying value by 6.2%.

Second quarter of fiscal 2025

During the second quarter of fiscal 2025, as a result of the continued decline in the Company’s market capitalization since the previous fiscal year and the recognition of personal care intangible asset impairment charges within the reporting units in its North America reportable segment, the Company completed an interim impairment test for goodwill for all of its reporting units utilizing either a quantitative or qualitative test. Consequently, the Company recognized a non-cash impairment charge of $91,267 to reduce the carrying value of the goodwill of the U.S. reporting unit. In addition to the aforementioned factors, while the Company’s previously announced Hain Reimagined strategy was still in effect, certain significant assumptions in the fair value test of the U.S. reporting unit had changed. Those changes in estimates included a decline in overall sales volume, an increase in the discount rate utilized in the DCF methodology as a result of certain developments related to the Company’s ability to implement its then-current strategy and a decrease in Enterprise Value (“E.V.”)/EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. For the qualitatively assessed reporting units (Canada, U.K., Western Europe and Ella’s Kitchen U.K.), the Company assessed qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts.

Third quarter of fiscal 2025

During the third quarter of fiscal 2025, as a result of a significant reduction in the Company’s actual and projected performance and cash flows primarily within its North America segment, the measurement of the personal care business as held for sale, as well as the continued decline in the Company’s market capitalization since the previous quarter, the Company completed an interim impairment test for goodwill for all of its reporting units. As of March 31, 2025, the U.S. and Canada reporting units’

40

Table of Contents

carrying amounts exceeded their estimated fair value, resulting in recognition of non-cash impairment charges of $88,712 and $21,539, respectively, to reduce their respective carrying values. The additional U.S. reporting unit impairment recorded during the third quarter of fiscal 2025 also reflected the sales volume decline that the Company continued to experience, which led to an incremental increase in the discount rate utilized to measure risk in the DCF methodology. Additionally, there was also a corresponding decrease in E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. The Canada reporting unit was affected by the PC business being classified as held for sale in addition to the Canadian market being affected by net sales volume declines similar to those that had been experienced by the U.S. reporting unit. For the qualitatively tested reporting units (U.K., Western Europe and Ella’s Kitchen U.K.), the Company assessed qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts, while noting a recent decline in performance within the U.K. reporting units.

Annual impairment testing as of April 1, 2025

While the Company’s annual impairment testing date is on April 1, 2025 (the first day of the fourth quarter of fiscal 2025), the previously aforementioned quantitative tests for the U.S. and Canada reporting units were utilized for the annual impairment test given there were no significant changes to the risks of these reporting units between March 31, 2025 and April 1, 2025. However, the Company performed quantitative tests for its other three reporting units (Western Europe, Ella’s Kitchen and U.K.) on April 1, 2025, which corroborated the results of the qualitative analysis that was performed during the third quarter of fiscal 2025. The fair values of Western Europe and Ella’s Kitchen significantly exceeded their carrying values.

Fourth quarter of fiscal 2025

As of June 30, 2025, the Company identified further indicators of impairment and determined it was necessary to perform a quantitative test of goodwill at the U.S., Canada and U.K. reporting units and a qualitative assessment of its Western Europe and Ella’s Kitchen U.K. reporting units. On a consolidated basis, the continued decline in the Company’s closing stock price per share from $6.91 as of June 30, 2024 to $1.52 as of June 30, 2025 was a significant indicator that led the Company to perform these additional tests. In addition, during the fourth quarter of fiscal 2025, the Board of Directors announced the exit of the Company’s former CEO and that a strategic review of the Company’s portfolio would be performed, as discussed in Note 1. Description of Business and Basis of Presentation. The following factors were also identified within the reporting units.

During the fourth quarter of fiscal 2025, the U.S. reporting unit experienced certain significant distribution losses with certain customers that affected both revenue and Adjusted EBITDA. Furthermore, given the continued known decline in the Company’s U.S. forecasts, the discount rate utilized to measure risk in the DCF methodology increased. In addition, there was a reduction in E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. These factors led to an impairment of $138,182 being recorded in our U.S. reporting unit for the three months ended June 30, 2025.

Furthermore, during the fourth quarter of fiscal 2025, the U.K. reporting unit had a reduction in Adjusted EBITDA due to certain regulations related to plastic and national insurance taxes that were enacted during the quarter, and the reduction of Adjusted EBITDA also impacted the discount rate utilized under the DCF approach. The U.K. reporting unit valuation was also impacted by a reduction in the E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. These factors led to the recognition of a non-cash goodwill impairment charge of $71,203 being recorded in our U.K. reporting unit as of June 30 2025.

The Canada reporting unit had goodwill of $17,549 remaining as of April 1, 2025. The remaining goodwill was impaired as a result of the Company’s strategic decision to close the Yves Veggie Cuisine® business on June 26, 2025, which is expected to be completed in fiscal 2026.

Subsequent to these impairment charges, the remaining goodwill at the U.S. and U.K. reporting units was $312,321 and $116,212, respectively, as of June 30, 2025. There was no remaining goodwill at the Canada reporting unit as of June 30, 2025. The goodwill related to the U.S. and U.K. reporting units are at risk of potential impairment if the fair value of these reporting units, and their associated assets, decrease in value due to the amount and timing of expected future cash flows, decreased customer demand for

41

Table of Contents

products, an inability to execute management’s business strategies, or general market conditions, such as economic downturns, and changes in interest rates, including discount rates. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company’s estimates. If the Company’s ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record additional impairment charges in future periods.

For the qualitatively tested reporting units (Western Europe and Ella’s Kitchen UK), the Company performed a qualitative evaluation as of June 30, 2025 to assess factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts, which was consistent with the conclusions reached on the annual quantitative impairment testing date of April 1, 2025.

We performed a market capitalization reconciliation with the expectation that the market capitalization should reconcile within a reasonable range to the sum of the fair values of the individual reporting units. Such reconciliation often includes both qualitative and quantitative assessments as is the case with the Company’s reporting units as of June 30, 2025. When an entity performs a qualitative assessment for some reporting units but proceeds to a quantitative assessment for others, reconciling the overall market capitalization to the aggregate fair value of reporting units can be challenging and requires significant judgment. There is no requirement to determine the fair value of reporting units for which only a qualitative impairment test is performed. Therefore, when performing an overall comparison of the sum of the fair values of the individual reporting units to the market capitalization, we included the current year fair value for reporting units for which a quantitative test was performed. Upon performing the market capitalization reconciliation, we noted a reasonable reconciliation between the sum of the reporting unit fair values and the Company’s market capitalization once adjusted for the impact of corporate costs not allocated to the reporting units.

Indefinite-Lived Intangible Assets

Indefinite-lived intangible assets consist primarily of acquired tradenames and trademarks. Indefinite-lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill, or on an interim basis if and when events or circumstances change that would more likely than not reduce the fair value of any of its indefinite-life intangible assets below their carrying value. In assessing fair value, the Company utilizes a “relief from royalty payments” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the assets, the carrying value is written down to fair value in the period identified.

The Company performs an indefinite-lived asset impairment test annually and more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. In accordance with ASC 350, we may first perform a qualitative assessment to determine whether it is necessary to perform a quantitative impairment test. If an entity elects to perform a qualitative assessment, it first shall assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired. One procedure we perform during interim periods to determine whether indicators of impairment are present includes a comparison of net sales used in the most recent quantitative impairment tests to forecasted net sales for the same fiscal year (or balance of the fiscal year when performing an interim review) in order to identify brands for which the current fiscal year net sales are expected to be lower than the forecasted fiscal year net sales per the latest quantitative test. The performance of these brands is then reviewed by management to determine if the shortfall to forecasted net sales was related to events and circumstances that are expected to be temporary in nature, or if it was caused by a more pervasive issue that could serve as in impairment indicator (e.g., loss of key customers, discontinuance of certain product categories within a brand, etc.). We use this risk-based approach to determine which brands we would quantitatively test for impairment, whether as part of fiscal year annual impairment testing or an interim period test.

During the fourth quarter of fiscal 2025, the Company quantitatively tested tradenames associated with its snacks and meal preparation brands, Sensible Portions®, Imagine® and Spectrum®. The estimated fair value of Spectrum® exceeded its carrying value by approximately 18%. The quantitative assessment indicated that the carrying value of Sensible Portions® and Imagine® tradenames exceeded their estimated fair value. The fair value was determined using the relief from royalty method, and an aggregate non-cash impairment charge of $21,100 was recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The Sensible Portions® and Spectrum® intangible assets are part of the North America reportable segment and have a remaining aggregate carrying value of $8,000 and $11,800, respectively, as of June 30, 2025. Imagine® intangible asset was also part of the North America reportable segment and have no remaining carrying value as of June 30, 2025. The Spectrum® and Sensible Portions® tradenames remain at risk of impairment in future periods in the event of unfavorable changes in assumptions, including forecasted future cashflows based on execution of strategic initiatives for increasing revenue, as well as discount rates and other macroeconomic factors.

42

Table of Contents

During the third quarter of fiscal 2025, the Company recorded a non-cash impairment charge of $960 within its North America reportable segment related to its Health Valley® trademark. The asset was part of the North America reportable segment and have no remaining carrying value as of June 30, 2025.

During the second quarter of fiscal 2025, the Company recorded a non-cash impairment charge of $15,733 within its North America reportable segment. Non-cash impairment charge of $12,085 was related to its personal care intangible assets, primarily Avalon Organics®, JASON®, and Live Clean® trademarks and tradenames and balance $3,648 was related to Belvedere™ trademark and customer relationships. The assets are part of the North America reportable segment and have and have no remaining carrying value as of June 30, 2025.

See Note 9, Goodwill and Other Intangible Assets in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K.

Stock-based Compensation

The Company utilizes a Monte Carlo simulation model to determine the fair value of market-based awards. The use of the Monte Carlo simulation model requires the Company to make estimates and assumptions, such as expected volatility, expected term and risk-free interest rate. For awards that contain a market condition, expense is recognized over the defined or derived service period using a Monte Carlo simulation model.

Valuation Allowances for Deferred Tax Assets

Deferred tax assets arise when we recognize expenses in our financial statements that will be allowed as income tax deductions in future periods. Deferred tax assets also include unused tax net operating losses and tax credits that we are allowed to carry forward to future years. Accounting rules permit us to carry deferred tax assets on the balance sheet at full value after consideration of the four sources of income, namely taxable income in prior year carryback years, the future reversals of existing taxable temporary differences, tax planning strategies, and future taxable income exclusive of reversing temporary differences, to determine if the deferred tax assets are realizable. A valuation allowance must be recorded against a deferred tax asset if they are not realizable after considering the four sources of income. Our determination of our valuation allowances is based upon a number of assumptions, judgments and estimates, including the reversal pattern of existing temporary differences and forecasted earnings.

Recent Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies and Practices, in the Notes to the Consolidated Financial Statements included in Item 8 of this Form 10-K for information regarding recent accounting pronouncements.

Seasonality

Certain of our product lines have seasonal fluctuations. Hot tea and soup sales are stronger in colder months, while sales of snack foods are stronger in the warmer months. As such, our results of operations and our cash flows for any particular quarter are not indicative of the results we expect for the full year, and our historical seasonality may not be indicative of future quarterly results of operations. Historically, net sales and diluted earnings per share in the first fiscal quarter have typically been the lowest of our four quarters.

43

Table of Contents

Item 7A. Quantitative an d Qualitative Disclosures About Market Risk

Market Risk

The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which the Company is exposed are:

•
interest rates on debt and cash equivalents;
•
foreign exchange rates, generating translation and transaction gains and losses; and
•
ingredient inputs.

Interest Rates

We centrally manage our debt and cash equivalents, considering investment opportunities and risks, tax consequences and overall financing strategies. Our cash equivalents consist primarily of money market funds or their equivalent. As of June 30, 2025, we had $706.1 million of variable rate debt outstanding under our Credit Agreement. We use interest rate swaps to hedge a portion of the interest rate risk related to our outstanding variable rate debt. As of June 30, 2025, the notional amount of the interest rate swaps was $400 million with fixed rate payments of 6.12%. Assuming current cash equivalents, variable rate borrowings and the effects of the interest rate swaps, a hypothetical change in average interest rates of one percentage point would have resulted in higher net interest expense of $3.5 million.

Foreign Currency Exchange Rates

Operating in international markets involves exposure to movements in currency exchange rates, which are volatile at times, and the impact of such movements, if material, could cause adjustments to our financing and operating strategies.

During fiscal 2025, approximately 50% of our consolidated net sales were generated from sales outside the U.S., while such sales outside the U.S. were 46% of net sales in fiscal 2024 and 43% of net sales in fiscal 2023. These revenues, along with related expenses and capital purchases, were conducted primarily in British Pounds Sterling, Euros and Canadian Dollars. Sales and operating income would have decreased by approximately $38.7 million and $3.0 million, respectively, if average foreign exchange rates had been lower by 5% against the U.S. Dollar in fiscal 2025. These amounts were determined by considering the impact of a hypothetical foreign exchange rate on the sales and operating income of the Company’s international operations.

Fluctuations in currency exchange rates may also impact the Stockholders’ Equity of the Company. Amounts invested in our non-U.S. subsidiaries are translated into United States Dollars at the exchange rates as of the last day of each reporting period. Any resulting cumulative translation adjustments are recorded in Stockholders’ Equity as Accumulated Other Comprehensive Loss. The cumulative translation adjustments component of Accumulated Other Comprehensive Loss increased by $71.3 million during the fiscal year ended June 30, 2025.

To manage that risk, the Company may enter into certain derivative financial instruments, when available on a cost-effective basis. We had approximately $128.8 million in notional amounts of cross-currency swaps at June 30, 2025. See Note 17, Derivatives and Hedging Activities, in the Notes to Consolidated Financial Statements included in Item 8 of this Form 10-K.

Ingredient Inputs Price Risk

The Company purchases ingredient inputs such as vegetables, fruits, oils, grains, beans, nuts, tea and herbs, spices, dairy products, plant-based surfactants, glycerin and alcohols, as well as packaging materials, to be used in its operations. These inputs are subject to price fluctuations that may create price risk. While not currently significant, some suppliers have sought to pass through to the Company all or a portion of the impact of new tariffs imposed on the suppliers. Although we sometimes hedge against fluctuations in the prices of the ingredients by using future or forward contracts or similar instruments, the majority of our future purchases of these items are subject to changes in price. We may enter into fixed purchase commitments in an attempt to secure an adequate supply of specific ingredients. These agreements are tied to specific market prices. Market risk is estimated as a hypothetical 10% increase or decrease in the weighted average cost of our primary inputs as of June 30, 2025. Based on our cost of goods sold during the fiscal year ended June 30, 2025, such a change would have resulted in an increase or decrease to cost of sales of approximately $92 million. We attempt to offset the impact of input cost increases with a combination of cost savings initiatives and efficiencies and price increases.

44

Table of Contents

Item 8. Financial Stat ements and Supplementary Data

The following consolidated financial statements of The Hain Celestial Group, Inc. and subsidiaries are included in Item 8:

Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) |  | 46
Consolidated Balance Sheets - June 30, 2025 and 2024 |  | 49
Consolidated Statements of Operations - Fiscal Years ended June 30, 2025, 2024 and 2023 |  | 50
Consolidated Statements of Comprehensive Loss - Fiscal Years ended June 30, 2025, 2024 and 2023 |  | 51
Consolidated Statements of Stockholders’ Equity - Fiscal Years ended June 30, 2025, 2024 and 2023 |  | 52
Consolidated Statements of Cash Flows - Fiscal Years ended June 30, 2025, 2024 and 2023 |  | 54
Notes to Consolidated Financial Statements |  | 55

The following consolidated financial statement schedule of The Hain Celestial Group, Inc. and subsidiaries is included in Item 15(a):

Schedule II - Valuation and qualifying accounts

All other schedules for which provision is made in the applicable accounting regulation of the SEC are not required under the related instructions or are inapplicable and therefore have been omitted.

45

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of The Hain Celestial Group, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of The Hain Celestial Group, Inc. and subsidiaries (the Company) as of June 30, 2025 and 2024, the related consolidated statements of operations, comprehensive loss, stockholders’ equity and cash flows for each of the three years in the period ended June 30, 2025, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2025, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated September 15, 2025 expressed an adverse opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

46

Table of Contents

|  | Estimation of the Trade and Promotional Incentive Accrual
Description of the Matter |  | For the year ended June 30, 2025, the Company’s reported net sales were $1.6 billion. As described in Note 2 of the consolidated financial statements, the Company offers certain customers trade and promotional incentive programs, which results in variable consideration in the Company’s contracts with its customers. The estimated costs of these programs are recorded as a reduction to revenue at the time a product is sold to the customer. The measurement of estimates of variable consideration specifically for the trade and promotional incentive accrual recorded at period end involves the use of judgment related to estimates of expected levels of performance and redemption rates. Auditing the estimates of variable consideration for the trade and promotional incentive accrual is complex because the revenue recognized is determined based on significant management estimates. In particular, estimates are made for expected levels of performance and redemption rates. These estimates are based on historical performance of customers, types and levels of promotions offered, and claims received from customers. Changes in these assumptions can have a significant impact on the amount of the revenue recognized.
How We Addressed the Matter in Our Audit |  | We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company’s estimation of the trade and promotional incentive accrual process. For example, we tested controls over management’s review of the significant assumptions described above, management’s validation of the completeness and accuracy of the data used in making their estimates, and other controls such as their retrospective review analysis of prior period estimates. To test the estimates of variable consideration for the trade and promotional incentive accrual, we performed audit procedures that included, among others, evaluating the assumptions used by the Company in establishing the estimates of the trade and promotional incentive accruals by comparing them to historical trends and third-party evidence as well as performing transactional testing for a sample of customer claim activity. We also tested the results of the Company’s retrospective review analyses performed on the prior year trade and promotional incentive accrual.

47

Table of Contents

|  | Valuation of the U.S., United Kingdom, and Canada Reporting Units
Description of the Matter |  | At June 30, 2025, the goodwill assigned to the Company’s U.S. and United Kingdom reporting units had carrying values of approximately $312.3 million and $116.2 million, respectively. The Canada reporting unit has no remaining goodwill. As discussed in Note 2 of the consolidated financial statements, the Company tests goodwill for impairment at the reporting unit level at least annually, or when circumstances indicate that the carrying amount of the asset may not be recoverable. If the carrying value of a reporting unit exceeds its fair value, the Company would then compare the carrying value of the goodwill to its implied fair value in order to determine the amount of the impairment, if any. Auditing the Company’s impairment tests for the goodwill in the U.S., United Kingdom, and Canada reporting units is complex due to the significant judgments required to estimate the fair value of the respective reporting units. The Company estimated the fair value of the reporting units using a combination of the discounted cash flow method, a form of the income approach, and the guideline public company method, a form of the market approach. The discounted cash flow method is largely dependent upon estimates made by management with respect to significant assumptions, such as projections of future revenue, future earnings before interest, tax, depreciation and amortization, the discount rate, and terminal growth rate, which are affected by expectations about future market or economic conditions.
How We Addressed the Matter in Our Audit |  | To test the estimated fair value of the U.S., United Kingdom, and Canada reporting units, we performed audit procedures that included, among others, testing the significant assumptions and testing the completeness and accuracy of the underlying data used by the Company in its analyses. We compared the significant assumptions used by management to current industry and economic trends, and to the historical results of the reporting unit, while also considering changes to the Company’s business model, customer base and product mix. We assessed the historical accuracy of management’s estimates and significant assumptions, such as projections of revenue growth rates and profitability by comparing management’s past projections to actual performance. We involved valuation specialists to assist in evaluating the Company’s methodology and significant assumptions, including the discount rate and terminal growth rate. We also performed sensitivity analyses to evaluate the impact that changes in the significant assumptions would have on the fair value of each of the reporting units.

/s/ Ernst & Young LLP

We have served as the Company’s auditor since 1994.

Jericho, New York

September 15, 2025

48

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED B ALANCE SHEETS

JUNE 30, 2025 AND JUNE 30, 2024

(In thousands, except par values)

|  | June 30, |
|  | 2025 |  |  | 2024 |
ASSETS |  |  |  |  |  |
Current assets: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 54,355 |  |  | $ | 54,307 |
Accounts receivable, less allowance for doubtful accounts of $1,337 and $1,517, respectively |  |  | 154,440 |  |  |  | 179,190 |
Inventories |  |  | 248,731 |  |  |  | 274,128 |
Prepaid expenses and other current assets |  |  | 43,169 |  |  |  | 49,434 |
Assets held for sale |  |  | 29,603 |  |  |  | — |
Total current assets |  |  | 530,298 |  |  |  | 557,059 |
Property, plant and equipment, net |  |  | 264,730 |  |  |  | 261,730 |
Goodwill |  |  | 500,961 |  |  |  | 929,304 |
Trademarks and other intangible assets, net |  |  | 210,905 |  |  |  | 244,799 |
Operating lease right-of-use assets, net |  |  | 71,171 |  |  |  | 86,634 |
Other assets |  |  | 25,213 |  |  |  | 38,022 |
Total assets |  | $ | 1,603,278 |  |  | $ | 2,117,548 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |
Accounts payable |  | $ | 188,307 |  |  | $ | 188,220 |
Accrued expenses and other current liabilities |  |  | 68,426 |  |  |  | 85,714 |
Current portion of long-term debt |  |  | 7,653 |  |  |  | 7,569 |
Liabilities related to assets held for sale |  |  | 12,987 |  |  |  | — |
Total current liabilities |  |  | 277,373 |  |  |  | 281,503 |
Long-term debt, less current portion |  |  | 697,168 |  |  |  | 736,523 |
Deferred income taxes |  |  | 40,332 |  |  |  | 47,826 |
Operating lease liabilities, noncurrent portion |  |  | 65,284 |  |  |  | 80,863 |
Other noncurrent liabilities |  |  | 48,116 |  |  |  | 27,920 |
Total liabilities |  |  | 1,128,273 |  |  |  | 1,174,635 |
Commitments and contingencies (Note 18) |  |  |  |  |  |
Stockholders’ equity: |  |  |  |  |  |
Preferred stock - $.01 par value, authorized 5,000 shares; issued and outstanding: none |  |  | — |  |  |  | — |
Common stock - $.01 par value, authorized 150,000 shares; issued: 112,491 and 111,867 shares, respectively; outstanding: 90,284 and 89,846 shares, respectively |  |  | 1,125 |  |  |  | 1,119 |
Additional paid-in capital |  |  | 1,238,402 |  |  |  | 1,230,253 |
Retained earnings |  |  | 46,678 |  |  |  | 577,519 |
Accumulated other comprehensive loss |  |  | (81,053 | ) |  |  | (137,245 | )
|  |  | 1,205,152 |  |  |  | 1,671,646 |
Less: Treasury stock, at cost, 22,207 and 22,021 shares, respectively |  |  | (730,147 | ) |  |  | (728,733 | )
Total stockholders’ equity |  |  | 475,005 |  |  |  | 942,913 |
Total liabilities and stockholders’ equity |  | $ | 1,603,278 |  |  | $ | 2,117,548 |

See notes to consolidated financial statements.

49

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATE MENTS OF OPERATIONS

FISCAL YEARS ENDED JUNE 30, 2025, 2024 AND 2023

(In thousands, except per share amounts)

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Net sales |  | $ | 1,559,780 |  |  | $ | 1,736,286 |  |  | $ | 1,796,643 |
Cost of sales |  |  | 1,225,722 |  |  |  | 1,355,454 |  |  |  | 1,400,229 |
Gross profit |  |  | 334,058 |  |  |  | 380,832 |  |  |  | 396,414 |
Selling, general and administrative expenses |  |  | 271,833 |  |  |  | 290,116 |  |  |  | 289,233 |
Goodwill impairment |  |  | 428,882 |  |  |  | — |  |  |  | — |
Intangibles and long-lived asset impairment |  |  | 66,940 |  |  |  | 76,143 |  |  |  | 175,501 |
Productivity and transformation costs |  |  | 21,530 |  |  |  | 27,741 |  |  |  | 7,284 |
Amortization of acquired intangible assets |  |  | 6,476 |  |  |  | 5,780 |  |  |  | 10,016 |
Operating loss |  |  | (461,603 | ) |  |  | (18,948 | ) |  |  | (85,620 | )
Interest and other financing expense, net |  |  | 51,253 |  |  |  | 57,213 |  |  |  | 45,783 |
Other expense (income), net |  |  | 875 |  |  |  | 4,120 |  |  |  | (1,822 | )
Loss before income taxes and equity in net loss of equity-method investees |  |  | (513,731 | ) |  |  | (80,281 | ) |  |  | (129,581 | )
Provision (benefit) for income taxes |  |  | 15,297 |  |  |  | (7,820 | ) |  |  | (14,178 | )
Equity in net loss of equity-method investees |  |  | 1,813 |  |  |  | 2,581 |  |  |  | 1,134 |
Net loss |  | $ | (530,841 | ) |  | $ | (75,042 | ) |  | $ | (116,537 | )
Net loss per common share: |  |  |  |  |  |  |  |  |
Basic |  | $ | (5.89 | ) |  | $ | (0.84 | ) |  | $ | (1.30 | )
Diluted |  | $ | (5.89 | ) |  | $ | (0.84 | ) |  | $ | (1.30 | )
Shares used in the calculation of net loss per common share: |  |  |  |  |  |  |  |  |
Basic |  |  | 90,127 |  |  |  | 89,750 |  |  |  | 89,396 |
Diluted |  |  | 90,127 |  |  |  | 89,750 |  |  |  | 89,396 |

See notes to consolidated financial statements.

50

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CO MPREHENSIVE LOSS

FISCAL YEARS ENDED JUNE 30, 2025, 2024 AND 2023

(In thousands)

|  | Fiscal Year Ended June 30, 2025 |  |  | Fiscal Year Ended June 30, 2024 |  |  | Fiscal Year Ended June 30, 2023 |
|  | Pretax amount |  |  | Tax benefit |  |  | After tax amount |  |  | Pretax amount |  |  | Tax benefit |  |  | After tax amount |  |  | Pretax amount |  |  | Tax (expense) benefit |  |  | After tax amount |
Net loss |  |  |  |  |  |  |  | $ | (530,841 | ) |  |  |  |  |  |  |  | $ | (75,042 | ) |  |  |  |  |  |  |  | $ | (116,537 | )
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments before reclassifications |  | $ | 71,324 |  |  | $ | — |  |  |  | 71,324 |  |  | $ | (9,045 | ) |  | $ | — |  |  |  | (9,045 | ) |  | $ | 30,197 |  |  | $ | — |  |  |  | 30,197 |
Change in deferred (losses) gains on cash flow hedging instruments |  |  | (9,276 | ) |  |  | 2,464 |  |  |  | (6,812 | ) |  |  | (2,007 | ) |  |  | 504 |  |  |  | (1,503 | ) |  |  | 13,850 |  |  |  | (3,471 | ) |  |  | 10,379 |
Change in deferred (losses) gains on fair value hedging instruments |  |  | (160 | ) |  |  | 47 |  |  |  | (113 | ) |  |  | (516 | ) |  |  | 128 |  |  |  | (388 | ) |  |  | 247 |  |  |  | (62 | ) |  |  | 185 |
Change in deferred losses on net investment hedging instruments |  |  | (10,917 | ) |  |  | 2,710 |  |  |  | (8,207 | ) |  |  | (126 | ) |  |  | 33 |  |  |  | (93 | ) |  |  | (3,242 | ) |  |  | 747 |  |  |  | (2,495 | )
Total other comprehensive income (loss) |  | $ | 50,971 |  |  | $ | 5,221 |  |  | $ | 56,192 |  |  | $ | (11,694 | ) |  | $ | 665 |  |  | $ | (11,029 | ) |  | $ | 41,052 |  |  | $ | (2,786 | ) |  | $ | 38,266 |
Total comprehensive loss |  |  |  |  |  |  |  | $ | (474,649 | ) |  |  |  |  |  |  |  | $ | (86,071 | ) |  |  |  |  |  |  |  | $ | (78,271 | )

See notes to consolidated financial statements.

51

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEME NT OF STOCKHOLDERS’ EQUITY

FISCAL YEARS ENDED JUNE 30, 2025, 2024 AND 2023

(In thousands, except par values)

|  | Common Stock |  |  | Additional |  |  |  |  |  |  |  |  |  |  |  | Accumulated Other |  |  |  |
|  |  |  |  | Amount |  |  | Paid-in |  |  | Retained |  |  | Treasury Stock |  |  | Comprehensive |  |  |  |
|  | Shares |  |  | at $0.01 |  |  | Capital |  |  | Earnings |  |  | Shares |  |  | Amount |  |  | Loss |  |  | Total |
Balance at June 30, 2022 |  |  | 111,090 |  |  | $ | 1,111 |  |  | $ | 1,203,126 |  |  | $ | 769,098 |  |  |  | 21,788 |  |  | $ | (725,685 | ) |  | $ | (164,482 | ) |  | $ | 1,083,168 |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (116,537 | ) |  |  |  |  |  |  |  |  |  |  |  | (116,537 | )
Other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 38,266 |  |  |  | 38,266 |
Issuance of common stock pursuant to stock-based compensation plans |  |  | 249 |  |  |  | 2 |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 |
Employee shares withheld for taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 76 |  |  |  | (1,415 | ) |  |  |  |  |  | (1,415 | )
Stock-based compensation expense |  |  |  |  |  |  |  |  | 14,423 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 14,423 |
Balance at June 30, 2023 |  |  | 111,339 |  |  | $ | 1,113 |  |  | $ | 1,217,549 |  |  | $ | 652,561 |  |  |  | 21,864 |  |  | $ | (727,100 | ) |  | $ | (126,216 | ) |  | $ | 1,017,907 |

Continued on next page

52

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FISCAL YEARS ENDED JUNE 30, 2025, 2024 AND 2023

(In thousands, except par values)

Continued from previous page

|  | Common Stock |  |  | Additional |  |  |  |  |  |  |  |  |  |  |  | Accumulated Other |  |  |  |
|  |  |  |  | Amount |  |  | Paid-in |  |  | Retained |  |  | Treasury Stock |  |  | Comprehensive |  |  |  |
|  | Shares |  |  | at $0.01 |  |  | Capital |  |  | Earnings |  |  | Shares |  |  | Amount |  |  | Loss |  |  | Total |
Balance at June 30, 2023 |  |  | 111,339 |  |  | $ | 1,113 |  |  | $ | 1,217,549 |  |  | $ | 652,561 |  |  |  | 21,864 |  |  | $ | (727,100 | ) |  | $ | (126,216 | ) |  | $ | 1,017,907 |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (75,042 | ) |  |  |  |  |  |  |  |  |  |  |  | (75,042 | )
Other comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,029 | ) |  |  | (11,029 | )
Issuance of common stock pursuant to stock-based compensation plans |  |  | 528 |  |  |  | 6 |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 |
Employee shares withheld for taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 157 |  |  |  | (1,633 | ) |  |  |  |  |  | (1,633 | )
Repurchases of common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | — |
Stock-based compensation expense |  |  |  |  |  |  |  |  | 12,704 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,704 |
Balance at June 30, 2024 |  |  | 111,867 |  |  | $ | 1,119 |  |  | $ | 1,230,253 |  |  | $ | 577,519 |  |  |  | 22,021 |  |  | $ | (728,733 | ) |  | $ | (137,245 | ) |  | $ | 942,913 |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (530,841 | ) |  |  |  |  |  |  |  |  |  |  |  | (530,841 | )
Other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 56,192 |  |  |  | 56,192 |
Issuance of common stock pursuant to stock-based compensation plans |  |  | 624 |  |  |  | 6 |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 |
Employee shares withheld for taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 186 |  |  |  | (1,414 | ) |  |  |  |  |  | (1,414 | )
Stock-based compensation expense |  |  |  |  |  |  |  |  | 8,149 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,149 |
Balance at June 30, 2025 |  |  | 112,491 |  |  | $ | 1,125 |  |  | $ | 1,238,402 |  |  | $ | 46,678 |  |  |  | 22,207 |  |  | $ | (730,147 | ) |  | $ | (81,053 | ) |  | $ | 475,005 |

See notes to consolidated financial statements.

53

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEM ENTS OF CASH FLOWS

FISCAL YEARS ENDED JUNE 30, 2025, 2024 AND 2023

(In thousands)

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
CASH FLOWS FROM OPERATING ACTIVITIES |  |  |  |  |  |  |  |  |
Net loss |  | $ | (530,841 | ) |  | $ | (75,042 | ) |  | $ | (116,537 | )
Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 44,259 |  |  |  | 44,665 |  |  |  | 50,777 |
Deferred income taxes |  |  | (4,423 | ) |  |  | (23,361 | ) |  |  | (25,953 | )
Equity in net loss of equity-method investees |  |  | 1,813 |  |  |  | 2,581 |  |  |  | 1,134 |
Stock-based compensation, net |  |  | 8,149 |  |  |  | 12,704 |  |  |  | 14,423 |
Goodwill impairment |  |  | 428,882 |  |  |  | — |  |  |  | — |
Intangibles and long-lived asset impairment |  |  | 66,940 |  |  |  | 76,143 |  |  |  | 175,501 |
(Gain) loss on sale of assets |  |  | (3,194 | ) |  |  | 3,634 |  |  |  | (3,529 | )
Other non-cash items, net |  |  | 2,138 |  |  |  | 1,104 |  |  |  | (1,271 | )
Increase (decrease) in cash attributable to changes in operating assets and liabilities: |  |  |  |  |  |  |  |  |
Accounts receivable |  |  | 25,204 |  |  |  | (18,963 | ) |  |  | 13,067 |
Inventories |  |  | (3,354 | ) |  |  | 31,471 |  |  |  | 189 |
Other current assets |  |  | 3,114 |  |  |  | 14,106 |  |  |  | (2,831 | )
Other assets and liabilities |  |  | 1,320 |  |  |  | (3,292 | ) |  |  | 2,546 |
Accounts payable and accrued expenses |  |  | (17,892 | ) |  |  | 50,605 |  |  |  | (40,697 | )
Net cash provided by operating activities |  |  | 22,115 |  |  |  | 116,355 |  |  |  | 66,819 |
CASH FLOWS FROM INVESTING ACTIVITIES |  |  |  |  |  |  |  |  |
Purchases of property, plant and equipment |  |  | (25,284 | ) |  |  | (33,461 | ) |  |  | (27,879 | )
Investments and joint ventures, including proceeds from dispositions |  |  | 12,570 |  |  |  | — |  |  |  | 433 |
Proceeds from sale of assets |  |  | 13,970 |  |  |  | 9,539 |  |  |  | 7,806 |
Proceeds from termination of net investment hedges |  |  | 2,363 |  |  |  | — |  |  |  | — |
Net cash provided by (used in) investing activities |  |  | 3,619 |  |  |  | (23,922 | ) |  |  | (19,640 | )
CASH FLOWS FROM FINANCING ACTIVITIES |  |  |  |  |  |  |  |  |
Borrowings under bank revolving credit facility |  |  | 221,000 |  |  |  | 186,000 |  |  |  | 328,000 |
Repayments under bank revolving credit facility |  |  | (245,500 | ) |  |  | (252,000 | ) |  |  | (380,000 | )
Repayments under term loan |  |  | (15,000 | ) |  |  | (18,200 | ) |  |  | (7,500 | )
Payments of other debt, net |  |  | (3,524 | ) |  |  | (3,896 | ) |  |  | (2,145 | )
Employee shares withheld for taxes |  |  | (1,414 | ) |  |  | (1,633 | ) |  |  | (1,415 | )
Proceeds from termination of fair value hedge |  |  | 552 |  |  |  | — |  |  |  | — |
Net cash used in financing activities |  |  | (43,886 | ) |  |  | (89,729 | ) |  |  | (63,060 | )
Effect of exchange rate changes on cash |  |  | 18,200 |  |  |  | (1,761 | ) |  |  | 3,733 |
Net increase (decrease) in cash and cash equivalents |  |  | 48 |  |  |  | 943 |  |  |  | (12,148 | )
Cash and cash equivalents at beginning of year |  |  | 54,307 |  |  |  | 53,364 |  |  |  | 65,512 |
Cash and cash equivalents at end of year |  | $ | 54,355 |  |  | $ | 54,307 |  |  | $ | 53,364 |

See notes to consolidated financial statements.

54

Table of Contents

THE HAIN CELESTIAL GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FI NANCIAL STATEMENTS

(Amounts in thousands, except par values and per share data)

1.
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

Description of Business

The Hain Celestial Group, Inc., a Delaware corporation (collectively with its subsidiaries, the “Company,” or “Hain Celestial,” “we,” “us” or “our”) was founded in 1993. Hain Celestial is a leading global health and wellness company whose purpose is to inspire healthier living for people, communities and the planet through better-for-you brands. For more than 30 years, Hain Celestial has intentionally focused on delivering nutrition and well-being that positively impacts today and tomorrow. Headquartered in Hoboken, N.J., Hain Celestial’s products across snacks, baby & kids, beverages, and meal preparation are marketed and sold in over 70 countries around the world. The Company operates under two reportable segments: North America and International.

The Company’s leading brands include Garden Veggie Snacks™, Terra® chips, Garden of Eatin’® snacks, Hartley’s® jelly, Earth’s Best® Organic and Ella’s Kitchen® baby and kids foods, Celestial Seasonings® teas, Joya® and Natumi® plant-based beverages, The Greek Gods® yogurt, Cully & Sully®, Yorkshire Provender®, New Covent Garden® and Imagine® soups, among others.

Strategic Review

We are focused on five actions to win in the marketplace and drive growth: aggressively streamlining our portfolio, accelerating brand renovation and innovation, implementing price increases along with broader revenue growth management, driving productivity and working capital efficiency, and enhancing our digital capabilities, inclusive of ecommerce.

During the fourth quarter of fiscal year 2025, we announced that our Board of Directors was conducting a comprehensive review of the Company’s portfolio with the assistance of our independent financial advisor. The Board is considering a broad range of strategic options to enhance value. Also, in the third quarter of fiscal year 2025, we announced that we were exploring strategic alternatives regarding our personal care business to focus on our portfolio of better-for-you food and beverages. The personal care business meets the criteria to be classified as held for sale as of June 30, 2025.

Basis of Presentation

The Company’s consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Investments in affiliated companies in which the Company exerts significant influence, but which it does not control, are accounted for under the equity method of accounting. As such, consolidated net loss includes the Company’s equity in the current earnings or losses of such companies.

Unless otherwise indicated, references in these consolidated financial statements to 2025, 2024 and 2023 or “fiscal” 2025, 2024 and 2023 or other years refer to the fiscal year ended June 30 of that respective year and references to 2025 or “fiscal” 2025 refer to the fiscal year ending June 30, 2025.

All dollar amounts in the consolidated financial statements, notes and tables have been rounded to the nearest thousands, except par values and per share amounts, unless otherwise indicated.

Reclassification

Certain prior year amounts have been reclassified to conform with current year presentation on the consolidated balance sheets related to investments and joint ventures to include it as part of other current assets. There were no reclassifications made to the consolidated statement of operations, consolidated statements of changes in stockholders’ equity or consolidated statements of cash flows.

Use of Estimates

The financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The accounting principles used required the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and amounts of income and expenses during the reporting periods presented. Actual results could differ from those estimates. These estimates include, among others, variable consideration related to revenue recognition for trade promotions and sales incentives, allowances for credit losses and returns, valuation of

55

Table of Contents

long-lived assets, goodwill and intangible assets (acquired in business combinations and analysis of impairment), stock-based compensation for market awards, and valuation allowances for deferred tax assets.

2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND PRACTICES

Cash and Cash Equivalents

The Company considers cash and cash equivalents to include cash in banks, commercial paper and deposits with financial institutions that can be liquidated without prior notice or penalty. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

In addition, cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand.

Revenue Recognition

The Company sells its products through specialty and natural food distributors, supermarkets, natural foods stores, mass-market and e-commerce retailers, food service channels and club, drug and convenience stores worldwide. The majority of the Company’s revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of products. The Company recognizes revenue as performance obligations are fulfilled when control passes to customers, which is typically upon delivery of the products to its customers. Customer contracts typically contain standard terms and conditions. In instances where formal written contracts are not in place, the Company considers the customer purchase orders to be contracts based on the criteria outlined in Accounting Standard Codification (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). Payment terms and conditions vary by customer and are based on the billing schedule established in contracts or purchase orders with customers, but the Company generally provides credit terms to customers ran ging from 30-91 days. T herefore, the Company has concluded that contracts do not include a significant financing component.

Sales include shipping and handling charges billed to the customer and are reported net of trade promotions and sales incentives, consumer coupon programs and discounts, including estimated allowances for returns and prompt pay discounts. Shipping and handling costs are accounted for as a fulfillment activity of promise to transfer products to customers and are included in the cost of sales line item on the consolidated statements of operations.

Variable Consideration

In addition to fixed contract consideration, many of the Company’s contracts include some form of variable consideration. The Company offers various trade promotions and sales incentive programs to customers and consumers, such as price discounts, slotting fees, in-store display incentives, cooperative advertising programs, new product introduction fees and coupons. The expenses associated with these programs are accounted for as reductions to the transaction price of the products and are therefore deducted from sales to determine reported net sales. Trade promotions and sales incentive accruals are subject to significant management estimates and assumptions. The critical assumptions used in estimating the accruals for trade promotions and sales incentives include the Company’s estimate of expected levels of performance and redemption rates. The Company exercises judgment in developing these assumptions. These assumptions are based upon historical performance of the retailer or distributor customers with similar types of promotions adjusted for current trends. The Company regularly reviews and revises, when deemed necessary, estimates of costs to the Company for these promotions and incentives based on what has been incurred by the customers. The terms of most of the promotion and incentive arrangements do not exceed a year and therefore do not require highly uncertain long-term estimates. Settlement of these liabilities typically occurs in subsequent periods primarily through an authorization process for deductions taken by a customer from amounts otherwise due to the Company. Differences between estimated expense and actual promotion and incentive costs are recognized in earnings in the period such differences are determined. Actual expenses may differ if the level of redemption rates and performance were to vary from estimates.

Costs to Obtain or Fulfill a Contract

As the Company’s contracts are generally shorter than one year, the Company has elected a practical expedient under ASC 606 that allows the Company to expense as incurred the incremental costs of obtaining a contract if the contract period is for one year or less. These costs are included in selling, general and administrative expenses on the consolidated statements of operations.

Allowances for Credit Losses

The Company routinely performs credit evaluations on existing and new customers and maintains an allowance for expected uncollectible accounts receivable which is recorded as an offset to trade accounts receivable on the consolidated balance sheets. Collectability of accounts receivable is assessed by applying a historical loss-rate methodology in accordance with ASC Topic 326, Financial Instruments - Credit Losses, adjusted as necessary based on the Company’s review of accounts receivable on an individual basis, specifically identifying customers with known disputes or collectability issues, and experience with trade

56

Table of Contents

receivable aging categories. The Company also considers market conditions and current and expected future economic conditions to inform adjustments to historical loss data. Changes to the allowance, if any, are classified as bad debt provisions within selling, general and administrative expenses on the consolidated statements o f operations. Credit losses have been within the Company’s expectations in recent years and are not material. While one of the Company’s customers represented approximately 18% and 19% of trade receivables balances as of June 30, 2025 and 2024, respectively, the Company believes that there is no significant or unusual credit exposure at this time.

Based on cash collection history and other statistical analysis, the Company estimates the amount of unauthorized deductions customers have taken that the Company expects will be collected and repaid in the near future and records a chargeback receivable which is a component of trade receivables. Differences between estimated collectible receivables and actual collections are recognized in earnings in the period such differences are determined.

Sales to one customer and its affiliates approximated 18%, 18% and 16% of sales during the fiscal years ended June 30, 2025, 2024 and 2023, respectively.

Inventory

Inventory is valued at the lower of cost or net realizable value, utilizing the first-in, first-out method. The Company provides write-downs for finished goods expected to become unsaleable due to age and specifically identifies and provides for slow moving or obsolete raw ingredients and packaging.

Property, Plant and Equipment

Property, plant and equipment is carried at cost and depreciated or amortized on a straight-line basis over the estimated useful lives or lease term (for leasehold improvements), whichever is shorter. The Company believes the useful lives assigned to the Company’s property, plant and equipment are within ranges generally used in consumer products manufacturing and distribution businesses. The Company’s manufacturing plants and distribution centers, and their related assets, are reviewed when impairment indicators are present by analyzing underlying cash flow projections. The Company believes no impairment of the carrying value of such assets exists other than as disclosed under Note 7, Property, Plant and Equipment, Net. Ordinary repairs and maintenance costs are expensed as incurred. The Company utilizes the following ranges of asset lives:

Buildings and improvements |  | 10 - 40 years
Machinery and equipment |  | 3 - 20 years
Furniture and fixtures |  | 3 - 15 years

Leasehold improvements are amortized over the shorter of the respective initial lease term or the estimated useful life of the assets and generally range from 3 to 20 years.

Software that is developed for internal use is recorded as a component of property, plant and equipment. Qualifying costs incurred to develop internal-use software are capitalized when (i) the preliminary project stage is completed, (ii) management has authorized further funding for the completion of the project and (iii) it is probable that the project will be completed and perform as intended. These capitalized costs include compensation for employees who develop internal-use software and external costs related to development of internal-use software. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended purpose. Once placed into service, internally developed software is amortized on a straight-line basis over its estimated useful life which generally ranges from 3 to 10 years. All other expenditures, including those incurred in order to maintain the asset’s current level of performance, are expensed as incurred. The net book value of internally developed software as of June 30, 2025 and 2024 wa s $11,861 and $12,240, respectively, and is included as a component of Computer Hardware and Software in Note 7, Property, Plant and Equipment, Net.

Goodwill and Other Indefinite-Lived Intangible Assets

Goodwill and other intangible assets with indefinite useful lives are not amortized but rather are tested at least annually for impairment, or when circumstances indicate that the carrying amount of the asset may not be recoverable. The Company performs its annual test for impairment at the beginning of the fourth quarter of its fiscal year.

Goodwill is tested for impairment at the reporting unit level. A reporting unit is an operating segment or a component of an operating segment. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. The Company may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. The impairment test for goodwill requires the Company to compare the fair value of a reporting unit to its carrying value. The Company uses a blended analysis of a discounted cash flow

57

Table of Contents

model and a market valuation approach to determine the fair values of its reporting units. If the carrying value of a reporting unit exceeds its fair value, the Company would then compare the carrying value of the goodwill to its implied fair value in order to determine the amount of the impairment, if any.

Indefinite-lived intangible assets, which are not amortized, consist primarily of acquired trademarks and tradenames. Indefinite-lived intangible assets are evaluated on an annual basis in conjunction with the Company’s evaluation of goodwill, or on an interim basis if and when events or circumstances change that would more likely than not reduce the fair value of any of its indefinite-lived intangible assets below their carrying value. In assessing fair value, the Company utilizes a “relief from royalty” methodology. This approach involves two steps: (i) estimating the royalty rates for each trademark and (ii) applying these royalty rates to a projected net sales stream and discounting the resulting cash flows to determine fair value. If the carrying value of the indefinite-lived intangible assets exceeds the fair value of the assets, the carrying value is written down to fair value in the period identified. This method includes significant management assumptions such as revenue growth rates, weighted average cost of capital and assumed royalty rates. See Note 9, Goodwill and Other Intangible Assets and Note 16, Fair Value Measurements, for additional information on goodwill and intangibles impairment charges.

Transfer of Financial Assets

The Company accounts for transfers of financial assets, such as non-recourse accounts receivable financing arrangements, when the Company has surrendered control over the related assets. Determining whether control has transferred requires an evaluation of relevant legal considerations, an assessment of the nature and extent of the Company’s continuing involvement with the assets transferred and any other relevant considerations. The Company has non-recourse financing arrangements in which eligible receivables are sold to third-party buyers in exchange for cash. The Company transferred accounts receivable in their entirety to the buyers and satisfied all of the conditions to rep ort the transfer of financial assets in their entirety as a sale. The principal amount of receivables sold under these arrangements was $289,431, $284,891 and $380,683 during the fiscal years ended June 30, 2025, 2024 and 2023, respectively. The incremental cost of financing receivables under these arrangements is included in selling, general and administrative expenses on the Company’s consolidated statements of operations. The proceeds from the sale of receivables are included in cash provided by operating activities on the consolidated statements of cash flows.

Cost of Sales

Included in cost of sales are the cost of products sold, including the costs of raw materials and labor and overhead required to produce the products, warehousing, distribution, supply chain costs, as well as costs associated with shipping and handling of inventory.

Foreign Currency Translation and Remeasurement

The assets and liabilities of international operations are translated at the exchange rates in effect at the balance sheet date. Revenue and expense accounts are translated at the monthly average exchange rates. Adjustments arising from the translation of the foreign currency financial statements of the Company’s international operations are reported as a component of accumulated other comprehensive loss on the consolidated balance sheets. Gains and losses arising from intercompany foreign currency transactions that are of a long-term nature are reported in the same manner as translation adjustments.

Gains and losses arising from intercompany foreign currency transactions that are not of a long-term nature and certain transactions of the Company’s subsidiaries which are denominated in currencies other than the subsidiaries’ functional currency are recognized as incurred in other expense (income), net on the consolidated statements of operations.

Selling, General and Administrative Expenses

Included in selling, general and administrative expenses are advertising costs, promotion costs not paid directly to the Company’s customers, salary and related benefit costs of the Company’s employees in the finance, human resources, information technology, legal, sales and marketing functions, facility related costs of the Company’s administrative functions, research and development costs, and costs paid to con sultants and third party providers for related services.

Research and Development Costs

Research and development costs are expensed as incurred and are included in selling, general and administrative expenses on the consolidated statements of operations. Research and development costs amounted to $5,222, $5,366 and $6,379 in fiscal 2025, 2024 and 2023, respectively, consisting primarily of personnel related costs. The Company’s research and development expenditures do not include the expenditures on such activities undertaken by co-packers and suppliers who develop numerous products on behalf of the Company and on their own initiative with the expectation that the Company will accept their new product ideas and market them under the Company’s brands.

Advertising Costs

58

Table of Contents

Advertising costs, which are included in selling, general and administrative expenses, amounted to $31,489, $39,660 and $43,035 in fiscal 2025, 2024 and 2023, respectively. Such costs are expensed as incurred.

Proceeds from Insurance Claims

In fiscal 2024, and 2023, the Company receive d $1,297 and $8,594 of proceeds from insurance claims, respectively, which are included in selling, general and administrative expenses on the consolidated statements of operations. There were no proceeds received from insurance claims in fiscal 2025.

Income Taxes

The Company follows the liability method of accounting for income taxes. Under the liability method, deferred taxes are determined based on the differences between the financial statement and tax bases of assets and liabilities at enacted rates in effect in the years in which the differences are expected to reverse. The Company also assesses the likelihood of future realization of deferred tax assets, including recent earnings results within taxing jurisdictions, expectations of future taxable income, the carryforward periods available and other relevant factors. Valuation allowances are provided for deferred tax assets to the extent it is more likely than not that the deferred tax assets will not be recoverable against future taxable income.

The Company recognizes liabilities for uncertain tax positions based on a two-step process prescribed by the authoritative guidance. The first step requires the Company to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, the Company must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires the Company to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50% likely of being realized upon ultimate settlement. The Company reevaluates the uncertain tax positions each period based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Depending on the jurisdiction, such a change in recognition or measurement may result in the recognition of a tax benefit or an additional charge to the tax provision in the period. The Company records interest and penalties in the provision for income taxes.

Fair Value of Financial Instruments

The fair value of financial instruments is the amount at which the instrument could be exchanged in a current transaction between willing parties. At June 30, 2025 and 2024, the carrying values of financial instruments such as accounts receivable, accounts payable, accrued expenses and other current liabilities, as well as borrowings under the Company’s credit facility and other borrowings, approximated fair value based upon either the short-term maturities or market interest rates of these instruments.

Derivative Instruments and Hedging Activities

ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

The Company records all derivatives on the consolidated balance sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The effective portion of changes in the fair value of derivative instruments that qualify for cash flow hedge and net investment hedge accounting treatment are recognized in stockholders’ equity as a component of accumulated other comprehensive loss until the hedged item is recognized in earnings. Changes in the fair value of fair value hedges, derivatives that do not qualify for hedge accounting treatment, as well as the ineffective portion of any cash flow hedges, are recognized currently in earnings as a component of interest and other financing expense, net on the consolidated statements of operations. The Company reports cash flows arising from derivative instruments consistent with the classification of cash flows from the

59

Table of Contents

underlying hedged items that these derivatives are hedging. Accordingly, the cash flows associated with derivatives designated as net investment hedges and fair value hedges are classified in cash flows from investing and financing activities, respectively, on the consolidated statements of cash flows. The C ompany may enter into derivative contracts that are intended to economically hedge certain of its risks, even though hedge accounting does not apply, or the Company elects not to apply hedge accounting.

Stock-Based Compensation

The Company uses the fair market value of the Company’s common stock on the grant date to measure fair value for service-based awards and a Monte Carlo simulation model to determine the fair value of market-based awards. The Company uses historical volatility to calculate the expected volatility matching the expected holding period. The fair value of stock-based compensation awards is recognized as an expense over the vesting period using the straight-line method. For awards that contain a market condition, expense is recognized over the defined or derived service period using a Monte Carlo simulation model. Compensation expense is recognized for these awards on a straight-line basis over the service period, regardless of the eventual number of shares that are earned based upon the market condition, provided that each grantee remains an employee at the end of the performance period. Compensation expense on awards that contain a market condition is reversed if at any time during the service period a grantee is no longer an employee.

The Company recognizes forfeitures as they occur at which time compensation cost previously recognized for an award that is forfeited because of failure to satisfy a condition is reversed in the period of the forfeiture.

The Company receives an income tax deduction in certain tax jurisdictions for restricted stock grants when they vest and for stock options exercised by employees equal to the excess of the market value of the Company’s common stock on the date of exercise over the option price. Excess tax benefits (tax benefits resulting from tax deductions in excess of compensation cost recognized) are classified as a cash flow provided by operating activities on the consolidated statements of cash flows.

Valuation of Long-Lived Assets

The Company periodically evaluates the carrying value of long-lived assets held and used in the business and with definite lives, when events and circumstances occur indicating that the carrying amount of the asset or its asset group may not be recoverable. An impairment test is performed when the estimated undiscounted cash flows associated with the asset or asset group is less than its carrying value. If the undiscounted cash flows are less than the carrying value of the asset or its asset group, the Company performs test to fair value the asset or its asset group. A loss is recognized based on the amount, if any, by which the carrying value exceeds the estimated fair value of the asset or asset group.

See Note 7, Property, Plant and Equipment, Net, Note 9, Goodwill and Other Intangible Assets, and Note 16, Fair Value Measurements, for additional information on long-lived asset impairment charges.

Leases

Arrangements containing leases are evaluated as an operating or finance lease at lease inception. For operating leases, the Company recognizes an operating lease right-of-use (“ROU”) asset and operating lease liability at lease commencement based on the present value of lease payments over the lease term.

With the exception of certain finance leases, an implicit rate of return is not readily determinable for the Company’s leases. For these leases, an incremental borrowing rate is used in determining the present value of lease payments and is calculated based on information available at the lease commencement date. The incremental borrowing rate is determined using a portfolio approach based on the rate of interest the Company would have to pay to borrow funds on a collateralized basis over a similar term. The Company references market yield curves which are risk-adjusted to approximate a collateralized rate in the currency of the lease. These rates are updated on a quarterly basis for measurement of new lease obligations.

The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. Leases with an initial term of 12 months or less are not recognized on the consolidated balance sheets. The Company has elected to separate lease and non-lease components.

Net Loss Per Share

Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted net loss per share reflects the potential dilution that would occur if securities or other contracts to issue common stock were exercised or converted into common stock.

60

Table of Contents

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures”, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this ASU effective June 30, 2025 and has incorporated such enhanced disclosures in Note 21, Segment Information.

Recently Issued Accounting Pronouncements Not Yet Adopted

In July 2025, the FASB issued ASU 2025-05, “Financial Instruments — Credit Losses (Topic 326) — Measurement of Credit Losses for Accounts Receivable and Contract Assets”, which will provide a practical expedient in developing reasonable and supportable forecasts as part of estimating expected credit losses: all entities may elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. The amendments are effective for fiscal years beginning after December 15, 2025 and for interim periods within fiscal years beginning after December 15, 2025. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”. The amendments address investor requests for more detailed expense information and require additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which will require entities to disclose more detailed information in the reconciliation of their statutory tax rate to their effective tax rate. The ASU also requires entities to disclose more detailed information about income taxes paid, including by jurisdiction, pretax income (loss) from continuing operations, and income tax expense (benefit). The amendments are effective for fiscal years beginning after December 15, 2024 and for interim periods within fiscal years beginning after December 15, 2025. The amendments should be applied on a prospective basis. Retrospective application is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future consolidated financial statements.

3.
LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share on the consolidated statements of operations:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |  |  |  |
Net loss |  | $ | (530,841 | ) |  | $ | (75,042 | ) |  | $ | (116,537 | )
Denominator: |  |  |  |  |  |  |  |  |
Basic and diluted weighted average shares outstanding |  |  | 90,127 |  |  |  | 89,750 |  |  |  | 89,396 |
Basic and diluted net loss per common share |  | $ | (5.89 | ) |  | $ | (0.84 | ) |  | $ | (1.30 | )

Due to the Company’s net loss in each of the twelve months ended June 30, 2025 and June 30, 2024, all common stock equivalents such as stock options, unvested restricted share units and performance share units have been excluded from the computation of diluted net loss per share. The effect of the stock options and unvested restricted share units would have been anti-dilutive to the computations. The performance share units were contingently issuable based on market conditions or performance goals and such conditions or goals had not been achieved during the year.

4.
ASSETS AND LIABILITIES HELD FOR SALE

During the third quarter of fiscal year 2025, the Company announced that it was exploring strategic alternatives regarding its personal care (“PC”) business to focus on its portfolio of better-for-you food and beverages. The Company determined that its PC business was held for sale and ascribed an aggregate $11,164 of goodwill from its U.S. and Canada reporting units to the PC business which are part of the North American reportable segme nt. The operating results of the business were not significant. The Company anticipates entering into a definitive agreement to sell these assets within 12 months from when it was initially

61

Table of Contents

classified as held for sale.

During fiscal 2025, the Company recorded a non-cash charge of $26,843 to write down the carrying amount of the disposal group to its estimated fair value less cost to dispose, which was reflected within intangibles and long-lived asset impairment on the consolidated statements of operations. The following table presents the major classes of assets and liabilities of the personal care business classified as held for sale:

|  | Fiscal Year Ended |
|  | June 30, 2025 |
ASSETS |  |  |
Accounts receivable, net |  | $ | 7,121 |
Inventories |  |  | 30,347 |
Prepaid expenses and other current assets |  |  | 1,112 |
Property, plant and equipment, net |  |  | 918 |
Goodwill |  |  | 11,164 |
Other noncurrent assets |  |  | 80 |
Operating lease right-of-use assets, net |  |  | 5,704 |
Allowance for reduction of assets held for sale |  |  | (26,843 | )
Assets held for sale |  | $ | 29,603 |
LIABILITIES |  |  |
Accounts payable |  | $ | 5,432 |
Operating lease liabilities |  |  | 5,793 |
Accrued expenses and other current liabilities |  |  | 1,762 |
Liabilities held for sale |  | $ | 12,987 |

5.
DISPOSITIONS

ParmCrisps®

On August 30, 2024, the Company completed the sale of its ParmCrisps® business for total cash consideration of $12,000, subject to customary post-closing adjustments. The divestiture is consistent with the Company’s portfolio simplification process. ParmCrisps® was part of the Company’s North America reportable segment. During fiscal 2025, the Company deconsolidated the net assets of ParmCrisps®, primarily consisting of $7,280, $6,725, and $1,282 of goodwill, inventory, and machinery and equipment, respectively, and recognized a pretax loss on sale of $3,863 recorded in other expense (income), net.

Queen Helene®

On June 3, 2024, the Company completed the divestiture of its Queen Helene® business (“QH”) for tota l cash consideration of $750. The sale of QH is consistent with the Company’s portfolio simplification process. QH was part of the Company’s North America reportable segment. During the fiscal year ended June 30, 2024, the Company deconsolidated the net assets of QH, pri marily consisting of $1,672 and $535 of inventory and goodwill, respectively, and recognized a pretax loss on sale of $1,466.

Thinsters®

On April 8, 2024, the Company completed the sale of its Thinsters® cookie business for total cash consideration of $7,700, subject to customary post-closing adjustments. The final purchase price was $7,264. The divestiture is consistent with the Company’s portfolio simplification process. Thinsters® was part of the Company’s North America reportable segment. During the fiscal year ended June 30, 2024, the Company deconsolidated the net assets of Thinsters®, primarily consisting of $5,732, $1,977, and $1,180 of goodwill, intangible assets, and inventory, respectively, and recognized a pretax loss on sale of $2,856.

Westbrae Natural®

On December 15, 2022, the Company completed the divestiture of its Westbrae Natural® brand (“Westbrae”) for total cash consideration of $7,498. The sale of Westbrae is consistent with the Company’s portfolio simplification process. Westbrae operated in the United States (“U.S.”) and was part of the Company’s North America reportable segment. During the fiscal year ended June 30, 2023, the Company deconsolidated the net assets of Westbrae, primarily consisting of $3,054 of goodwill, and recognized a pretax gain on sale of $3,488.

62

Table of Contents

6.
INVENTORIES

Inventories consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Finished goods |  | $ | 177,990 |  |  | $ | 178,150 |
Raw materials, work-in-progress and packaging |  |  | 70,741 |  |  |  | 95,978 |
|  | $ | 248,731 |  |  | $ | 274,128 |

7.
PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Land |  | $ | 11,926 |  |  | $ | 11,381 |
Buildings and improvements |  |  | 61,788 |  |  |  | 57,030 |
Machinery and equipment |  |  | 347,867 |  |  |  | 325,174 |
Computer hardware and software |  |  | 56,466 |  |  |  | 54,139 |
Furniture and fixtures |  |  | 22,599 |  |  |  | 20,943 |
Leasehold improvements |  |  | 38,680 |  |  |  | 39,255 |
Construction in progress |  |  | 12,692 |  |  |  | 12,783 |
|  |  | 552,018 |  |  |  | 520,705 |
Less: Accumulated depreciation |  |  | 287,288 |  |  |  | 258,975 |
|  | $ | 264,730 |  |  | $ | 261,730 |

Depreciation expense for the fiscal years ended June 30, 2025, 2024 and 2023 was $32,494, $34,332 and $35,893, respectively.

During the fiscal year ended June 30, 2025, as a result of the continued decline in actual and projected performance and cash flows related to certain PC, Yves Veggie Cuisine® and Linda McCartney’s® (under license) production facilities, the Company completed interim impairment tests of the respective asset groups. The Company determined that the estimated fair values of the Linda McCartney’s® (under license) meat free asset group and the Yves Veggie Cuisine® asset group exceeded their respective carrying amounts. However, the carrying amount of the PC asset group exceeded its estimated fair value. The Company recognized a non-cash impairment charge of $2,654 to reduce the carrying value of certain PC production assets in the North America reportable segment to their estimated fair value. Impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statement of operations.

During the fiscal year ended June 30, 2024, the Company recognized aggregated non-cash impairment charges of $26,541. This included a non-cash impairment charge of $5,875 to reduce the carrying amount of ParmCrisps® machinery and equipment to its estimated fair value and a non-cash impairment charge of $20,666 related to the former Bell, CA production facility, reflecting asset reductions in connection with the facility’s closure. These charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. In fiscal 2025, the Company recognized a $1,600 pretax gain on the sale of such long-lived assets, which was included as a component of other expense (income), net on the consolidated statement of operations.

During the fiscal year ended June 30, 2024, the Company completed the sale of a facility in the North America reportable segment for total cash proceeds of $1,182, net of brokerage and other fees, resulting in a loss of $68, which was included as a component of other expense (income), net on the consolidated statement of operations.

During the fiscal year ended June 30, 2024, the Company recognized a non-cash impairment charge of $2,763, related to write-down of projects machinery and equipment in the International reportable segment related to the multi-year growth, transformation and restructuring program (the “Restructuring Program”). See Note 19, Transformation Program.

63

Table of Contents

8.
LEASES

The Company leases office space, warehouse and distribution facilities, manufacturing equipment and vehicles primarily in North America and Western Europe. The Company determines if an arrangement is or contains a lease at inception. Right of use assets related to finance leases are included in property, plant and equipment, net on the consolidated balance sheets. Lease liabilities for finance leases are included in the current and non-current portions of long-term debt on the consolidated balance sheets. The current portion of the operating lease liabilities is included in accrued expenses and other current liabilities on the consolidated balance sheets. The Company does not have any related party leases, and sublease transactions are de minimis.

The components of lease expenses for the fiscal years ended June 30, 2025, 2024 and 2023 were as follows:

|  | Fiscal Year Ended |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Operating lease expenses |  | $ | 14,019 |  |  | $ | 17,446 |  |  | $ | 18,173 |
Finance lease expenses |  |  | 209 |  |  |  | 147 |  |  |  | 227 |
Variable lease expenses |  |  | 671 |  |  |  | 723 |  |  |  | 740 |
Short-term lease expenses |  |  | 1,247 |  |  |  | 1,565 |  |  |  | 2,003 |
Total lease expenses |  | $ | 16,146 |  |  | $ | 19,881 |  |  | $ | 21,143 |

Supplemental balance sheet information related to leases is as follows:

Leases |  | Classification |  | Fiscal Year Ended June 30, |
|  |  |  | 2025 |  |  | 2024 |
Assets |  |  |  |  |  |  |  |
Operating lease ROU assets |  | Operating lease right-of-use assets, net* |  | $ | 76,875 |  |  | $ | 86,634 |
Finance lease ROU assets, net |  | Property, plant and equipment, net |  |  | 588 |  |  |  | 206 |
Total leased assets |  |  |  | $ | 77,463 |  |  | $ | 86,840 |
Liabilities |  |  |  |  |  |  |  |
Current |  |  |  |  |  |  |  |
Operating |  | Accrued expenses and other current liabilities* |  | $ | 14,908 |  |  | $ | 10,759 |
Finance |  | Current portion of long-term debt |  |  | 153 |  |  |  | 85 |
Non-current |  |  |  |  |  |  |  |
Operating |  | Operating lease liabilities, noncurrent portion |  |  | 65,284 |  |  |  | 80,863 |
Finance |  | Long-term debt, less current portion |  |  | 462 |  |  |  | 137 |
Total lease liabilities |  |  |  | $ | 80,807 |  |  | $ | 91,844 |

* Includes leases related to personal care business that was reclassified as assets held for sale. See Note 4, Assets and Liabilities Held for Sale, for more information.

Additional information related to leases is as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Supplemental cash flow information |  |  |  |  |  |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |  |
Operating cash flows from operating leases |  | $ | 15,007 |  |  | $ | 16,529 |  |  | $ | 16,446 |
Operating cash flows from finance leases |  | $ | 16 |  |  | $ | 12 |  |  | $ | 16 |
Financing cash flows from finance leases |  | $ | 130 |  |  | $ | 81 |  |  | $ | 161 |
ROU assets obtained in exchange for lease obligations: |  |  |  |  |  |  |  |  |
Operating leases(1)(2)(3) |  | $ | (2,954 | ) |  | $ | 4,243 |  |  | $ | (2,627 | )
Finance leases |  | $ | 514 |  |  | $ | 35 |  |  | $ | 118 |
Weighted average remaining lease term: |  |  |  |  |  |  |  |  |
Operating leases |  | 8.2 years |  |  | 8.8 years |  |  | 10.4 years |
Finance leases |  | 4.0 years |  |  | 3.0 years |  |  | 3.9 years |
Weighted average discount rate: |  |  |  |  |  |  |  |  |
Operating leases |  |  | 5.0 | % |  |  | 5.0 | % |  |  | 4.8 | %
Finance leases |  |  | 6.7 | % |  |  | 4.6 | % |  |  | 4.7 | %

64

Table of Contents

(1) Includes adjustment for termination of two operating leases during fiscal year ended June 30, 2025, which resulted in a reduction of ROU assets and lease liabilities of $5,346 and $4,037, respectively, and recognition of an accumulated gain of $1,309 related to lease terminations.

(2) Includes adjustment for remeasurement of an operating lease during fiscal year ended June 30, 2024, which resulted in a net reduction of an ROU asset and a corresponding reduction in lease liability of $9,375.

(3) Includes adjustment for modification of an operating lease for the fiscal year ended June 30, 2023, which resulted in a reduction of ROU assets and lease liabilities of $13,876 and $17,244, respectively, and recognition of a gain of $3,368 related to the modification.

Maturities of lease liabilities as of June 30, 2025 were as follows:

Fiscal Year |  | Operating leases |  |  | Finance leases |  |  | Total |
2026 |  | $ | 13,975 |  |  | $ | 177 |  |  | $ | 14,152 |
2027 |  |  | 13,591 |  |  |  | 163 |  |  |  | 13,754 |
2028 |  |  | 12,516 |  |  |  | 136 |  |  |  | 12,652 |
2029 |  |  | 11,696 |  |  |  | 110 |  |  |  | 11,806 |
2030 |  |  | 10,420 |  |  |  | 118 |  |  |  | 10,538 |
Thereafter |  |  | 35,579 |  |  |  | — |  |  |  | 35,579 |
Total lease payments |  |  | 97,777 |  |  |  | 704 |  |  |  | 98,481 |
Less: Imputed interest |  |  | 17,585 |  |  |  | 89 |  |  |  | 17,674 |
Total lease liabilities |  | $ | 80,192 |  |  | $ | 615 |  |  | $ | 80,807 |

65

Table of Contents

9.
GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The following table provides the changes in the carrying value of goodwill by reportable segment:

|  | North America |  |  | International |  |  | Total |
Balance as of June 30, 2023(1) |  | $ | 697,053 |  |  | $ | 241,587 |  |  | $ | 938,640 |
Divestiture(2) |  |  | (6,267 | ) |  |  | — |  |  |  | (6,267 | )
Translation |  |  | (1,318 | ) |  |  | (1,751 | ) |  |  | (3,069 | )
Balance as of June 30, 2024 |  |  | 689,468 |  |  |  | 239,836 |  |  |  | 929,304 |
Divestiture(3) |  |  | (7,280 | ) |  |  | — |  |  |  | (7,280 | )
Impairment charges |  |  | (357,679 | ) |  |  | (71,203 | ) |  |  | (428,882 | )
Reclassification of goodwill to held for sale(4) |  |  | (11,164 | ) |  |  | — |  |  |  | (11,164 | )
Translation |  |  | (1,024 | ) |  |  | 20,007 |  |  |  | 18,983 |
Balance as of June 30, 2025 |  | $ | 312,321 |  |  | $ | 188,640 |  |  | $ | 500,961 |

(1)
The total carrying value of goodwill as of June 30, 2023 is reflected net of $134,277 of accumulated impairment charges, of which $7,700 is related to the North America reportable segment and $126,577 is related to the International reportable segment.
(2)
During the fiscal year ended June 30, 2024, the Company completed the divestitures of Thinsters® and Queen Helene, both were components of the North America reportable segment. Goodwill of $5,732 and $535 was assigned to divested components of Thinsters® and Queen Helene®, respectively, on a relative fair value basis.
(3)
Represents the goodwill assigned to the ParmCrisps® business in connection with the divestiture of such business, which was ascribed on a relative fair value basis. See Note 5, Disposition, for more information.
(4)
Represents the goodwill ascribed to the PC business in connection with the classification such business as held for sale. See Note 4, Assets and Liabilities Held for Sale, for more information.

In fiscal 2025, the Company recorded aggregated non-cash goodwill impairment charges of $357,679 within its North America segment and $71,203 within our International reportable segment as a result of goodwill impairment testing discussed below. The fair values for the quantitatively tested reporting units were estimated using a blended approach of the Discounted Cash Flow (“DCF”) method income approach and the Guideline Public Company Methodology (“GPCM”) market approach. Set forth is a table of each reporting unit’s goodwill carrying value as of, and impairment charges and other activity recorded during, the periods presented:

|  | Reporting Unit |
(Dollars in thousands) |  | U.S. |  |  | Canada |  |  | U.K. |
Goodwill as of June 30, 2024 |  | $ | 641,053 |  |  | $ | 48,415 |  |  | $ | 173,538 |
Impairment charge during three months ended September 30, 2024 |  |  | — |  |  |  | — |  |  |  | — |
Divestiture during three months ended September 30, 2024 |  |  | (7,280 | ) |  |  | — |  |  |  | — |
Impairment charge during three months ended December 31, 2024 |  |  | (91,267 | ) |  |  | — |  |  |  | — |
Impairment charge during three months ended March 31, 2025 |  |  | (88,712 | ) |  |  | (21,539 | ) |  |  | — |
Reclassification of goodwill to held for sale during three months ended March 31, 2025 |  |  | (3,291 | ) |  |  | (7,873 | ) |  |  | — |
Impairment charge during three months ended June 30, 2025 |  |  | (138,182 | ) |  |  | (17,979 | ) |  |  | (71,203 | )
Translation |  |  | — |  |  |  | (1,024 | ) |  |  | 13,877 |
Goodwill as of June 30, 2025 |  | $ | 312,321 |  |  | $ | — |  |  | $ | 116,212 |

As of June 30, 2024, the Company had tested its U.S. reporting unit’s goodwill for impairment and, as previously disclosed, determined that the U.S. reporting unit’s goodwill was at risk, given that the fair value of the reporting unit was greater than its carrying value by 6.2%.

Second quarter of fiscal 2025

During the second quarter of fiscal 2025, as a result of the continued decline in the Company’s market capitalization since the previous fiscal year and the recognition of PC intangible asset impairment charges within the reporting units in its North America reportable segment, the Company completed an interim impairment test for goodwill for all of its reporting units utilizing either a quantitative or qualitative test. Consequently, the Company recognized a non-cash impairment charge of $91,267 to reduce the

66

Table of Contents

carrying value of the goodwill of the U.S. reporting unit. In addition to the aforementioned factors, while the Company’s previously announced Hain Reimagined strategy was still in effect, certain significant assumptions in the fair value test of the U.S. reporting unit had changed. Those changes in estimates included a decline in overall sales volume, an increase in the discount rate utilized in the DCF methodology as a result of certain developments related to the Company’s ability to implement its then-current strategy and a decrease in Enterprise Value (“E.V.”)/EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. For the qualitatively assessed reporting units (Canada, U.K., Western Europe and Ella’s Kitchen U.K.), the Company assessed qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts.

Third quarter of fiscal 2025

During the third quarter of fiscal 2025, as a result of a significant reduction in the Company’s actual and projected performance and cash flows primarily within its North America segment, the measurement of the PC business as held for sale, as well as the continued decline in the Company’s market capitalization since the previous quarter, the Company completed an interim impairment test for goodwill for all of its reporting units. As of March 31, 2025, the U.S. and Canada reporting units’ carrying amounts exceeded their estimated fair value, resulting in recognition of non-cash impairment charges of $88,712 and $21,539, respectively, to reduce their respective carrying values. The additional U.S. reporting unit impairment recorded during the third quarter of fiscal 2025 also reflected the sales volume decline that the Company continued to experience, which led to an incremental increase in the discount rate utilized to measure risk in the DCF methodology. Additionally, there was also a corresponding decrease in E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. The Canada reporting unit was affected by the PC business being classified as held for sale in addition to the Canadian market being affected by net sales volume declines similar to those that had been experienced by the U.S. reporting unit. For the qualitatively tested reporting units (U.K., Western Europe and Ella’s Kitchen U.K.), the Company assessed qualitative factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts, while noting a recent decline in performance within the U.K. reporting units.

Annual impairment testing as of April 1, 2025

While the Company’s annual impairment testing date is on April 1, 2025 (the first day of the fourth quarter of fiscal 2025), the previously aforementioned quantitative tests for the U.S. and Canada reporting units were utilized for the annual impairment test given there were no significant changes to the risks of these reporting units between March 31, 2025 and April 1, 2025. However, the Company performed quantitative tests for its other three reporting units (Western Europe, Ella’s Kitchen and U.K.) on April 1, 2025, which corroborated the results of the qualitative analysis that was performed during the third quarter of fiscal 2025. The fair values of Western Europe and Ella’s Kitchen significantly exceeded their carrying values.

Fourth quarter of fiscal 2025

As of June 30, 2025, the Company identified further indicators of impairment and determined it was necessary to perform a quantitative test of goodwill at the U.S., Canada and U.K. reporting units and a qualitative assessment of its Western Europe and Ella’s Kitchen U.K. reporting units. On a consolidated basis, the continued decline in the Company’s closing stock price per share from $6.91 as of June 30, 2024 to $1.52 as of June 30, 2025 was a significant indicator that led the Company to perform these additional tests. In addition, during the fourth quarter of fiscal 2025, the Board of Directors announced the exit of the Company’s former CEO and that a strategic review of the Company’s portfolio would be performed, as discussed in Note 1. Description of Business and Basis of Presentation. The following factors were also identified within the reporting units.

During the fourth quarter of fiscal 2025, the U.S. reporting unit experienced certain significant distribution losses with certain customers that affected both revenue and Adjusted EBITDA. Furthermore, given the continued known decline in the Company’s U.S. forecasts, the discount rate utilized to measure risk in the DCF methodology increased. In addition, there was a reduction in E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. These factors led to an impairment of $138,182 being recorded in our U.S. reporting unit for the three months ended June 30, 2025.

67

Table of Contents

Furthermore, during the fourth quarter of fiscal 2025, the U.K. reporting unit had a reduction in Adjusted EBITDA due to certain regulations related to plastic and national insurance taxes that were enacted during the quarter, and the reduction of Adjusted EBITDA also impacted the discount rate utilized under the DCF approach. The U.K. reporting unit valuation was also impacted by a reduction in the E.V./EBITDA multiples of comparable publicly traded companies, which were utilized in the GPCM under the market approach. These factors led to the recognition of a non-cash goodwill impairment charge of $71,203 being recorded in our U.K. reporting unit as of June 30, 2025.

The Canada reporting unit had goodwill of $17,549 remaining as of April 1, 2025. The remaining goodwill was impaired as a result of the Company’s strategic decision to close the Yves Veggie Cuisine® business on June 26, 2025, which is expected to be completed in fiscal 2026.

Subsequent to these impairment charges, the remaining goodwill at the U.S. and U.K. reporting units was $312,321 and $116,212, respectively, as of June 30, 2025. There was no remaining goodwill at the Canada reporting unit as of June 30, 2025. The goodwill related to the U.S. and U.K. reporting units are at risk of potential impairment if the fair value of these reporting units, and their associated assets, decrease in value due to the amount and timing of expected future cash flows, decreased customer demand for products, an inability to execute management’s business strategies, or general market conditions, such as economic downturns, and changes in interest rates, including discount rates. Future cash flow estimates are, by their nature, subjective, and actual results may differ materially from the Company’s estimates. If the Company’s ongoing cash flow projections are not met or if market factors utilized in the impairment test deteriorate, including an unfavorable change in the terminal growth rate or the weighted-average cost of capital, the Company may have to record additional impairment charges in future periods.

For the qualitatively tested reporting units (Western Europe and Ella’s Kitchen UK), the Company performed a qualitative evaluation as of June 30, 2025 to assess factors to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount, including goodwill. The Company concluded that the qualitatively tested reporting units’ estimated fair values exceeded their carrying amounts, which was consistent with the conclusions reached on the annual quantitative impairment testing date of April 1, 2025.

Other Intangible Assets

The following table includes the gross carrying amount and accumulated amortization, where applicable, for intangible assets, excluding goodwill:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Non-amortized intangible assets: |  |  |  |  |  |
Trademarks and tradenames(1) |  | $ | 179,282 |  |  | $ | 195,237 |
Amortized intangible assets: |  |  |  |  |  |
Other intangibles(2) |  |  | 159,162 |  |  |  | 167,886 |
Less: Accumulated amortization |  |  | (127,539 | ) |  |  | (118,324 | )
Net amortized intangible assets |  |  | 31,623 |  |  |  | 49,562 |
Net other intangible assets |  | $ | 210,905 |  |  | $ | 244,799 |

(1)
The gross carrying value of trademarks and tradenames is reflected net of $275,990 and $251,551 of accumulated impairment charges as of June 30, 2025 and 2024, respectively.
(2)
The reduction in carrying value of other intangible assets as of June 30, 2025 reflected accumulated non-cash impairment charges of $30,326 an d $17,032 recognized in the fiscal year ended June 30, 2025 and 2024, respectively.

During the fourth quarter of fiscal 2025, the Company quantitatively tested tradenames associated with its snacks and meal preparation brands, Sensible Portions®, Imagine® and Spectrum®. The estimated fair value of Spectrum® exceeded its carrying value by approximately 18.6%. The quantitative assessment indicated that the carrying value of Sensible Portions® and Imagine® tradenames exceeded their estimated fair value. The fair value was determined using the relief from royalty method, and an aggregate non-cash impairment charge of $21,100 was recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The Sensible Portions® and Spectrum® intangible assets are part of the North America reportable segment and had a remaining aggregate carrying value of $8,000 and $11,800, respectively, as of June 30, 2025. The Imagine® intangible asset was also part of the North America reportable segment and had no remaining carrying value as of June 30, 2025. The Spectrum® and Sensible Portions® tradenames remain at risk of impairment in future periods in the event of

68

Table of Contents

unfavorable changes in assumptions, including forecasted future cash flows based on execution of strategic initiatives for increasing revenue, as well as discount rates and other macroeconomic factors.

During the third quarter of fiscal 2025, the Company recorded a non-cash impairment charge of $960 within its North America reportable segment related to its Health Valley® trademark. The asset was part of the North America reportable segment and had no remaining carrying value as of June 30, 2025.

During the second quarter of fiscal 2025, the Company recorded a non-cash impairment charge of $15,733 within its North America reportable segment. Non-cash impairment charges of $12,085 were related to the PC intangible assets, primarily Avalon Organics®, JASON®, and Live Clean® trademarks and tradenames and $3,648 was related to Belvedere™ trademark and customer relationships. The assets are part of the North America reportable segment and had no remaining carrying value as of June 30, 2025.

During the third quarter of fiscal 2024, the Company recorded a non-cash impairment charge of $10,797 related to the indefinite and definite lived intangible assets associated with Thinsters® in connection with the probable sale of the Thinsters® cookie business. The Company concluded that, as of March 31, 2024, there was a high probability that the sale of the Thinsters® business would occur and, therefore, a quantitative impairment test was performed. To determine the amount of the impairment, the Company compared the carrying amount of the Thinsters® assets to its estimated fair value (which was the expected selling price less transaction costs).

During the third quarter of fiscal 2024, the Company recorded non-cash impairment charges of $12,815 and $8,000 for certain North America personal care tradenames (namely, Alba Botanica®, Avalon Organics®, and JASON®) and the ParmCrisps® trademark, respectively, to reduce the carrying amounts of such intangible assets to their estimated fair values of $13,000 and nil, respectively. The fair value was determined using the relief from royalty method, and impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The assets are part of the North America reportable segment. As a result of the same factors triggering the interim impairment tests for the ParmCrisps® trademark, the Company completed impairment tests of the ParmCrisps® asset group, which was primarily comprised of amortizable customer relationships, machinery and equipment and operating lease right-of-use assets. The Company determined that the carrying amount of the ParmCrisps® asset group exceeded the estimated fair value. During the fiscal year ended June 30, 2024, the Company recorded non-cash impairment charges of $10,586 to reduce the carrying amount of the ParmCrisps® customer relationships to their estimated fair value which was determined using a discounted cash flow analysis. Impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The customer relationship intangible asset was part of the North America reportable segment and was fully impaired.

In the fourth quarter of fiscal 2024, the Company quantitatively tested another intangible asset. The assessment indicated that the carrying value of the trademarks associated with its plant-based beverage brands, Happy™ and Joya®, exceeded its estimated fair value. The fair value was determined using the relief from royalty method, and a non-cash impairment charge of $2,260 was recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The Happy™ and Joya® intangible assets are part of the International reportable segment and had a remaining aggregate carrying value of $3,761 as of June 30, 2024.

During the fourth quarter of fiscal 2023, the Company recorded non-cash impairment charges of $4,767, $4,691 and $9,150 for the Imagine®, Joya®, and Queen Helene® intangible assets, respectively, to reduce the carrying amount of such intangible assets to their estimated fair value. The fair values were determined using the relief from royalty method, and impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The Imagine® and Queen Helene® intangible assets are part of the North America reportable segment and had a remaining aggregate carrying value of $3,100 as of June 30, 2024. The Joya® intangible assets are part of the International reportable segment and had a remaining aggregate carrying value of $3,761 as of June 30, 2024.

During fiscal 2023, the Company recorded non-cash impairment charges of $102,000 and $8,500 for the ParmCrisps® and Thinsters® trademarks, respectively, to reduce the carrying amount of such intangible assets to their estimated fair value. The fair values were determined using the relief from royalty method, and impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The assets are part of the North America reportable segment and were fully impaired as of June 30, 2024. As a result of the same factors triggering the interim impairment tests for the ParmCrisps® and Thinsters® trademarks, the Company completed interim impairment tests of the ParmCrisps® and Thinsters® asset groups, which were primarily comprised of amortizable customer relationships. The Company determined that the carrying amount of the ParmCrisps® asset group exceeded its estimated fair value. During the fiscal year ended June 30, 2023, the Company recorded non-cash impairment charges of $45,798 to reduce the carrying amount of the ParmCrisps® customer relationships, the primary asset in the casset group, to their estimated fair value. Impairment charges were recorded within intangibles and long-lived asset impairment on the consolidated statements of operations. The fair value of the Thinsters® asset group exceeded its carrying amount. During the fiscal year ended June 30, 2024, the Company completed the sale of the Thinsters® business as discussed in Note 5, Dispositions.

69

Table of Contents

Non-cash impairment charges, recorded within intangibles and long-lived asset impairment on the consolidated statements of operations, for the fiscal years ended June 30, 2025, June 30, 2024 and June 30, 2023 were as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Sensible Portions® tradename |  | $ | 18,000 |  |  | $ | — |  |  | $ | — |
Personal care tradenames (Alba Botanica®, Avalon Organics®, and JASON®) |  |  | 12,085 |  |  |  | 12,815 |  |  |  | — |
Belvedere™ trademark and customer relationships |  |  | 3,648 |  |  |  | — |  |  |  | — |
Imagine® tradename |  |  | 3,100 |  |  |  | — |  |  |  | 4,767 |
Health Valley® trademark |  |  | 960 |  |  |  | — |  |  |  | — |
Thinsters® trademark and customer relationships |  |  | — |  |  |  | 10,797 |  |  |  | 8,500 |
ParmCrisps® customer relationships |  |  | — |  |  |  | 10,586 |  |  |  | 45,798 |
ParmCrisps® trademark |  |  | — |  |  |  | 8,000 |  |  |  | 102,000 |
Happy™ and Joya® trademarks |  |  | — |  |  |  | 2,260 |  |  |  | 4,691 |
Queen Helene® |  |  | — |  |  |  | — |  |  |  | 9,150 |
Other |  |  | — |  |  |  | 144 |  |  |  | — |
|  | $ | 37,793 |  |  | $ | 44,602 |  |  | $ | 174,906 |

Amortized intangible assets, which are deemed to have a finite life, primarily consist of customer relationships, trademarks and tradenames and are amortized over their estimated use ful lives of 7 to 25 years. The weighted average remaining amortization period of amortized intangible assets is 8.37 years. Expected amortization ex pense for the next five fiscal years is as follows:

|  | Fiscal Year Ending June 30, |
|  | 2026 |  |  | 2027 |  |  | 2028 |  |  | 2029 |  |  | 2030 |
Estimated amortization expense |  | $ | 4,701 |  |  | $ | 4,667 |  |  | $ | 3,971 |  |  | $ | 3,355 |  |  | $ | 3,355 |

10.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Payroll, employee benefits and other administrative accruals |  | $ | 38,211 |  |  | $ | 43,408 |
Facility, freight and warehousing accruals |  |  | 9,250 |  |  |  | 9,365 |
Short-term operating lease liabilities |  |  | 9,115 |  |  |  | 10,759 |
Selling and marketing related accruals |  |  | 6,892 |  |  |  | 11,485 |
Other accruals |  |  | 4,958 |  |  |  | 10,697 |
|  | $ | 68,426 |  |  | $ | 85,714 |

11.
DEBT AND BORROWINGS

Debt and borrowings consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Revolving credit facility |  | $ | 450,500 |  |  | $ | 475,000 |
Term loans |  |  | 255,550 |  |  |  | 270,550 |
Less: Unamortized issuance costs |  |  | (1,844 | ) |  |  | (1,680 | )
Other borrowings(1) |  |  | 615 |  |  |  | 222 |
|  |  | 704,821 |  |  |  | 744,092 |
Short-term borrowings and current portion of long-term debt(2) |  |  | 7,653 |  |  |  | 7,569 |
Long-term debt, less current portion |  | $ | 697,168 |  |  | $ | 736,523 |

(1)
Includes $615 (2024: $222) of finance lease obligations.
(2)
Includes $153 (2024: $85) of short-term finance lease obligations.

Credit Agreement

70

Table of Contents

On December 22, 2021, the Company entered into a Fourth Amended and Restated Credit Agreement (as subsequently amended, the “Credit Agreement”). The Credit Agreement originally provided for senior secured financing of $1,100,000 in the aggregate, consisting of (1) $300,000 in aggregate principal amount of term loans (the “Term Loans”) and (2) an $800,000 senior secured revolving credit facility (which includes borrowing capacity available for letters of credit, and was originally comprised of a $440,000 U.S. revolving credit facility and $360,000 global revolving credit facility) (the “Revolver”). Both the Revolver and the Term Loans mature on December 22, 2026. Th e Company’s obligations under the Credit Agreement are guaranteed by certain existing and future domestic subsidiaries of the Company and are secured by liens on assets of the Company and its material domestic subsidiaries, including the equity interest in each of their direct subsidiaries and intellectual property, subject to agreed-upon exceptions.

The Credit Agreement includes financial covenants that require compliance with a consolidated secured leverage ratio, a consolidated leverage ratio and a consolidated interest coverage ratio. On August 22, 2023, the Company entered into a Second Amendment (the “Second Amendment”) to the Credit Agreement. Pursuant to the Second Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 until September 30, 2023, 5.25:1.00 until December 31, 2023, 5.00:1.00 until December 31, 2024, and 4.25:1.00 thereafter. See below for a description of the Third Amendment and Fourth Amendment (each as defined below). Following the Fourth Amendment, the Company’s maximum consolidated secured leverage ratio under the Credit Agreement was 5.00:1.00 for the quarter ended June 30, 2025 and is 5.50:1.00 for the quarter ending September 30, 2025 and thereafter. Pursuant to the Credit Agreement, the Company’s maximum consolidated leverage ratio is 6.00:1.00 and, through June 30, 2025, its minimum interest coverage ratio was 2.50:1.00.

From the date of the Second Amendment until the date of the Third Amendment, loans under the Credit Agreement bore interest at (a) the Secured Overnight Financing Rate plus a credit spread adjustment of 0.10% (“Term SOFR”) plus 2.5% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 1.5% per annum.

On May 5, 2025, the Company entered into a Third Amendment (the “Third Amendment”) to the Credit Agreement. Pursuant to the Third Amendment, the Company’s maximum consolidated secured leverage ratio was amended to be 4.75:1.00 for the quarter ending June 30, 2025 through (and including) the quarter ending March 31, 2026, 4.50:1.00 for the quarter ending June 30, 2026, and 4.25:1.00 for the quarter ending September 30, 2026 and thereafter.

Commencing on the date of the Third Amendment, loans under the Credit Agreement bore interest at (a) Term SOFR plus 3.00% per annum or (b) the Base Rate plus 2.00% per annum.

The Third Amendment also reduced the size of the Revolver from $800,000 to $700,000 in the aggregate, with the U.S. revolving credit facility reduced from $440,000 to $385,000 and the global revolving credit facility reduced from $360,000 to $315,000.

On September 11, 2025, the Compa ny entered into a Fourth Amendment (the “Fourth Amendment”) to the Credit Agreement. Pursuant to the Fourth Amendment, (x) the Company’s maximum consolidated secured leverage ratio was amended to be 5.00:1.00 for the quarter ending June 30, 2025 and 5.50:1.00 for the quarter ending September 30, 2025 and thereafter, (y) the Company’s minimum consolidated interest coverage ratio was amended to be 2.00:1.00 for the quarter ending September 30, 2025 and thereafter and (z) a covenant was added requiring the Company to maintain a minimum Consolidated EBITDA (as such term is defined in the Credit Agreement as amended by the Fourth Amendment) of (i) $17,000 for the quarter ending September 30, 2025 and (ii) $52,000 for the cumulative two quarters ending September 30, 2025 and on December 31, 2025. The aforementioned financial covenants use financial measures that are defined under the Credit Agreement and not pursuant to U.S. generally accepted accounting principles. Please refer to the Credit Agreement and amendments filed as exhibits to this Form 10-K for further information related to the calculation thereof.

Commencing on the date of the Fourth Amendment, loans under the Credit Agreement bear interest at (a) Term SOFR plus 4.00% per annum or (b) the Base Rate plus 3.00% per annum.

The Fourth Amendment also reduced the size of the Revolver from $700,000 to $600,000 in the aggregate, with the U.S. revolving credit facility reduced from $385,000 to $330,000 and the global revolving credit facility reduced from $315,000 to $270,000.

Excluding the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 7.34%. The Company uses interest rate swaps to hedge a portion of the interest rate risk related to its outstanding variable rate debt. As of June 30, 2025, the notional amount of the interest rate swaps was $400,000 with fixed rate payments of 6.12%. Including the impact of hedges, the weighted average interest rate on outstanding borrowings under the Credit Agreement at June 30, 2025 was 6.44%. Additionally, the Credit Agreement contains a commitment fee of 0.25% per annum on the amount unused under the Credit Agreement.

As of June 30, 2025, there were $450,500 of loans under the Revolver, $255,550 of Term Loans, and $2,775 of letters of credit outstanding under the Credit Agreement. As of June 30, 2025, $246,725 was available under the Credit Agreement, subject to compliance with the financial covenants. As of June 30, 2025, the Company was in compliance with all associated covenants.

71

Table of Contents

In connection with amendments to the Credit Agreement during the second quarter of fiscal year 2023, and the first quarter of fiscal 2024, the Company incurred debt issuance costs of approximately $5,841, of which $5,729 was deferred. Of the total deferred costs, $4,198 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on the consolidated balance sheets, and $1,531 are being recorded as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net over the term of the Credit Agreement utilizing the effective interest rate method. In May 2025, the Company amended the credit agreement that decreased the borrowing capacity of the Revolver, resulting in write-off of $380 of previously capitalized deferred costs.

In connection with the Second Amendment to its Credit Agreement during the fourth quarter of fiscal year 2025, the Company incurred debt issuance costs of approximately $3,448, of which $3,413 was deferred. Of the total deferred costs, $2,476 were associated with the Revolver and are being amortized on a straight-line basis within Other assets on our consolidated balance sheets, and $937 are being amortized on a straight-line basis, which approximates the effective interest method, as an adjustment to the carrying amount of the Term Loans as a component of Interest and other financing expense, net over the term of the Credit Agreement.

Maturities of all debt instruments, excluding unamortized issuance costs, at June 30, 2025, are as follows:

Due in Fiscal Year |  | Amount |
2026 |  | $ | 7,653 |
2027 |  |  | 698,692 |
2028 |  |  | 319 |
Total debt and borrowings |  | $ | 706,664 |

Interest paid during the fiscal years ended June 30, 2025, 2024 and 2023 amounted t o $46,265, $52,456 and $41,698, respectively.

12.
INCOME TAXES

The components of loss before income taxes and equity in net loss of equity-method investees were as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Domestic |  | $ | (456,528 | ) |  | $ | (148,014 | ) |  | $ | (183,601 | )
Foreign |  |  | (57,203 | ) |  |  | 67,733 |  |  |  | 54,020 |
Total |  | $ | (513,731 | ) |  | $ | (80,281 | ) |  | $ | (129,581 | )

The provision (benefit) for income taxes consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Current: |  |  |  |  |  |  |  |  |
Federal |  | $ | 3,686 |  |  | $ | (55 | ) |  | $ | 3,103 |
State and local |  |  | 1,260 |  |  |  | 616 |  |  |  | 953 |
Foreign |  |  | 14,774 |  |  |  | 14,980 |  |  |  | 7,719 |
|  |  | 19,720 |  |  |  | 15,541 |  |  |  | 11,775 |
Deferred: |  |  |  |  |  |  |  |  |
Federal |  |  | 2,642 |  |  |  | (23,403 | ) |  |  | (23,551 | )
State and local |  |  | (5,599 | ) |  |  | (2,386 | ) |  |  | 271 |
Foreign |  |  | (1,466 | ) |  |  | 2,428 |  |  |  | (2,673 | )
|  |  | (4,423 | ) |  |  | (23,361 | ) |  |  | (25,953 | )
Total |  | $ | 15,297 |  |  | $ | (7,820 | ) |  | $ | (14,178 | )

Cash paid for income taxes, net of refunds, during the fiscal years ended June 30, 2025 and June 30, 2024 amounted to $12,099 and $10,303, respectively.

72

Table of Contents

The reconciliation of the U.S. federal statutory rate to the Company’s effective rate on (loss) income before (benefit) provision for income taxes is as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | % |  |  | 2024 |  |  | % |  |  | 2023 |  |  | % |
Expected United States federal income tax at statutory rate |  | $ | (107,884 | ) |  |  | 21.0 | % |  | $ | (16,857 | ) |  |  | 21.0 | % |  | $ | (27,233 | ) |  |  | 21.0 | %
State income taxes, net of federal benefit |  |  | (11,431 | ) |  |  | 2.2 | % |  |  | (5,060 | ) |  |  | 6.3 | % |  |  | (4,866 | ) |  |  | 3.8 | %
U.S. tax on foreign earnings |  |  | 3,466 |  |  |  | (0.7 | )% |  |  | 266 |  |  |  | (0.3 | )% |  |  | 1,946 |  |  |  | (1.5 | )%
Foreign income at different rates |  |  | (6,538 | ) |  |  | 1.3 | % |  |  | (313 | ) |  |  | 0.3 | % |  |  | (905 | ) |  |  | 0.7 | %
Change in valuation allowance(a) |  |  | 28,757 |  |  |  | (5.6 | )% |  |  | 15,075 |  |  |  | (18.8 | )% |  |  | 14,935 |  |  |  | (11.5 | )%
Change in reserves for uncertain tax positions(b) |  |  | 25,863 |  |  |  | (5.0 | )% |  |  | 2,044 |  |  |  | (2.5 | )% |  |  | 637 |  |  |  | (0.5 | )%
Impairment of goodwill and intangibles(c) |  |  | 77,615 |  |  |  | (15.2 | )% |  |  | — |  |  |  | — | % |  |  | — |  |  |  | — | %
Gain (loss) on disposal of subsidiary |  |  | 2,104 |  |  |  | (0.4 | )% |  |  | (1,116 | ) |  |  | 1.4 | % |  |  | — |  |  |  | — | %
Stock-based compensation |  | 393 |  |  |  | (0.1 | )% |  |  | 945 |  |  |  | (1.2 | )% |  |  | — |  |  |  | — | %
Return to provision |  |  | (301 | ) |  |  | 0.1 | % |  |  | (4,274 | ) |  |  | 5.3 | % |  |  | — |  |  |  | — | %
Loss on capital asset |  |  | 1,004 |  |  |  | (0.2 | )% |  |  | — |  |  |  | — | % |  |  | — |  |  |  | — | %
Other |  |  | 2,249 |  |  |  | (0.4 | )% |  |  | 1,470 |  |  |  | (1.8 | )% |  |  | 1,308 |  |  |  | (1.1 | )%
Provision (benefit) for income taxes |  | $ | 15,297 |  |  |  | (3.0 | )% |  | $ | (7,820 | ) |  |  | 9.7 | % |  | $ | (14,178 | ) |  |  | 10.9 | %

(a) The Company estimated that it would not be able to utilize certain of its federal tax credit, federal tax losses and state tax loss carryovers due to its history of pretax losses and inability to carry back tax losses or credits for refunds. This negative evidence resulted in the Company increasing the valuation allowance on worldwide deferred tax assets in the year ended June 30, 2025 by $28,757, in the year ended June 30, 2024 by $15,075, and in the year ended June 30, 2023 by $14,935.

(b) The Company recorded an unrecognized tax benefit that may not be fully supported under audit.

(c) The Company recorded impairments of goodwill and intangibles to certain IP and most of the goodwill impaired did not have a deferred tax liability associated with it. Therefore the impact of these impairments is recorded as an impact to the effective tax rate.

U.S. federal tax regulations include a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries and a measure to tax certain intercompany payments under the base erosion anti-abuse tax (“BEAT”) regime. For the fiscal years ended June 30, 2025, 2024 and 2023, the Company did not generate intercompany transactions that met the BEAT threshold but does have to include GILTI tax relating to the Company’s foreign subsidiaries.

The Company elected to account for GILTI tax as a current period cost and did no t record an expense during the fiscal year ended June 30, 2025. The GILTI tax expense is included in the U.S. tax benefit on foreign earnings in the effective tax rate which also includes tax expense related to Subpart F income and unremitted earnings in total.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Deferred tax assets and liabilities consisted of the following:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Noncurrent deferred tax assets (liabilities): |  |  |  |  |  |
Basis difference on inventory |  | $ | 3,877 |  |  | $ | 4,884 |
Reserves not currently deductible |  |  | 6,014 |  |  |  | 8,386 |
Basis difference on intangible assets |  |  | (29,280 | ) |  |  | (62,549 | )
Basis difference on property and equipment |  |  | (18,198 | ) |  |  | (14,946 | )
Other comprehensive loss (income) |  |  | 2,302 |  |  |  | (2,887 | )
Net operating loss and tax credit carryforwards |  |  | 74,121 |  |  |  | 67,186 |
Stock-based compensation |  |  | 1,342 |  |  |  | 1,591 |
Unremitted earnings of foreign subsidiaries |  |  | (3,980 | ) |  |  | (1,873 | )
Operating lease liability |  |  | 15,905 |  |  |  | 18,615 |
Lease ROU assets |  |  | (14,931 | ) |  |  | (17,309 | )
Other |  |  | 18,879 |  |  |  | 18,702 |
Valuation allowances |  |  | (96,383 | ) |  |  | (67,626 | )
Noncurrent deferred tax liabilities, net |  | $ | (40,332 | ) |  | $ | (47,826 | )

73

Table of Contents

At June 30, 2025 and 2024, the Company had U.S. federal NOL carryforwards of approximately $113,258 and $67,138, respectively, certain of which will not expire until 2033. Certain of these federal loss carryforwards are subject to Internal Revenue Code Section 382, which imposes limitations on utilization following certain changes in ownership of the entity generating the loss carryforward. The Company had foreign NOL carryforwards of approximately $14,815 and $9,035 at June 30, 2025 and 2024, respectively, the majority of which are indefinite lived.

For the year ended June 30, 2025, the Company determined that $172,525 of foreign earnings are not permanently reinvested with a corresponding deferred tax liability of $3,980. The Company continues to rein vest $610,988 o f undistributed earnings of its foreign subsidiaries and may be subject to additional foreign withholding taxes and U.S. state income taxes if it reverses its indefinite reinvestment assertion on these foreign earnings in the future. All other outside basis differences not related to earnings were impractical to account for at this period of time and are currently considered as being permanent in duration.

As required by the authoritative guidance on accounting for income taxes, the Company evaluates the realizability of deferred tax assets on a jurisdictional basis at each reporting date. Accounting for income taxes requires that a valuation allowance be established when it is more likely than not that all or a portion of the deferred tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred tax assets are not more likely than not realizable, the Company establishes a valuation allowance. The Company recorded valuation allowances in the amounts of $96,383 and $67,626 at June 30, 2025 and 2024, respectively.

The changes in valuation allowances against deferred income tax assets were as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
Balance at beginning of year |  | $ | 67,626 |  |  | $ | 52,551 |
Additions charged to income tax expense |  |  | 28,193 |  |  |  | 18,998 |
Reductions credited to income tax expense |  |  | (829 | ) |  |  | (3,858 | )
Currency translation adjustments |  |  | 1,393 |  |  |  | (65 | )
Balance at end of year |  | $ | 96,383 |  |  | $ | 67,626 |

Unrecognized tax benefits activity, including interest and penalties, is summarized below:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Balance at beginning of year |  | $ | 26,060 |  |  | $ | 23,967 |  |  | $ | 21,901 |
Additions based on tax positions related to the current year |  |  | 24,555 |  |  |  | 1,906 |  |  |  | 1,519 |
Additions based on tax positions related to prior years |  |  | 1,308 |  |  |  | 187 |  |  |  | 815 |
Reductions due to lapse in statute of limitations and settlements |  |  | — |  |  |  | — |  |  |  | (268 | )
Balance at end of year |  | $ | 51,923 |  |  | $ | 26,060 |  |  | $ | 23,967 |

As of June 30, 2025, the Company had $51,923 of unrecognized tax benefits, of which $48,112 represents an amount that, if recognized, would impact the effective tax rate in future periods. As of June 30, 2024, the Company had $26,060 of unrecognized tax benefits, of which $22,249 represents the amount that, if recognized, would impact the effective tax rate in future periods. As of June 30, 2023, the Company had $23,967 of unrecognized tax benefits of which $20,155 would impact the effective income tax rate in future periods. Accrued liabilities for interest and penalties were $6,124 and $4,921 at June 30, 2025 and 2024, respectively.

The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and several foreign jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to fiscal 2014. However, to the extent the Company generated NOLs or tax credits in closed tax years, future use of the NOL or tax credit carryforward balance would be subject to examination within the relevant statute of limitations for the year in which utilized. The Company is no longer subject to tax examinations in the U.K. for years prior to fiscal 2021. Given the uncertainty regarding when tax authorities will complete their examinations and the possible outcomes of their examinations, a current estimate of the range of reasonably possible significant increases or decreases of income tax that may occur within the next twelve months cannot be made. Although there are various tax audits currently ongoing, the Company does not believe the ultimate outcome of such audits will have a material impact on the Company’s consolidated financial statements.

74

Table of Contents

13.
STOCKHOLDERS’ EQUITY

Preferred Stock

The Company is authorized to issue “blank check” preferred stock of up to 5,000 shares with such designations, rights and preferences as may be determined from time to time by the Board of Directors. Accordingly, the Board of Directors is empowered to issue, without stockholder approval, preferred stock with dividends, liquidation, conversion, voting or other rights which could decrease the amount of earnings and assets available for distribution to holders of the Company’s common stock. At June 30, 2025 and 2024, no preferred stock was issued or outstanding.

Accumulated Other Comprehensive Loss

The following table presents the changes in accumulated other comprehensive loss (“AOCL”):

|  | Foreign Currency Translation Adjustment, Net |  |  | Deferred Gains (Losses) on Cash Flow Hedging Instruments, Net |  |  | Deferred (Losses) Gains on Fair Value Hedging Instruments, Net |  |  | Deferred (Losses) Gains on Net Investment Hedging Instruments, Net |  |  | Total |
Balance at June 30, 2022 |  | $ | (168,225 | ) |  | $ | 519 |  |  | $ | 500 |  |  | $ | 2,724 |  |  | $ | (164,482 | )
Other comprehensive income (loss) before reclassifications |  |  | 30,197 |  |  |  | 15,390 |  |  |  | (249 | ) |  |  | (1,022 | ) |  |  | 44,316 |
Amounts reclassified into (income) loss |  |  | — |  |  |  | (5,011 | ) |  |  | 434 |  |  |  | (1,473 | ) |  |  | (6,050 | )
Net change in accumulated other comprehensive income (loss) for the fiscal year ended June 30, 2023(1) |  |  | 30,197 |  |  |  | 10,379 |  |  |  | 185 |  |  |  | (2,495 | ) |  |  | 38,266 |
Balance at June 30, 2023 |  |  | (138,028 | ) |  |  | 10,898 |  |  |  | 685 |  |  |  | 229 |  |  |  | (126,216 | )
Other comprehensive (loss) income before reclassifications |  |  | (9,045 | ) |  |  | 5,545 |  |  |  | 342 |  |  |  | 1,390 |  |  |  | (1,768 | )
Amounts reclassified into income |  |  | — |  |  |  | (7,048 | ) |  |  | (730 | ) |  |  | (1,483 | ) |  |  | (9,261 | )
Net change in accumulated other comprehensive loss for the fiscal year ended June 30, 2024(1) |  |  | (9,045 | ) |  |  | (1,503 | ) |  |  | (388 | ) |  |  | (93 | ) |  |  | (11,029 | )
Balance at June 30, 2024 |  |  | (147,073 | ) |  |  | 9,395 |  |  |  | 297 |  |  |  | 136 |  |  |  | (137,245 | )
Other comprehensive income (loss) before reclassifications |  |  | 71,324 |  |  |  | (1,892 | ) |  |  | (1,670 | ) |  |  | (6,782 | ) |  |  | 60,980 |
Amounts reclassified into (income) loss |  |  | — |  |  |  | (4,920 | ) |  |  | 1,557 |  |  |  | (1,425 | ) |  |  | (4,788 | )
Net change in accumulated other comprehensive income (loss) for the fiscal year ended June 30, 2025(1) |  |  | 71,324 |  |  |  | (6,812 | ) |  |  | (113 | ) |  |  | (8,207 | ) |  |  | 56,192 |
Balance at June 30, 2025 |  | $ | (75,749 | ) |  | $ | 2,583 |  |  | $ | 184 |  |  | $ | (8,071 | ) |  | $ | (81,053 | )

(1)
See Note 17, Derivatives and Hedging Activities, for the amounts reclassified into income (expense) for deferred gains (losses) on hedging instruments recorded in the consolidated statements of operations during the fiscal years ended June 30, 2025, 2024, and 2023.

Share Repurchase Program

In January 2022, the Company’s Board of Directors authorized the repurchase of up to $200.0 million of the Company’s issued and outstanding common stock. Repurchases may be made from time to time in the open market, pursuant to pre-set trading plans, in private transactions or otherwise. The current 2022 authorization does not have a stated expiration date. The extent to which the Company repurchases its shares and the timing of such repurchases will depend upon market conditions and other corporate considerations. During the fiscal year ended June 30, 2025, the Company did no t repurchase any shares under the repurchase program. As of June 30, 2025, the Company had $173.5 million of remaining authorization under the share repurchase program.

14.
STOCK-BASED COMPENSATION AND INCENTIVE PERFORMANCE PLANS

The Company maintains a shareholder-approved plan, The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (as amended, the “2022 Plan”), which was approved at the Company’s 2022 Annual Meeting of Shareholders held on November 17, 2022, and further amended at the Company’s 2024 Annual Meeting of Shareholders held on October 31, 2024. The 2022 Plan permits the Company to continue making equity-based and other incentive awards in a manner intended to properly incentivize its employees, directors, consultants and other service providers by aligning their interests with the interests of the

75

Table of Contents

Company’s shareholders. The 2022 Plan is administered by the Compensation Committee of the Company’s Board of Directors. The Company also historically granted shares under its Amended and Restated 2002 Long-Term Incentive and Stock Award Plan and its 2019 Equity Inducement Award Program.

In the second quarter of fiscal 2025, a new form of awards was granted to employees that can be settled in cash or stock, at the Company’s discretion. These awards are accounted for as liability-based equity awards since the Company has the ability and intent to settle such awards in cash.

76

Table of Contents

Stock-Based Award Activity During Past Three Years

Stock-based awards are generally issued in the form of restricted share units (“RSUs”), which are service-based awards, and performance share units (“PSUs”) that are subject to the achievement of minimum market conditions or performance goals. RSU awards to employees generally provide for vesting in equal annual installments over a period of three years, with different vesting periods in certain cases. RSU awards to non-employee directors generally provide for a vesting period of one year. For PSU awards, the following share figures are stated at target levels, and the awards outstanding as of June 30, 2025 generally provide for vesting at 0% to 150% or 200% of the target level. Awards of PSUs and RSUs are issued at no cost to the recipient. A summary of all stock-based award activity for the twelve months ended June 30, 2025 is as follows:

|  | 2025 |  |  | 2024 |  |  | 2023 |
|  | Number of Shares and Units |  |  | Weighted Average Grant Date Fair Value (per share) |  |  | Number of Shares and Units |  |  | Weighted Average Grant Date Fair Value (per share) |  |  | Number of Shares and Units |  |  | Weighted Average Grant Date Fair Value (per share) |
Non-vested at beginning of period - RSUs and PSUs |  |  | 2,165 |  |  | $ | 15.03 |  |  |  | 1,288 |  |  | $ | 26.37 |  |  |  | 790 |  |  | $ | 42.44 |
Granted |  |  | 2,278 |  |  | $ | 6.94 |  |  |  | 1,768 |  |  | $ | 11.83 |  |  |  | 1,242 |  |  | $ | 20.34 |
Vested |  |  | (624 | ) |  | $ | 13.52 |  |  |  | (528 | ) |  | $ | 27.38 |  |  |  | (250 | ) |  | $ | 36.23 |
Forfeited |  |  | (1,192 | ) |  | $ | 13.46 |  |  |  | (363 | ) |  | $ | 19.13 |  |  |  | (494 | ) |  | $ | 31.92 |
Non-vested at end of period - RSUs and PSUs |  |  | 2,627 |  |  | $ | 9.09 |  |  |  | 2,165 |  |  | $ | 15.03 |  |  |  | 1,288 |  |  | $ | 26.37 |

The fair value of RSUs and PSUs granted and of shares vested, and the tax benefit recognized from restricted shares vesting, for the last three fiscal years ended June 30 was as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Fair value of RSUs and PSUs granted |  | $ | 15,806 |  |  | $ | 20,726 |  |  | $ | 25,258 |
Fair value of RSUs and PSUs vested |  | $ | 4,826 |  |  | $ | 5,545 |  |  | $ | 4,684 |
Tax benefit recognized from RSUs and PSUs vesting |  | $ | 625 |  |  | $ | 673 |  |  | $ | 631 |

At June 30, 2025, $11,241 of unrecognized stock-based compensation expense related to non-vested RSUs and PSUs was expected to be recognized over a weighted average period of approximately 0.99 years.

77

Table of Contents

Cash-Settled Award Activity

The Company grants cash-settled awards that are either service-based or subject to the achievement of minimum market conditions or performance goals. Service-based cash awards generally provide for vesting in equal annual installments over a period of three years, with different vesting periods in certain cases. For cash awards tied to minimum market conditions or performance goals, award amounts are stated at target levels with vesting at 0% to 150% of the target level depending on conditions or performance. Cash-based awards are issued at no cost to the recipient.

The fair value of these cash-settled awards is measured at each reporting period until the awards are settled. The performance-based cash-settled award liability at June 30, 2025 was recorded ratably based on the Company’s projected achievement at the end of the measurement period. The cash incentive award liability was $697 at June 30, 2025, $622 of which is classified as a current liability and reported in accrued expenses and other current liabilities, and the balance included in other non-current liabilities within the consolidated balance sheets.

During the three months ended June 30, 2025, the estimated fair value of grant ed cash-settled awards was $4,749. For the reporting period, the Company recognized a forfeiture adjustment of $1,152. As of June 30, 2025, the total remaining non-vested cash-settled awards outstanding was $3,597.

Long-Term Incentive Program

In conjunction with the Stock Award Plans, the Company maintains a long-term incentive program (“LTIP”) that provides for equity awards, including market-based PSUs that can be earned over defined performance periods. The participants of the LTIP include certain of the Company’s executive officers and other key executives. The LTIP is administered by the Compensation and Talent Management Committee, which is responsible for, among other items, selecting the specific performance measures for awards, setting the target performance required to receive an award after the completion of the performance period, and determining the specific payout to the participants.

For RSUs, the Company uses the fair market value of the Company’s common stock on the grant date to measure fair value for service-based awards and for market-based PSUs, the Company uses a Monte Carlo simulation model to determine the fair value of those awards granted under the LTIP. The fair value of RSUs and PSUs is then used to record stock-based compensation expense. The use of the Monte Carlo simulation model requires the Company to make estimates and assumptions and therefore, the Company has included additional information regarding the terms of the PSUs granted and the inputs into the Monte Carlo simulation model below.

2025-2027 LTIP

During the fiscal year ended June 30, 2025, the Company granted market-based PSU awards under the LTIP with a total target payout of 652 shares of common stock. At June 30, 2025, there were 476 such shares outstanding under the LTIP. Such PSU awards will vest, if at all, pursuant to a defined calculation of relative total shareholder return (“TSR”) over the period from October 29, 2024 through the earlier of: (i) October 28, 2027; (ii) the date the participant’s employment is terminated due to death or Disability (as defined in the award agreement); or (iii) the effective date of a Change in Control (as defined in the award agreement) (the “2025 TSR Performance Period”). Total shares eligible to vest range from zero to 150% of the target amount. Grant date fair values are calculated using a Monte Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

|  | Relative TSR PSUs |
Grant date fair value (per target share) |  | $ | 9.89 |
Risk-free interest rate |  |  | 4.09 | %
Expected volatility |  |  | 20.90 | %
Expected term |  | 3.00 years |

2024-2026 LTIP

During the fiscal year ended June 30, 2024, the Company granted market-based PSU awards under the LTIP with a total target payout of 618 shares of common stock. At June 30, 2025, there were 556 such shares outstanding under the LTIP. Such PSU awards will vest, if at all, pursuant to a defined calculation of either relative TSR or absolute TSR (as defined in the award agreement) over the period from October 26, 2023 through the earlier of: (i) October 25, 2026; (ii) the date the participant’s employment is terminated due to death or Disability (as defined in the award agreement); or (iii) the effective date of a Change in Control (as defined in the award agreement) (the “2024 TSR Performance Period”). Vesting of 370 target shares of the outstanding PSU awards is pursuant to a defined calculation of relative TSR over the 2024 TSR Performance Period (the “2024 Relative TSR PSUs”). Vesting of 185 target shares of the outstanding PSU awards is pursuant to the achievement of pre-established three-year compound annual TSR targets over the 2024 TSR Performance Period (the “2024 Absolute TSR PSUs”).

78

Table of Contents

Total shares eligible to vest for both the 2024 Relative TSR PSUs and 2024 Absolute TSR PSUs range from zero to 200% of the target amount. Grant date fair values are calculated using a Monte Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

|  | Fiscal Year ended June 30, 2025 |
|  | Absolute TSR PSUs |  |  | Relative TSR PSUs |
Grant date fair value (per target share) |  | $ | 12.23 |  |  | $ | 15.42 |
Risk-free interest rate |  |  | 4.98 | % |  |  | 4.98 | %
Expected volatility |  |  | 33.70 | % |  |  | 23.10 | %
Expected term |  | 3.00 years |  |  | 3.00 years |

2023-2025 LTIP

During the fiscal year ended June 30, 2023, the Company granted market-based PSU awards under the LTIP with a total target payout of 429 shares of common stock. At June 30, 2024, 249 of such shares were outstanding. Such PSU awards will vest, if at all, pursuant to a defined calculation of either relative TSR or absolute TSR (as defined in the award agreement) over the period from September 6, 2022 through the earlier of: (i) September 6, 2025; (ii) the date the participant’s employment is terminated due to death or Disability (as defined in the award agreement); or (iii) the effective date of a Change in Control (as defined in the award agreement) (the “2023 TSR Performance Period”). Vesting of 167 target shares of the outstanding PSU awards is pursuant to a defined calculation of relative TSR over the 2023 TSR Performance Period (the “2023 Relative TSR PSUs”). Vesting of 82 target shares of the outstanding PSU awards is pursuant to the achievement of pre-established three-year compound annual TSR targets over the 2023 TSR Performance Period (the “2023 Absolute TSR PSUs”). Total shares eligible to vest for both the 2023 Relative TSR PSUs and 2023 Absolute TSR PSUs range from zero to 200% of the target amount. Grant date fair values are calculated using a Monte Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

|  | Fiscal Year ended June 30, 2024 |
|  | Absolute TSR PSUs |  |  | Relative TSR PSUs |
Grant date fair value (per target share) |  | $ | 12.23 |  |  | $ | 15.42 |
Risk-free interest rate |  |  | 4.98 | % |  |  | 4.98 | %
Expected volatility |  |  | 33.70 | % |  |  | 23.10 | %
Expected term |  | 3.00 years |  |  | 3.00 years |

2022-2024 LTIP

During the fiscal year ended June 30, 2022, the Company granted market-based PSU awards under the LTIP with a total target payout of 193 shares of common stock. At June 30, 2024, 44 of such shares were outstanding. Vesting is pursuant to a defined calculation of either relative TSR or absolute TSR (as defined in the award agreement) over the period from November 18, 2021 through the earlier of: (i) November 17, 2024; (ii) the date the participant’s employment is terminated due to death or Disability (as defined in the award agreement); or (iii) the effective date of a Change in Control (as defined in the award agreement) (the “2022 TSR Performance Period”). Vesting of 29 target shares of the outstanding PSU awards is pursuant to a defined calculation of relative TSR over the 2022 TSR Performance Period (the “2022 Relative TSR PSUs”). Vesting of 15 target shares of the outstanding PSU awards is pursuant to the achievement of pre-established three-year compound annual TSR targets over the 2022 TSR Performance Period (the “2022 Absolute TSR PSUs”). Total shares eligible to vest for both the 2022 Relative TSR PSUs and 2022 Absolute TSR PSUs range from 0% to 200% of the target amount.

Grant date fair values are calculated using a Monte Carlo simulation model with weighted average grant date fair values per target share and related valuation assumptions as follows:

|  | Fiscal Year ended June 30, 2023 |
|  | Absolute TSR PSUs |  |  | Relative TSR PSUs |
Grant date fair value (per target share) |  | $ | 20.18 |  |  | $ | 27.47 |
Risk-free interest rate |  |  | 3.54 | % |  |  | 3.54 | %
Expected volatility |  |  | 40.30 | % |  |  | 26.60 | %
Expected term |  | 3.00 years |  |  | 3.00 years |

79

Table of Contents

CEO Succession

On November 22, 2022, the Board approved a succession plan pursuant to which Mark L. Schiller, the Company’s former CEO, transitioned from his position as President and Chief Executive Officer of the Company effective as of December 31, 2022, and Wendy P. Davidson was appointed to the role of President and Chief Executive Officer and as a director on the Board, in each case effective as of January 1, 2023. As of December 31, 2022, certain of Mr. Schiller’s stock-based compensation awards were modified and others were forfeited.

On January 1, 2023, Ms. Davidson received the following awards under the 2023 - 2025 LTIP: 36 Relative TSR PSUs (at target), 18 Absolute TSR PSUs (at target) and 36 RSUs. The Relative TSR PSUs and Absolute TSR PSUs had the same TSR Performance Period, performance goals and beginning stock price as those applicable to awards granted to other employees under the 2023 - 2025 LTIP. The RSUs would vest in one-third (1/3) installments on each of September 6, 2023, 2024 and 2025. Additionally, in recognition of the compensation Ms. Davidson forfeited by leaving her former employer, Ms. Davidson also received a one-time make-whole RSU award of 95 RSUs that would vest in one-third (1/3) installments on each of the first, second and third anniversaries of January 1, 2023. Grant date fair values were calculated using a Monte-Carlo simulation model with grant date fair values per target share and related valuation assumptions as follows:

|  | Absolute TSR PSUs |  |  | Relative TSR PSUs |
Grant date fair value (per target share) |  | $ | 13.84 |  |  | $ | 19.54 |
Risk-free interest rate |  |  | 4.28 | % |  |  | 4.28 | %
Expected volatility |  |  | 40.70 | % |  |  | 28.20 | %
Expected term |  | 3.00 years |  |  | 3.00 years |

On May 7, 2025, the Company announced that Ms. Davidson departed as President and Chief Executive Officer and as a member of the Board effective May 6, 2025. In accordance with the agreement governing her make-whole RSU award, the remaining 32 unvested make-whole RSUs accelerated and vested as of May 6, 2025. All other unvested equity awards held by Ms. Davidson were forfeited in their entirety as of such date.

The Hain Board is executing its leadership succession plan to identify the Company’s next CEO. The Board appointed Alison E. Lewis, a member of the Board since September 2024, as Interim President and CEO. In connection with her appointment, Ms. Lewis received an RSU award of 621 RSUs that vest over a one-year period subject to Ms. Lewis’s continued employment as Interim President and Chief Executive Officer and certain other exceptions.

Summary of Stock-Based Compensation

Compensation cost and related income tax benefits recognized on the consolidated statements of operations for stock-based compensation plans were as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Selling, general and administrative expense |  |  |  |  |  |  |  |  |
Stock-based awards |  | $ | 8,149 |  |  | $ | 12,704 |  |  | $ | 14,423 |
Cash-settled awards |  |  | 697 |  |  | $ | — |  |  | $ | — |
Total selling, general and administrative expense |  | $ | 8,846 |  |  | $ | 12,704 |  |  | $ | 14,423 |
Related income tax benefit |  | $ | 882 |  |  | $ | 1,409 |  |  | $ | 1,734 |

Stock Options

The Company did not grant any stock options in fiscal years 2025, 2024 or 2023, and there were no stock options exercised during these periods. There were 122 stock options outstanding at each of June 30, 2025, 2024 and 2023, relating to a grant under a prior plan. Although no further awards can be granted under the prior plan, the stock options outstanding continue in accordance with the terms of the plan and grant. For stock options outstanding and exercisable at June 30, 2025, the aggregate intrinsic value (the difference between the closing stock price on the last day of trading in the year and the exercise price) was $567, and the weighted average remaining contractual life was 6.0 years. The weighted average exercise price of these stock options was $2.26. At June 30, 2025, there was no unrecognized compensation expense related to stock option awards.

80

Table of Contents

15.
INVESTMENTS

On May 22, 2025, the Company sold its minority equity interest in Chop’t Creative Salad Company LLC, predecessor to Founders Table for a total consideration of $10,000. The Company recorded a pre-tax gain of $5,396 in other expense (income), net in the consolidated statements of operations. The investment, which the Company acquired on October 27, 2015, had previously been accounted for as an equity method investment due to the Company’s representation on the Board of Directors.

16.
FAIR VALUE MEASUREMENTS

The Company’s financial assets and liabilities measured at fair value are required to be grouped in one of three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:

•
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
•
Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
•
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:

|  | Total |  |  | Quoted prices in active markets (Level 1) |  |  | Significant other observable inputs (Level 2) |  |  | Significant unobservable inputs (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  | $ | 5,835 |  |  | $ | — |  |  | $ | 5,835 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  | $ | 19,706 |  |  | $ | — |  |  | $ | 19,706 |  |  | $ | — |

The following table presents assets and liabilities measured at fair value on a recurring basis as of June 30, 2024:

|  | Total |  |  | Quoted prices in active markets (Level 1) |  |  | Significant other observable inputs (Level 2) |  |  | Significant unobservable inputs (Level 3) |
Assets: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  | $ | 14,982 |  |  | $ | — |  |  | $ | 14,982 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Derivative financial instruments |  | $ | 3,333 |  |  | $ | — |  |  | $ | 3,333 |  |  | $ | — |

There were no transfers of financial instruments between the three levels of fair value hierarchy during the fiscal years ended June 30, 2025 or 2024.

Derivative Instruments

The Company uses interest rate swaps to manage interest rate risk and cross-currency swaps and foreign currency exchange contracts to manage exposure to currency fluctuations. These instruments are valued using techniques like DCF analysis, which considers the contractual terms and market-based inputs such as interest rate curves and implied volatilities. The fair values of interest rate swaps are determined by netting the discounted future fixed and variable cash flows. The variable cash flows are based on expected future interest rates.

Credit valuation adjustments are made to reflect the nonperformance risk of both the Company and its counterparties. Most inputs used to value derivatives fall within Level 2 of the fair value hierarchy, but credit valuation adjustments use Level 3 inputs, such as current credit spreads. The impact of these adjustments was not significant to the overall valuation, so all derivatives as of June 30, 2025 and June 30, 2024 were classified as Level 2.

81

Table of Contents

Nonrecurring Fair Value Measurements

The Company measures certain non-financial assets, such as goodwill, indefinite and definite lived intangible assets, and long-lived assets (property and equipment, and right-of-use lease assets), at fair value on a nonrecurring basis. These assets are initially measured at fair value at the time of acquisition or purchase, with adjustments only for foreign currency translation. Periodically, these assets are tested for impairment by comparing their carrying values to their estimated fair values. If an asset is impaired, the Company recognizes an impairment expense equal to the excess of the carrying value over the estimated fair value.

For indefinite-lived intangible assets, fair value is determined using the relief from royalty approach, considering factors like future growth, royalty rates, discount rates, and other variables. Fair value measurements for reporting units where goodwill resides are estimated using a blended analysis of the DCF income approach and GPCM market approach, which involve significant management judgment and Level 3 inputs, such as economic conditions and customer demand. For long-lived assets the Company compares the fair value of the assets to their carrying value utilizing a valuation technique commensurate with the underlying assets. These measurements are performed at least annually for impairment testing. The Company bases its fair value estimates on reasonable assumptions but acknowledges their unpredictability and inherent uncertainty. See Note 7, Property, Plant and Equipment, Net and Note 9, Goodwill and Other Intangible Assets for further information. For assets where a fair value test was performed, the Company utilized nonrecurring fair value measurements which are classified as Level 3.

17.
DERIVATIVES AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposures to a wide variety of business and operational risks. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s receivables and borrowings.

Certain of the Company’s foreign operations expose the Company to fluctuations of foreign exchange rates. These fluctuations may impact the value of the Company’s cash receipts and payments in terms of the Company’s functional currency. The Company enters into derivative financial instruments to protect the value or fix the amount of certain assets and liabilities in terms of its functional currency, the U.S. Dollar. Accordingly, the Company uses derivative financial instruments to manage and mitigate such risks. The Company does not use derivatives for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During fiscal 2024 and 2023, such derivatives were used to hedge the variable cash flows associated with existing variable rate debt.

For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings. Amounts reported in AOCL related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate debt. During the next 12 months, the Company estimates that an additional $3,094 will be reclassified as a decrease to interest expense.

As of June 30, 2025, the Company had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:

Interest Rate Derivative |  | Number of Instruments |  | Notional Amount |
Interest rate swap |  | 4 |  | $ | 400,000 |

Cash Flow Hedges of Foreign Exchange Risk

The Company is exposed to fluctuations in various foreign currencies against its functional currency, the U.S. Dollar. The Company, at times, uses forward contracts to manage its exposure to fluctuations in the GBP-EUR exchange rates. The Company designates these derivatives as cash flow hedges of foreign exchange risks.

82

Table of Contents

For derivatives designated and that qualify as cash flow hedges of foreign exchange risk, the gain or loss on the derivative is recorded in AOCL and subsequently reclassified in the same period during which the hedged transaction affects earnings within the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, t he Company estimates that an additional $114 relating to the foreign currency forward contracts will be reclassified to interest expense.

As of June 30, 2025, the Company had the following outstanding foreign currency derivatives that were used to hedge its foreign exchange risks:

Foreign Currency Derivative |  | Number of Instruments |  | Notional Sold |  |  | Notional Purchased |
Foreign currency forward contract |  | 3 |  | £ | 14,067 |  |  | € | 16,600 |

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in its European foreign entities and their exposure to the Euro. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in the foreign exchange rate on its foreign investment in Western Europe. Currency forward agreements involve fixing the USD-EUR exchange rate for delivery of a specified amount of foreign currency on a specified date. The currency forward agreements are typically cash settled in U.S. Dollars for their fair value at or close to their settlement date. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

For derivatives designated as net investment hedges, the gain or loss on the derivative is reported in AOCL as part of the cumulative translation adjustment. Amounts are reclassified out of AOCL into earnings when the hedged net investment is either sold or substantially liquidated.

During the fiscal year ended June 30, 2025, the Company terminated four EUR-USD cross-currency swaps across various counterparties and received proceeds of $2,363. The Company simultaneously entered into new, at-market cross currency swaps with the same aggregate notional amount as the previous net investment hedges. The gain from termination will remain in AOCL until the net investment is sold or substantially liquidated.

As of June 30, 2025, the Company had the following outstanding foreign currency derivatives that were used to hedge its net investments in foreign operations:

Foreign Currency Derivative |  | Number of Instruments |  | Notional Sold |  |  | Notional Purchased |
Cross-currency swap |  | 4 |  | € | 100,300 |  |  | $ | 103,312 |

Fair Value Hedges

The Company is exposed to changes in the fair value of certain of its foreign denominated intercompany loans due to changes in foreign exchange spot rates. The Company uses fixed-to-fixed cross-currency swaps to hedge its exposure to changes in foreign exchange rates affecting gains and losses on intercompany loan principal and interest. Cross-currency swaps involve the receipt of functional-currency-fixed-rate amounts from a counterparty in exchange for the Company making foreign-currency-fixed-rate payments over the life of the agreement.

For derivatives designated and that qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in interest and other financing expense, net.

Gains and losses on the derivative representing hedge components excluded from the assessment of effectiveness are recognized over the life of the hedge on a systematic and rational basis, as documented at hedge inception in accordance with the Company’s accounting policy election. The earnings recognition of excluded components is presented in the same income statement line item as the earnings effect of the hedged transaction. During the next 12 months, the Company estimates that an additional $476 relating to cross-currency swaps will be reclassified as a decrease to interest expense.

During the three months ended June 30, 2025, the Company terminated one EUR-USD cross-currency swap and received proceeds of $552. The Company simultaneously entered into a new, at-market cross currency swap with the same notional amount as the previous fair value hedge. A portion of gain was recognized in the statement of comprehensive loss, and the balance was deferred to AOCL where it will be amortized on a straight-line basis.

As of June 30, 2025, the Company had the following outstanding foreign currency derivatives that were used to hedge changes in fair value attributable to foreign exchange risk:

Foreign Currency Derivative |  | Number of Instruments |  | Notional Sold |  |  | Notional Purchased |
Cross-currency swap |  | 1 |  | € | 24,700 |  |  | $ | 25,453 |

83

Table of Contents

As of June 30, 2025, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustment for fair value hedges:

|  | Carrying Amount of the Hedged Asset |  |  | Cumulative Amount of Fair Value Hedge Adjustment Included in the Carrying Amount of the Hedged Asset |
|  | Fiscal Year Ended June 30, |  |  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Intercompany loan receivable |  | $ | 28,982 |  |  | $ | 26,465 |  |  | $ | 2,517 |  |  | $ | (480 | )

Designated Hedges

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheets as of June 30, 2025:

|  | Asset Derivatives |  |  | Liability Derivatives |
|  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Interest rate swaps |  | Prepaid expenses and other current assets |  | $ | 3,091 |  |  | Accrued expenses and other current liabilities |  | $ | — |
Interest rate swaps |  | Other noncurrent assets |  |  | 140 |  |  | Other noncurrent liabilities |  |  | — |
Cross-currency swaps |  | Prepaid expenses and other current assets |  |  | 2,335 |  |  | Accrued expenses and other current liabilities |  |  | — |
Cross-currency swaps |  | Other noncurrent assets |  |  | — |  |  | Other noncurrent liabilities |  |  | 19,706 |
Foreign currency forward contracts |  | Prepaid expenses and other current assets |  |  | 269 |  |  | Accrued expenses and other current liabilities |  |  | — |
Total derivatives designated as hedging instruments |  |  |  | $ | 5,835 |  |  |  |  | $ | 19,706 |

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheets as of June 30, 2024:

|  | Asset Derivatives |  |  | Liability Derivatives |
|  | Balance Sheet Location |  | Fair Value |  |  | Balance Sheet Location |  | Fair Value |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Interest rate swaps |  | Prepaid expenses and other current assets |  | $ | 7,455 |  |  | Accrued expenses and other current liabilities |  | $ | — |
Interest rate swaps |  | Other noncurrent assets |  |  | 5,151 |  |  | Other noncurrent liabilities |  |  | — |
Cross-currency swaps |  | Prepaid expenses and other current assets |  |  | 2,376 |  |  | Accrued expenses and other current liabilities |  |  | — |
Cross-currency swaps |  | Other noncurrent assets |  |  | — |  |  | Other noncurrent liabilities |  |  | 3,333 |
Total derivatives designated as hedging instruments |  |  |  | $ | 14,982 |  |  |  |  | $ | 3,333 |

84

Table of Contents

The following table presents the pre-tax effect of the Company’s cash flow hedges, net investment hedges, and fair value hedges on AOCL for fiscal years ended June 30, 2025, 2024 and 2023:

|  | Amount of (Loss) Gain Recognized in AOCL on Derivatives |
|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | (2,696 | ) |  | $ | 7,300 |  |  | $ | 20,413 |
Foreign currency forward contracts |  |  | 89 |  |  |  | 50 |  |  |  | 80 |
Derivatives in net investment hedging relationships: |  |  |  |  |  |  |  |  |
Cross-currency swaps |  |  | (8,999 | ) |  |  | 1,843 |  |  |  | (1,279 | )
Derivatives in fair value hedging relationships: |  |  |  |  |  |  |  |  |
Cross-currency swaps |  |  | (2,216 | ) |  |  | 454 |  |  |  | (310 | )
|  | $ | (13,822 | ) |  | $ | 9,647 |  |  | $ | 18,904 |

The following table presents the pre-tax effect of the Company’s cash flow hedges, net investment hedges, and fair value hedges on the consolidated statements of operations, recorded in interest and other financing expense, net, for fiscal years ended June 30, 2025, 2024 and 2023:

|  | Amount of Gain (Loss) Reclassified from AOCL into Income (Expense) |
|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Derivatives in cash flow hedging relationships: |  |  |  |  |  |  |  |  |
Interest and other financing expense, net: |  |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | 6,581 |  |  | $ | 9,348 |  |  | $ | 6,918 |
Cross-currency swaps |  |  | — |  |  |  | — |  |  |  | (275 | )
Foreign currency forward contracts |  |  | 126 |  |  |  | — |  |  |  | — |
Cost of sales: |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  |  | (38 | ) |  |  | 9 |  |  |  | — |
Derivatives in net investment hedging relationships: |  |  |  |  |  |  |  |  |
Cross-currency swaps |  |  | 1,918 |  |  |  | 1,969 |  |  |  | 1,963 |
Derivatives in fair value hedging relationships: |  |  |  |  |  |  |  |  |
Cross-currency swaps(1) |  |  | (2,056 | ) |  |  | 970 |  |  |  | (557 | )
|  | $ | 6,531 |  |  | $ | 12,296 |  |  | $ | 8,049 |

(1)
Net of amount that is excluded from effectiveness testing. The amount of gain, excluded from effectiveness testing, reclassified from AOCL into income for fiscal years 2025, 2024, and 2023 was $460, $490, and $489, respectively.
18.
COMMITMENTS AND CONTINGENCIES

Securities Class Actions Filed in Federal Court

The Company and certain of its former officers (collectively, the “Defendants”) are defendants in a consolidated class action complaint in the Eastern District of New York under the caption In re The Hain Celestial Group, Inc. Securities Litigation (the “Consolidated Securities Action”). A Corrected Consolidated Amended Complaint was filed in the summer of 2017, which asserted violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 based on allegedly materially false or misleading statements and omissions in public statements, press releases and SEC filings regarding the Company’s business, prospects, financial results and internal controls.

After Defendants’ initial motion to dismiss was granted without prejudice to replead in October 2017, the Co-Lead Plaintiffs filed a Second Amended Consolidated Class Action Complaint on May 6, 2019 (the “Second Amended Complaint”), which made allegations similar to those in the previous complaint. After several years of motion practice and related court orders, on September 29, 2023, the District Court granted Defendants’ Motion to Dismiss the Second Amended Complaint. Co-Lead Plaintiffs filed a notice of appeal on October 26, 2023, appealing the District Court’s decision dismissing the Second Amended Complaint to the Second Circuit, and the appeal was fully briefed as of June 3, 2024. The Court held oral argument on Plaintiffs’ appeal on December 5, 2024, and the Parties await a decision.

Additional Stockholder Class Action and Derivative Complaints Filed in Federal Court

85

Table of Contents

The former Board of Directors and certain former officers of the Company are defendants in a consolidated action, originally filed in 2017 in the Eastern District of New York, under the caption In re The Hain Celestial Group, Inc. Stockholder Class and Derivative Litigation (the “Consolidated Stockholder Class and Derivative Action”). The plaintiffs allege that the Company’s former directors and certain former officers made materially false and misleading statements in press releases and SEC filings regarding the Company’s business, prospects and financial results and that the Company violated its by-laws and Delaware law by failing to hold its 2016 Annual Stockholders Meeting and claim breach of fiduciary duty, unjust enrichment and corporate waste.

After several years of motion practice and related court orders in the related Consolidated Securities Action, on July 24, 2020, the plaintiffs made a stockholder litigation demand on the Board containing overlapping factual allegations to those set forth in the Consolidated Stockholder Class and Derivative Action. On November 3, 2020, Plaintiffs were informed that the Board had finished investigating and resolved, among other things, that the demand should be rejected. In light of developments in the Consolidated Securities Action referenced above that remanded that case for further proceedings, the parties submitted a joint status report on December 29, 2021 requesting that the District Court continue the temporary stay pending the District Court’s reconsideration of the Defendants’ motion to dismiss the Second Amended Complaint in the Consolidated Securities Action. The parties have agreed to extend the stay during the pendency of the pending appeal in the Consolidated Securities Action, most recently through the earlier of September 29, 2025 or 30 days after the Second Circuit issues a decision on plaintiffs’ appeal.

Baby Food Class Action Litigation

Since February 2021, the Company has been named in numerous consumer class actions alleging that the Company’s Earth’s Best® baby food products (the “Products”) contain unsafe and undisclosed levels of various naturally occurring heavy metals, namely lead, arsenic, cadmium and mercury. Those actions were transferred and consolidated as a single lawsuit in the U.S. District Court for the Eastern District of New York captioned In re Hain Celestial Heavy Metals Baby Food Litigation, Case No. 2:21-cv-678 (the “Consolidated Proceeding”). In the Consolidated Proceeding, the plaintiffs generally allege that the Company violated various state consumer protection laws and assert other state and common law warranty and unjust enrichment claims related to the alleged failure to disclose the presence of these metals, arguing that consumers would have either not purchased the Products or would have paid less for them had the Company made adequate disclosures. The Company filed a motion to dismiss the Consolidated Class Action Complaint. Following oral argument on August 1, 2024, the Court issued an order on December 27, 2024 in which it granted the Company’s motion to dismiss with respect to Plaintiffs’ claims arising out of the alleged presence of lead, cadmium, mercury, or other substances, as well as any claims challenging the use of the “USDA Organic” seal on the Products’ labeling, and denied the Company’s motion to dismiss with respect to Plaintiffs’ claims arising out of the alleged presence of arsenic in the Products. The Company filed its answer to the Consolidated Class Action Complaint on January 23, 2025. One consumer class action is pending in New York Supreme Court, Nassau County, which the court has stayed in deference to the Consolidated Proceeding. The Company denies the allegations in these lawsuits and contends that its baby foods are safe and properly labeled.

The claims raised in these lawsuits were brought in the wake of a highly publicized report issued by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy on Oversight and Reform, dated February 4, 2021 (the “House Report”), addressing the presence of heavy metals in baby foods made by certain manufacturers, including the Company. Since the publication of the House Report, the Company has also received information requests with respect to the advertising and quality of its baby foods from certain governmental authorities, as such authorities investigate the claims made in the House Report. The Company is fully cooperating with these requests and has provided documents and other requested information.

The Company has been named in one civil government enforcement action, State of New Mexico ex rel. Balderas v. Nurture, Inc., et al., which was filed by the New Mexico Attorney General against the Company and several other manufacturers based on the alleged presence of heavy metals in their baby food products. The Company and several other manufacturers moved to dismiss the New Mexico Attorney General’s lawsuit, and the Court denied that motion. The Company filed its answer to the New Mexico Attorney General’s amended complaint on April 23, 2022, and discovery is ongoing. The Company denies the New Mexico Attorney General’s allegations and maintains that its baby foods are safe, properly labeled, and compliant with New Mexico law.

In addition to the consumer class actions discussed above, the Company is currently named in numerous lawsuits in state and federal courts alleging some form of personal injury from the ingestion of the Company’s Products, purportedly due to unsafe and undisclosed levels of various naturally occurring heavy metals. These lawsuits generally allege injuries related to neurological development disorders such as autism and attention deficit hyperactivity disorder.

86

Table of Contents

Baby Food Multidistrict Litigation

On January 4, 2024, plaintiffs in federal cases across the country filed a Motion to Transfer Actions for Coordinated or Consolidated Pretrial Proceedings. On April 11, 2024, the United States Judicial Panel on Multidistrict Litigation granted plaintiffs’ motion and transferred the cases to the Northern District of California for coordinated or consolidated pretrial proceedings. On April 15, 2024, the court issued an order staying all outstanding discovery proceedings and pending motions and vacating all previously scheduled hearing dates. There are approximately 80 federal cases filed against the Company pending in the multi-district litigation (“MDL”). Plaintiffs filed their Master Complaint on July 15, 2024. On December 18, 2024, Defendants filed motions to dismiss the Master Complaint, which the Court granted in part and denied in part. The MDL is first proceeding with general causation discovery. Expert discovery is ongoing and Rule 702 briefing will proceed during the fall of 2025, with opening briefs due on September 26, 2025. The Court will hold a Rule 702 hearing during the week of December 8, 2025.

Baby Food California State Court Cases

There are currently seven personal injury cases against the Company pending in two California state Superior Courts relating to the same allegations regarding trace levels of heavy metals in the Products. These cases are now included in Judicial Council Coordinated Proceedings (“JCCP”). In June 2024, the cases were assigned a trial coordination judge. All but one of the cases have been stayed.

In that case, Landon R. v. The Hain Celestial Group, Inc., et al., No. 23STCV24844, discovery has closed. The Court held hearings on the parties’ Sargon and Summary Judgment Motions on August 11-13, 2025. Trial is currently set for March 16, 2026.

Palmquist v. The Hain Celestial Group

During a jury trial in February 2023 in the baby food-related matter Palmquist v. The Hain Celestial Group, Inc., the court granted the Company’s motion for a directed verdict, finding no liability for the Company. The Court entered Final Judgment in the Company’s favor on March 3, 2023.

Plaintiffs appealed in the Fifth Circuit, and on May 28, 2024, the Fifth Circuit reversed the district court’s order denying Plaintiff’s motion to remand the case and vacated the final judgement of the district court. The Company filed a Petition for En Banc Reconsideration, which the Fifth Circuit denied. On January 7, 2025, the Company filed a Petition for a Writ of Certiorari in the United States Supreme Court. The Supreme Court granted the Petition on April 28, 2025. The Company filed its opening brief on June 26, 2025. Respondents filed their opposition brief on August 11, 2025 and the Company filed its Reply in September 2025. The Court will hear argument on November 4, 2025.

The case has been remanded to Texas state court, where it is now pending in the District Court of Brazoria County, Texas. Discovery is ongoing, but the trial has been continued pending a decision at the United States Supreme Court.

With respect to all of the above-described baby food matters, the Company denies that its Products led to any of the alleged injuries and will defend these cases vigorously. That said, as is common in circumstances of this nature, additional lawsuits may be filed against the Company in the future, asserting similar or different legal theories and seeking similar or different types of damages and relief. Such lawsuits may be resolved in a manner adverse to us, and we may incur substantial costs or damages not covered by insurance, which could have a material adverse effect on our financial condition and business.

Other

In addition to the matters described above, the Company is and may be a defendant in lawsuits from time to time in the normal course of business.

With respect to all litigation and related matters, the Company records a liability when the Company believes it is probable that a liability has been incurred and the amount can be reasonably estimated. As of the end of the period covered by this report, the Company has not recorded a liability for any of the matters disclosed in this note. It is possible that some matters could require the Company to pay damages, incur other costs or establish accruals in amounts that could not be reasonably estimated as of the end of the period covered by this report.

87

Table of Contents

19.
TRANSFORMATION PROGRAM

During the first quarter of fiscal year 2024, the Company initiated a multi-year growth, transformation and restructuring program (the “Restructuring Program”). The Restructuring Program is intended to optimize the Company’s portfolio, improve underlying profitability and increase its flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The savings initiatives are expected to impact the Company’s reportable segments and Corporate and Other.

Implementation of the Restructuring Program is expected to be completed by the end of the 2027 fiscal year and is comprised of contract termination costs, asset write-downs, employee-related costs and other transformation-related expenses.

For the fiscal year ended June 30, 2025, expenses associated with the Restructuring Program in the amount of $21,530, $2,685, and $1,599, respectively, were recorded in productivity and transformation costs, intangibles and long-lived asset impairment, and cost of sales, respectively, on the consolidated statements of operations. For the fiscal year ended June 30, 2024, expenses associated with the Restructuring Program in the amount of $27,741, $24,782 and $7,725 were recorded in productivity and transformation costs, intangibles and long-lived asset impairment, and cost of sales, respectively, on the consolidated statements of operations.

The table below sets forth expenses associated with the Restructuring Program for the fiscal years ended June 30, 2025 and 2024 by reportable segment and Corporate and Other.

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
North America |  | $ | 12,019 |  |  | $ | 32,775 |
Corporate and Other |  |  | 10,026 |  |  |  | 20,753 |
International |  |  | 3,769 |  |  |  | 6,720 |
|  | $ | 25,814 |  |  | $ | 60,248 |

The following table displays the activities and liability balances relating to the Restructuring Program for the fiscal years ended June 30, 2025 and 2024. The Company expects to pay the remaining accrued restructuring costs during the next 12 months.

|  | Balance at June 30, 2024 |  |  | Charges |  |  | Amounts Paid |  |  | Non-cash settlements/ Adjustments 2 |  |  | Balance at June 30, 2025 |
Employee-related costs |  | $ | 1,985 |  |  | $ | 8,297 |  |  | $ | (7,852 | ) |  | $ | — |  |  | $ | 2,430 |
Contract termination costs |  |  | 347 |  |  |  | 1,589 |  |  |  | (1,669 | ) |  |  | (59 | ) |  |  | 208 |
Asset write-downs 1 |  |  | — |  |  |  | 2,685 |  |  |  | — |  |  |  | (2,685 | ) |  |  | — |
Other transformation-related expenses 2 |  |  | 3,988 |  |  |  | 13,243 |  |  |  | (15,651 | ) |  |  | (1,200 | ) |  |  | 380 |
|  | $ | 6,320 |  |  | $ | 25,814 |  |  | $ | (25,172 | ) |  | $ | (3,944 | ) |  | $ | 3,018 |
|  | Balance at June 30, 2023 |  |  | Charges |  |  | Amounts Paid |  |  | Non-cash settlements/ Adjustments 2 |  |  | Balance at June 30, 2024 |
Employee-related costs 3 |  | $ | — |  |  | $ | 7,012 |  |  | $ | (4,992 | ) |  | $ | (35 | ) |  | $ | 1,985 |
Contract termination costs |  |  | — |  |  |  | 5,439 |  |  |  | (4,757 | ) |  |  | (335 | ) |  |  | 347 |
Asset write-downs 1 |  |  | — |  |  |  | 26,922 |  |  |  | — |  |  |  | (26,922 | ) |  |  | — |
Other transformation-related expenses 2 |  |  | — |  |  |  | 20,875 |  |  |  | (16,887 | ) |  |  | — |  |  |  | 3,988 |
|  | $ | — |  |  | $ | 60,248 |  |  | $ | (26,636 | ) |  | $ | (27,292 | ) |  | $ | 6,320 |

1 Represents non-cash asset write-downs including asset impairment and accelerated depreciation.

2 Other transformation-related expenses primarily include consultancy charges related to reorganization of global functions and related personnel resource requirements, and rationalizing sourcing and supply chain processes.

3 Employee-related costs include $1,130 severance related to executive officer succession.

88

Table of Contents

20.
DEFINED CONTRIBUTION PLANS

The Company has a 401(k) Employee Retirement Plan (the “Plan”) to provide retirement benefits for eligible employees. All full-time employees of the Company and its wholly-owned domestic subsidiaries are eligible to participate upon completion of 30 days of service. On an annual basis, the Company m ay, in its sole discretion, make certain matching contributions. For the fiscal years ended June 30, 2025, 2024 and 2023, the Company made contrib utions to the Plan of $2,441, $2,560 and $2,307, respectively, and recorded retirement plan expense in the amount of $2,547, $2,675 and $2,457, respectively. In addition, while certain of the Company’s international subsidiaries maintain separate defined contribution plans for their employees, except for the U.K., the amounts are not significant to the Company’s consolidated financial statements.

Certain U.K. subsidiaries offer an auto-enrollment defined contribution plan to all employees. Employees must be aged 22 or over but under the State Pension age and have earned over £10. Employees outside of these criteria have the option to opt-in. Employees must contribute a minimum percentage to the plan and the U.K. subsidiaries make matching contributions. For the fiscal years ended June 30, 2025, 2024 and 2023, there were contributions and retirement plan expense recorded in the amount of $2,715, $2,421 and $2,096, respectively.

21.
SEGMENT INFORMATION

The Company’s organizational structure consists of two geographic based reportable segments: North America and International, which are also the operating segments. This structure is in line with how the Company’s Chief Operating Decision Maker (“CODM”) asse sses the Company’s performance and allocates resources. The Interim President and Chief Executive Officer is the CODM of the Company. The Company’s measure of segment profitability is Adjusted EBITDA of each reportable segment and also uses net sales in order to analyze segment results, trends and allocate resources. On a monthly basis, the CODM reviews how actual results compare to forecasts and prior periods when making decisions regarding strategic initiatives and capital investments to segments.

Segment Adjusted EBITDA excludes: net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized and certain realized currency losses, certain litigation and related costs, plant closure related costs, net, productivity and transformation costs, warehouse and manufacturing consolidation and other costs, net, costs associated with acquisitions, divestitures and other transactions, (gain) loss on sale of assets, intangibles and long-lived asset impairments and other adjustments. In addition, Segment Adjusted EBITDA does not include Corporate and Other expenses related to the Company’s centralized administrative functions, which do not specifically relate to a reportable segment. Such Corporate and Other expenses are comprised mainly of compensation and related expenses of certain of the Company’s senior executive officers and other employees who perform duties related to the entire enterprise, litigation expense and expenses for certain professional fees, facilities, and other items which benefit the Company as a whole.

89

Table of Contents

The following tables set forth financial information about eac h of the Company’s reportable segment’s revenue, significant segment expenses and measure of segment profit or loss for the fiscal years ended June 30, 2025, 2024 and 2023. Information about total assets by segment is not disclosed because such information is not reported to or used by the Company’s CODM for purposes of assessing segment performance or allocating resources. Transactions between reportable segments were insignificant for all periods presented.

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Net Sales: |  |  |  |  |  |  |  |  |
North America |  | $ | 888,626 |  |  | $ | 1,055,527 |  |  | $ | 1,139,162 |
International |  |  | 671,154 |  |  |  | 680,759 |  |  |  | 657,481 |
|  |  | 1,559,780 |  |  |  | 1,736,286 |  |  |  | 1,796,643 |
Cost of sales, adjusted to exclude restructuring activities: |  |  |  |  |  |  |  |  |
North America |  |  | (693,951 | ) |  |  | (816,680 | ) |  |  | (875,608 | )
International |  |  | (530,006 | ) |  |  | (529,812 | ) |  |  | (523,512 | )
|  |  | (1,223,957 | ) |  |  | (1,346,492 | ) |  |  | (1,399,120 | )
Marketing expense: |  |  |  |  |  |  |  |  |
North America |  |  | (41,462 | ) |  |  | (45,294 | ) |  |  | (45,830 | )
International |  |  | (18,760 | ) |  |  | (18,355 | ) |  |  | (17,833 | )
|  |  | (60,222 | ) |  |  | (63,649 | ) |  |  | (63,663 | )
Other selling, general and administrative expenses, adjusted to exclude restructuring activities and depreciation and amortization: |  |  |  |  |  |  |  |  |
North America |  |  | (102,867 | ) |  |  | (112,728 | ) |  |  | (117,277 | )
International |  |  | (64,323 | ) |  |  | (64,514 | ) |  |  | (62,708 | )
|  |  | (167,190 | ) |  |  | (177,242 | ) |  |  | (179,985 | )
Depreciation and amortization and other adjustments: |  |  |  |  |  |  |  |  |
North America |  |  | 15,124 |  |  |  | 17,903 |  |  |  | 22,996 |
International |  |  | 27,935 |  |  |  | 26,896 |  |  |  | 29,517 |
|  |  | 43,059 |  |  |  | 44,799 |  |  |  | 52,513 |
Segment Adjusted EBITDA: |  |  |  |  |  |  |  |  |
North America |  |  | 65,470 |  |  |  | 98,728 |  |  |  | 123,443 |
International |  |  | 86,000 |  |  |  | 94,974 |  |  |  | 82,945 |
Total Reportable Segments Adjusted EBITDA |  |  | 151,470 |  |  |  | 193,702 |  |  |  | 206,388 |
Corporate and Other |  |  | (37,681 | ) |  |  | (39,180 | ) |  |  | (39,766 | )
|  |  | 113,789 |  |  |  | 154,522 |  |  |  | 166,622 |
Depreciation and amortization |  |  | (44,259 | ) |  |  | (44,665 | ) |  |  | (50,777 | )
Equity in net loss of equity-method investees |  |  | (1,813 | ) |  |  | (2,581 | ) |  |  | (1,134 | )
Interest expense, net |  |  | (47,773 | ) |  |  | (54,232 | ) |  |  | (43,936 | )
(Provision) benefit for income taxes |  |  | (15,297 | ) |  |  | 7,820 |  |  |  | 14,178 |
Stock-based compensation, net |  |  | (8,149 | ) |  |  | (12,704 | ) |  |  | (14,423 | )
Unrealized and certain realized currency losses |  |  | (3,823 | ) |  |  | (17 | ) |  |  | (929 | )
Certain litigation expenses, net(a) |  |  | (3,473 | ) |  |  | (7,262 | ) |  |  | 1,369 |
Restructuring activities |  |  |  |  |  |  |  |  |
Productivity and transformation costs |  |  | (21,530 | ) |  |  | (27,741 | ) |  |  | (7,284 | )
Plant closure related costs, net |  |  | (1,215 | ) |  |  | (5,251 | ) |  |  | (94 | )
Warehouse/manufacturing consolidation and other costs, net |  |  | (384 | ) |  |  | (995 | ) |  |  | (1,026 | )
CEO succession |  |  | (4,774 | ) |  |  | — |  |  |  | (5,113 | )
Acquisitions, divestitures and other |  |  |  |  |  |  |  |  |
Gain (loss) on sale of assets |  |  | 3,194 |  |  |  | (4,384 | ) |  |  | 3,529 |
Transaction and integration costs, net |  |  | 488 |  |  |  | 34 |  |  |  | (2,018 | )
Impairment charges |  |  |  |  |  |  |  |  |
Goodwill impairment |  |  | (428,882 | ) |  |  | — |  |  |  | — |
Intangibles and long-lived asset impairment |  |  | (66,940 | ) |  |  | (76,143 | ) |  |  | (175,501 | )
Other |  |  | — |  |  |  | (1,443 | ) |  |  | — |
Net loss |  | $ | (530,841 | ) |  | $ | (75,042 | ) |  | $ | (116,537 | )

(a) Expenses and items relating to securities class action, baby food litigation and SEC investigation.

90

Table of Contents

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Snacks |  | $ | 371,012 |  |  | $ | 463,261 |  |  | $ | 486,411 |
Baby & Kids |  |  | 241,553 |  |  |  | 252,481 |  |  |  | 284,834 |
Beverages |  |  | 245,147 |  |  |  | 253,008 |  |  |  | 239,199 |
Meal Preparation |  |  | 639,506 |  |  |  | 662,116 |  |  |  | 653,114 |
Personal Care |  |  | 62,562 |  |  |  | 105,420 |  |  |  | 133,085 |
|  | $ | 1,559,780 |  |  | $ | 1,736,286 |  |  | $ | 1,796,643 |

The Company’s net sales by geographic region, which are generally based on the location of the Company’s subsidiary, are as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
United States |  | $ | 777,605 |  |  | $ | 940,367 |  |  | $ | 1,025,988 |
United Kingdom |  |  | 492,046 |  |  |  | 497,150 |  |  |  | 477,400 |
Western Europe |  |  | 179,108 |  |  |  | 183,609 |  |  |  | 180,080 |
Canada |  |  | 111,021 |  |  |  | 115,160 |  |  |  | 113,175 |
|  | $ | 1,559,780 |  |  | $ | 1,736,286 |  |  | $ | 1,796,643 |

The Company’s long-lived assets, which primarily represent property, plant and equipment, net and operating lease right-of-use assets, net by geographic region are as follows:

|  | Fiscal Year Ended June 30, |
|  | 2025 |  |  | 2024 |
United States |  | $ | 129,558 |  |  | $ | 137,398 |
United Kingdom |  |  | 129,799 |  |  |  | 125,945 |
Western Europe |  |  | 65,491 |  |  |  | 66,785 |
Canada |  |  | 11,053 |  |  |  | 18,236 |
|  | $ | 335,901 |  |  | $ | 348,364 |

91

Table of Contents

Item 9. Changes in and D isagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. C ontrols and Procedures

Evaluation of Disclosure Controls and Procedures

Our Interim Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), with the assistance of other members of management, have performed an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2025. Based on this evaluation, our CEO and CFO have concluded that as of June 30, 2025, the Company’s disclosure controls and procedures were not effective due to the material weakness described below under “Management’s Report on Internal Control Over Financial Reporting.”

Notwithstanding the material weakness, and based on the additional analyses and other procedures to ensure that our consolidated financial statements were prepared in accordance with U.S. GAAP, our management believes that the consolidated financial statements included in this Annual Report on Form 10-K fairly present, in all material respects, our financial condition, results of operations and cash flows as of the dates, and for the periods presented, in conformity with U.S. GAAP.

Management’s Report on Internal Control over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

The Company’s internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of the Company’s management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets of the Company that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision, and with the participation, of management, including the CEO and CFO, we conducted an evaluation of the effectiveness of internal control over financial reporting as of June 30, 2025. In making this assessment, management used the criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this assessment, management, including the Company’s CEO and CFO, has concluded that our internal control over financial reporting was not effective as of June 30, 2025, due to the below described material weakness. Additionally, the material weakness was not a contributing factor to the impairments in the carrying value of goodwill and indefinite-lived intangible assets recorded during the fourth quarter of fiscal year 2025.

A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement in our annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, the Company did not design and operate effective controls as of June 30, 2025 to review on a timely basis and in sufficient detail the projected financial information and certain key assumptions and underlying calculations used in goodwill and indefinite-lived intangible asset quantitative impairment tests that were performed throughout the year.

These control deficiencies did not result in a material misstatement of the impairment losses in the interim or annual consolidated financial statements and there were no changes to previously issued financial statements. Notwithstanding the material weakness, we have concluded that the financial statements and other financial information included in this Annual Report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity with U.S. GAAP. The Company is in process of remediating this material weakness.

In response to the material weakness identified, with the oversight of the Audit Committee of our Board of Directors, we are conducting a detailed review and performing remediation activities to design and implement management review controls to ensure that control objectives are met. While we believe that our efforts to date have improved our internal control over financial reporting, the full impact of these changes had not been realized by June 30, 2025, and certain remediation activities are continuing

92

Table of Contents

to take place. The material weakness in our internal control over financial reporting will not be considered remediated until the remediated controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

The effectiveness of the Company’s internal control over financial reporting as of June 30, 2025 has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report which appears herein.

Changes in Internal Control over Financial Reporting

Other than the changes described above, there were no changes in internal controls over financial reporting that occurred during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

93

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of The Hain Celestial Group, Inc.

Opinion on Internal Control Over Financial Reporting

We have audited The Hain Celestial Group, Inc. and subsidiaries’ internal control over financial reporting as of June 30, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, because of the effect of the material weakness described below on the achievement of the objectives of the control criteria, The Hain Celestial Group, Inc. and subsidiaries (the Company) has not maintained effective internal control over financial reporting as of June 30, 2025, based on the COSO criteria.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment. Management has identified a material weakness in the design and operation of its controls over determining the fair value of goodwill and indefinite lived intangible assets used in its quantitative impairment tests.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of June 30, 2025 and 2024, the related consolidated statements of operations, comprehensive loss, stockholders’ equity and cash flows for each of the three years in the period ended June 30, 2025, and the related notes and financial statement schedule listed in the Index at Item 15(a). This material weakness was considered in determining the nature, timing and extent of audit tests applied in our audit of the 2025 consolidated financial statements, and this report does not affect our report dated September 15, 2025, which expressed an unqualified opinion thereon.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

94

Table of Contents

/s/ Ernst & Young LLP
Jericho, New York
September 15, 2025

95

Table of Contents

Item 9B. Oth er Information

Fourth Amendment to Fourth Amended and Restated Credit Agreement

On September 11, 2025, the Company entered into the Fourth Amendment (the “Fourth Amendment”) to its Fourth Amended and Restated Credit Agreement, dated December 22, 2021 (the “Credit Agreement”), by and among the Company, the lenders party thereto and Bank of America, N.A., as administrative agent.

Pursuant to the Fourth Amendment, the Company and the lenders agreed to, among other things, amend certain provisions relating to interest rate, revolving commitment availability, mandatory prepayment, reporting and the affirmative and negative covenants under the Credit Agreement. The amendments to financial covenants under the Fourth Amendment include (x) an increase in the Company’s maximum consolidated secured leverage ratio level to 5.00:1.00 for the quarter ended June 30, 2025 and to 5.50:1.00 for the quarter ending September 30, 2025 and thereafter, (y) a decrease in the Company’s minimum consolidated interest coverage ratio level to 2.00:1.00 for the quarter ending September 30, 2025 and thereafter and (z) the addition of a covenant to maintain a minimum Consolidated EBITDA (as such term is defined in the Credit Agreement as amended by the Fourth Amendment) of (i) $17,000,000 for the fiscal quarter ending September 30, 2025 and (ii) $52,000,000 for the cumulative two fiscal quarters ending September 30, 2025 and on December 31, 2025.

Following the Fourth Amendment, loans under the Credit Agreement will bear interest at (a) the Secured Overnight Financing Rate plus a credit spread adjustment of 0.10% plus 4.0% per annum or (b) the Base Rate (as defined in the Credit Agreement) plus 3.0% per annum.

The Fourth Amendment also reduced the size of the revolving credit facility under the Credit Agreement from $700 million to $600 million in the aggregate, with the U.S. revolving credit facility reduced from $385 million to $330 million and the global revolving credit facility reduced from $315 million to $270 million.

Departure of Global Chief Supply Chain Officer

On September 12, 2025, the Company eliminated the position of Global Chief Supply Chain Officer as part of a restructuring of the Company’s operating model. Accordingly, Steven R. Golliher, the Company’s current Global Chief Supply Chain Officer, will leave the Company effective November 3, 2025.

Mr. Golliher is entitled to severance due to the termination of his employment by the Company without cause, as described in the Proxy Statement for the Company’s 2024 Annual Meeting of Stockholders filed with the SEC on September 19, 2024, subject to his execution of a separation agreement and release of claims.

Rule 10b5-1 Trading Arrangements and Non-Rule 10b5-1 Trading Arrangements

During the three months ended June 30, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended), adopted, terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).

Item 9C. Disclosure Rega rding Foreign Jurisdictions that Prevent Inspections

Not applicable.

96

Table of Contents

PAR T III

Item 10. Directors, Exec utive Officers and Corporate Governance

The information required by this item is incorporated by reference to the Company’s Proxy Statement for the 2025 Annual Meeting of Stockholders of the Company to be filed with the SEC within 120 days of the fiscal year ended June 30, 2025 (the “2025 Proxy Statement”).

Item 11. Exe cutive Compensation

The information required by this item is incorporated by reference to the 2025 Proxy Statement.

Item 12. Security Own ership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item is incorporated by reference to the 2025 Proxy Statement.

Item 13. Certain Relatio nships and Related Transactions, and Director Independence

The information required by this item is incorporated by reference to the 2025 Proxy Statement.

Item 14. Principal Acc ountant Fees and Services

The information required by this item is incorporated by reference to the 2025 Proxy Statement.

97

Table of Contents

PAR T IV

Item 15. Exhibit and F inancial Statement Schedules

(a)(1) Financial Statements. The following consolidated financial statements of The Hain Celestial Group, Inc. are filed as part of this report under Part II, Item 8 - Financial Statements and Supplementary Data:

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets - June 30, 2025 and 2024

Consolidated Statements of Operations - Fiscal Years ended June 30, 2025, 2024 and 2023

Consolidated Statements of Comprehensive Loss - Fiscal Years ended June 30, 2025, 2024 and 2023

Consolidated Statements of Stockholders’ Equity - Fiscal Years ended June 30, 2025, 2024 and 2023

Consolidated Statements of Cash Flows - Fiscal Years ended June 30, 2025, 2024 and 2023

Notes to Consolidated Financial Statements

(a)(2) Financial Statement Schedules. The following financial statement schedule should be read in conjunction with the consolidated financial statements included in Part II, Item 8, of this Annual Report on Form 10-K. All other financial schedules are not required under the related instructions or are not applicable and therefore have been omitted.

98

Table of Contents

The Hain Celestial Group, Inc. and Subsidiaries

Schedule II - Valuation and Qualifying Accounts

Column A |  | Column B |  |  | Column C |  |  | Column D |  |  | Column E |
|  |  |  |  | Additions |  |  |  |  |  |  |
|  | Balance at beginning of period |  |  | Charged to costs and expenses (ii) |  |  | Deductions - describe (i) |  |  | Balance at end of period |
Fiscal Year Ended June 30, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts |  | $ | 1,517 |  |  | $ | 78 |  |  | $ | (258 | ) |  | $ | 1,337 |
Valuation allowance for deferred tax assets |  | $ | 67,626 |  |  | $ | 30,706 |  |  | $ | (1,949 | ) |  | $ | 96,383 |
Fiscal Year Ended June 30, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts |  | $ | 2,750 |  |  | $ | 1,066 |  |  | $ | (2,299 | ) |  | $ | 1,517 |
Valuation allowance for deferred tax assets |  | $ | 52,551 |  |  | $ | 18,998 |  |  | $ | (3,923 | ) |  | $ | 67,626 |
Fiscal Year Ended June 30, 2023 |  |  |  |  |  |  |  |  |  |  |  |
Allowance for doubtful accounts |  | $ | 1,731 |  |  | $ | 1,450 |  |  | $ | (431 | ) |  | $ | 2,750 |
Valuation allowance for deferred tax assets |  | $ | 36,891 |  |  | $ | 23,212 |  |  | $ | (7,552 | ) |  | $ | 52,551 |

(i)
Amounts written off and changes in exchange rates.
(ii)
Includes item related to THWR purchase accounting (2025: nil; 2024: nil; 2023: $291)

(a)(3) Exhibits. The exhibits filed as part of this Annual Report on Form 10-K are listed on the Exhibit Index immediately following Item 16. “Form 10-K Summary,” which is incorporated herein by reference.

99

Table of Contents

Item 16. For m 10-K Summary

None.

100

Table of Contents

EXHIBI T INDEX

Exhibit Number |  | Description
3.1 |  | Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on August 26, 2021).
3.2 |  | The Hain Celestial Group, Inc. Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
4.1 |  | Specimen of common stock certificate (incorporated by reference to Exhibit 4.1 of Amendment No. 1 to the Company’s Registration Statement on Form S-4 filed with the SEC on April 24, 2000).
4.2 |  | Description of Registrant’s Securities (incorporated by reference to Exhibit 4.2 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, filed with the SEC on August 29, 2019).
10.1.1 |  | Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2021).
10.1.2 |  | First Amendment, dated December 16, 2022, to the Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2022).
10.1.3 |  | Second Amendment, dated August 22, 2023, to the Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, filed with the SEC on November 7, 2023).
10.1.4 |  | Third Amendment, dated May 5, 2025, to the Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent.
10.1.5 |  | Fourth Amendment, dated September 11, 2025, to the Fourth Amended and Restated Credit Agreement, dated December 22, 2021, by and among the Company, the Lenders party thereto and Bank of America, N.A., as administrative agent.
10.1.6 |  | Amended and Restated Security and Pledge Agreement, dated December 22, 2021, by and among the Company, certain wholly-owned subsidiaries of the Company party thereto from time to time, and Bank of America, N.A., as administrative agent (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed with the SEC on December 28, 2021).
10.2.1* |  | The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.1 of the Company’s Registration Statement on Form S-8 (Commission File No. 333-268439) filed with the Securities and Exchange Commission on November 17, 2022).
10.2.2* |  | First Amendment to The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 5, 2024).
10.2.3* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Non-Employee Director Awards (incorporated by reference to Exhibit 10.6 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
10.2.4* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2025-2027 LTIP (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
10.2.5* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2025-2027 LTIP (Relative Total Shareholder Return) (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
10.2.6* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2025-2027 LTIP (Adjusted EBITDA Margin) (incorporated by reference to Exhibit 10.4 of the

101

Table of Contents

|  | Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
10.2.7* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2025-2027 LTIP (Unlevered Free Cash Flow) (incorporated by reference to Exhibit 10.5 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024, filed with the SEC on February 10, 2025).
10.2.8* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2024-2026 LTIP (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023, filed with the SEC on February 7, 2024).
10.2.9* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2024-2026 LTIP (Relative Total Shareholder Return) (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023, filed with the SEC on February 7, 2024).
10.2.10* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – 2024-2026 LTIP (Absolute Total Shareholder Return) (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023, filed with the SEC on February 7, 2024).
10.2.11* |  | Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (2023-2025 LTIP) (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 9, 2023).
10.2.12* |  | Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (2023-2025 LTIP; Relative Total Shareholder Return) (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 9, 2023).
10.2.13* |  | Performance Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (2023-2025 LTIP; Absolute Total Shareholder Return) (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 9, 2023).
10.2.14* |  | Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Wendy P. Davidson (Make-Whole RSU Award) (incorporated by reference to Exhibit 10.4 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023, filed with the SEC on May 9, 2023).
10.2.15* |  | Restricted Share Unit Agreement under The Hain Celestial Group, Inc. 2022 Long Term Incentive and Stock Award Plan – Alison E. Lewis.
10.3.1* |  | The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan (incorporated by reference to Exhibit 10.2.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, filed with the SEC on August 29, 2019).
10.3.2* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – Non-Employee Director Awards (incorporated by reference to Exhibit 10.4 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 3, 2022).
10.3.3* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2022-2024 LTIP (incorporated by reference to Exhibit 10.5 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 3, 2022).
10.3.4* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2022-2024 LTIP (Relative Total Shareholder Return) (incorporated by reference to Exhibit 10.7 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 3, 2022).
10.3.5* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2022-2024 LTIP (Absolute Total Shareholder Return) (incorporated by reference to Exhibit 10.6 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 3, 2022).

102

Table of Contents

10.3.6* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – Special Recognition Awards (incorporated by reference to Exhibit 10.8 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2021, filed with the SEC on February 3, 2022).
10.3.7* |  | Form of Restricted Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2023-2025 LTIP (incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022, filed with the SEC on November 8, 2022).
10.3.8* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2023-2025 LTIP (Relative Total Shareholder Return) (incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022, filed with the SEC on November 8, 2022).
10.3.9* |  | Form of Performance Share Unit Agreement under The Hain Celestial Group, Inc. Amended and Restated 2002 Long Term Incentive and Stock Award Plan – 2023-2025 LTIP (Absolute Total Shareholder Return) (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022, filed with the SEC on November 8, 2022).
10.4* |  | The Hain Celestial Group, Inc. Amended and Restated Executive Incentive Plan (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 1, 2019).
10.5* |  | Offer Letter, dated May 8, 2025, between the Company and Alison E. Lewis.
10.6.1* |  | Employment Agreement, dated as of November 22, 2022, between the Company and Wendy Davidson (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 28, 2022).
10.6.2* |  | Separation Agreement, dated May 21, 2025, between the Company and Wendy Davidson.
10.7* |  | Offer Letter, dated August 23, 2023, between the Company and Lee A. Boyce (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023, filed with the SEC on November 7, 2023).
10.8* |  | Offer Letter, dated March 15, 2024, between the Company and Chad Marquardt.
10.9* |  | Separation Agreement, dated August 1, 2025, between the Company and Chad Marquardt.
10.10* |  | Form of Change in Control Agreement (incorporated by reference to Exhibit 10.12 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2019, filed with the SEC on August 29, 2019).
10.11* |  | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020, filed with the SEC on May 7, 2020).
10.12* |  | Form of Confidentiality, Non-Interference, and Invention Assignment Agreement (incorporated by reference to Exhibit 10.8 of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019, filed with the SEC on May 9, 2019).
19.1 |  | The Hain Celestial Group, Inc. Insider Trading Policy.
21.1 |  | Subsidiaries of the Company.
23.1 |  | Consent of Independent Registered Public Accounting Firm - Ernst & Young LLP.
31.1 |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
31.2 |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
32.1 |  | Certification by CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification by CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

103

Table of Contents

97.1 |  | The Hain Celestial Group, Inc. Incentive Compensation Clawback Policy (incorporated by reference to Exhibit 97.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC on August 27, 2024).
101 |  | The following materials from the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025, formatted in inline XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Loss, (iv) the Consolidated Statements of Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows, (vi) Notes to Consolidated Financial Statements, and (vii) Financial Statement Schedule.
104 |  | Cover Page Interactive Data File (formatted in inline XBRL and contained in Exhibit 101).
* |  | Indicates management contract or compensatory plan or arrangement.

The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.

104

Table of Contents

SIGNA TURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|  | THE HAIN CELESTIAL GROUP, INC.
Date: | September 15, 2025 | /s/ Lee A. Boyce
|  | Lee A. Boyce Chief Financial Officer (Principal Financial Officer)

105

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature |  | Title |  | Date
/s/ Alison E. Lewis |  | Interim President, Chief Executive Officer and Director (Principal Executive Officer) |  | September 15, 2025
Alison E. Lewis |  |  |  |
/s/ Lee A. Boyce |  | Chief Financial Officer (Principal Financial Officer) |  | September 15, 2025
Lee A. Boyce |  |  |  |
/s/ Michael J. Ragusa |  | Senior Vice President and Chief Accounting Officer (Principal Accounting Officer) |  | September 15, 2025
Michael J. Ragusa |  |  |  |
/s/ Dawn Zier |  | Chair of the Board |  | September 15, 2025
Dawn Zier |  |  |  |
/s/ Neil Campbell |  | Director |  | September 15, 2025
Neil Campbell |  |  |  |
/s/ Celeste A. Clark |  | Director |  | September 15, 2025
Celeste A. Clark |  |  |  |
/s/ Shervin J. Korangy |  | Director |  | September 15, 2025
Shervin J. Korangy |  |  |  |
/s/ Michael B. Sims |  | Director |  | September 15, 2025
Michael B. Sims |  |  |  |
/s/ Carlyn R. Taylor |  | Director |  | September 15, 2025
Carlyn R. Taylor |  |  |  |

106